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ABSTRACT 
Introduction and aims: 
Helicobacter pylori establishes a chronic infection in the stomach of almost half 
the world's population. A small proportion of patients go on to develop peptic 
ulcer disease and in some cases gastric cancer. Numerous factors influence the 
outcome of infection, including host, bacterial and environmental factors. The 
impact of bacterial colonisation density on the outcome of disease is poorly 
understood. The aim of this study was to investigate the determinants of bacterial 
density and the implications in disease. 
Methods: 
Gastric biopsies were collected from 50 H. pylori infected patients attending the 
Queen's Medical Centre, Nottingham for a routine upper GI endoscopy. Patient 
disease status was determined as having gastritis, duodenal ulcer disease (DUD), 
or gastric ulcer disease (GUD). Histological analysis for inflammation, activity, 
H. pylori density, atrophy and intestinal metaplasia were assessed according to the 
Sydney scoring system. Bacterial strains were cultured from gastric biopsies. 
Isolated bacterial DNA was used for genotyping strain virulence for CagA, VacA 
and DupA status. In order to determine accurate levels of colonisation in gastric 
tissue samples, a quantitative real-time PCR (qPCR) assay was developed based 
on the quantification of H. pylori 16S rRNA copy number, relative to the number 
of human GAPDH copy numbers. Quantification of IL8, ILIO, TGFß, FOXP3, 
h, 8Dl and LL37 mRNA levels in gastric tissue were assessed by real-time RT- 
PCR. The impact of host factors on bacterial density was assessed in vitro using 
H. pylori infected or uninfected AGS gastric epithelial cells, treated with 
recombinant cytokine. Colony forming units (CFUs) were enumerated in culture 
suspensions. The in vitro model was also used to examine the impact of cagA, 
cage, and vacA isogenic deletion mutant strains on bacterial density. Also, h, 8D1 
expression levels were measured in culture suspensions, and IL-8 secretion levels 
in were assessed by ELISA. 
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Results and conclusions: 
The pattern of colonisation in the gastric mucosa was found to be associated with 
the disease profile that develops, with an antral-predominant colonisation was 
associated with DUD, whereas corpus-predominant colonisation was associated 
with GUD. Bacterial factors that may drive the pattern of bacterial density in the 
stomach were then investigated, and strains expressing the dupA virulence factor 
were coincident with antral-predominant colonisation in the gastric mucosa. cagA 
and vacA were not found to be associated with bacterial density in vivo or in vitro. 
To assess the relationship between colonisation density and the host response, 
firstly IL8 mRNA expression levels were measured in gastric biopsies. An inverse 
relationship between bacterial load and expression of this pro-inflammatory 
cytokine was observed, but only at high IL8 expression levels and with higher H. 
pylori density. The inflammatory cytokines IL-10, TNFa, IL-17 and IL-22 did not 
impact CFU counts in vitro. No association was observed between bacterial load 
and expression levels of the immunosuppressive genes ILIO, TGFBI and FOXP3. 
However, increased CFU counts were found on treatment of H. pylori infected 
AGS cells with recombinant IL-10 and TGFß in vitro. Also, reduced expression of 
these immunosuppressive genes was associated with the presence of atrophy and 
intestinal metaplasia. In addition, ILIO and FOXP3 expression levels were 
negatively associated with mononuclear cell (MNC) infiltration. 
Reduced expression levels of the antimicrobial peptide (AMP) defensiv h, BDl 
were found with H. pylori infection in vivo and in vitro, and a negative association 
between hßDl expression and bacterial load was observed in vivo. A small 
increase in hßDl expression was observed in AGS cells infected with the cagPAI 
defective mutant strain in comparison to the wild type strain, suggesting a 
possible role for the CagPAI in modulating hßDl expression. In contrast, 
expression levels of the antimicrobial peptide LL37 were upregulated in the H. 
Mori infected gastric mucosa. 
In conclusion, the localisation of H. pylori in the gastric mucosa is associated with 
the disease profile that develops in the stomach. The patterns of colonisation 
observed may be influenced by the dupA virulence determinant. Host immune 
responses, were not associated with colonisation density. However, increased 
Treg responses may be associated with protecting the host from the deleterious 
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effects of inflammation. The direct modulation of bacterial load may be regulated 
by AMPs. In the H. pylori infected mucosa, reduced hßDl expression was 
observed, which may assist persistent colonisation. 
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Chapter 1 
1. INTRODUCTION 
Helicobacter pylori (H. pylori) is a Gram-negative, motile bacterium that 
persistently colonises the human stomach. All infections are associated with the 
development of gastritis (Blaser & Parsonnet, 1994; Marshall & Warren, 1984). 
Although most infections remain asymptomatic, a small proportion of the infected 
population develop gastric and duodenal ulcer disease (Honda et al., 1998; 
Kuipers et al., 1995a), and persistence of infection has been linked with gastric 
cancer (Huang et al., 1998; Uemura et al., 2001). 
The aim of this study was to determine the implications of bacterial density in 
disease, and to determine factors that influence bacterial load in the human host. 
This introduction gives a general background to H. pylori infection and the host 
immune system. 
The presence of a curved bacillus in the human stomach has been documented for 
over a century. As early as 1875, spiral bacteria were found colonising the mucus 
lining of the human stomach, and later spiral bacteria were discovered in the 
stomach of dogs (Bizzozero, 1893), but the bacteria could not be cultured 
(Krienitz, 1906; Luger, 1917). It was not until 1983 that Robin Warren and Barry 
Marshall successfully isolated and cultured the organism from human stomachs, 
and suggested a causal association between this bacterium and peptic ulcer 
disease, which had originally been linked to environmental factors such as stress 
and spicy food (Marshall & Warren, 1984). In one of their most significant 
experiments, Barry Marshall fulfilled Koch's postulates by infecting himself with 
H. pylori and subsequently developed gastritis, and then went on to show the 
successful treatment of gastritis with antibiotics, work for which they were 
awarded the Nobel Prize in 2005. 
The bacterium was initially named Campylobacter pyloridis, later corrected to 
Campylobacter pylori, and in 1989 DNA sequencing, as well as other data, 
showed that the bacterium did not belong in the Campylobacter genus and was 
placed in its own, named Helicobacter (Goodwin et al., 1989). There are now 
over 30 species recognised within this genus that infect the gastrointestinal tract of 
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different animals including cats, dogs (Hanninen et al., 1996; Paster et al., 1991), 
rodents (Fox et al., 1995) and other mammals (Fox, 2002). 
1.1 H. PYLORI EPIDEMIOLOGY AND 
TRANSMISSION 
It is estimated that almost half the world's population are infected with H. pylori 
(Torres et at, 2000). Infection rates differ between developing and western 
countries, where rates of infection have been declining for years (Group, 1993; 
Torres et al., 2000). Estimated prevalence in developed countries such as western 
Europe and the US varies between 30-50%, whereas prevalence can range 
between 50-90% in developing countries such as in Africa and Asia (Perez-Perez 
et at, 2004). The high prevalence rate recorded in developing countries is largely 
thought to be due to low socio-economic status, crowded living conditions, bed 
sharing between several siblings, and unclean water sources that are common to 
these geographical regions (Dominici et al., 1999; Ertem et at, 2003; Lindkvist et 
al., 1998; Webb et al., 1994). The incidence of H. pylori infection appears to be 
declining worldwide, however this is more rapid in developed countries, which is 
thought to be caused by improved sanitation reducing the chances of childhood 
infection (Cullen et at, 1993; Parsonnet et al., 1992; Sipponen et al., 1996). 
Another marked difference between H. pylori infection in western and developing 
countries is the age at which infection is acquired. Individuals are often infected at 
much younger ages in developing countries compared to western countries. 
Previous studies have reported H. pylori infection rates of 23% in children 
younger than 3 in Vietnam (Rowland et al., 1999), 33% in Egypt (Okuda et at, 
2007), and 40% in children younger than 6 in Brazil (Frenck et at, 2006). In 
Bangladesh, prevalence was reported to reach as high as 80% in children younger 
than 5 (Nguyen et al., 2006). Comparative studies in Western countries show 
much lower incidence of infection, with rates of 13.6% reported in Sweden 
(Rothenbacher & Brenner, 2003), 6% in Finland (Rehnberg-Laiho et al., 1998), 
and 2.4% in Germany (Rowland et al., 2006) for children younger than 3. 
The acquisition of H. pylori usually occurs during childhood and persists for life 
unless treated with antibiotics. Reinfection of children older than 5 years is rare 
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regardless of socio-economic status, and infections occurring in adults for the first 
time are similarly rare (Malaty, 2007; Rothenbacher & Brenner, 2003). 
Epidemiological studies have reported several possible modes of transmission; 
however, the exact mechanisms are not yet fully understood. It is widely thought 
that person-person contact is the most likely mode of transmission. Many studies 
have reported the role of familial clustering as key to H. pylori transmission, with 
mother-to-child transmission regarded as a more predominant route of infection 
(Farrell et al., 2005; Kivi et al., 2005; Tindberg et al., 2001). Furthermore, the 
rarity of reinfection in children older than 5, after which they spend less time at 
home, also highlights the importance of close family contact in the transmission 
of H. pylori (Malaty, 2007). However, a difference in strains between family 
members is common in developing countries, and suggests other modes of 
transmission in such areas (Schwarz et a!., 2008). An oral-oral route, probably 
through oesophageal reflux into the mouth or from vomit (Allaker et al., 2002; 
Kabir, 2004) is supported by the detection of H. pylori DNA in vomitus, saliva, 
and dental plaque (Brown, 2000). Waterbourne transmission, possibly through 
faecal contamination, is another potential source of transmission. Infection rates in 
children were found to be much higher in households using municipal water 
supplies (Klein et al., 1991), whereas families using containers that separated their 
drinking water were less likely to be infected (Glynn et al., 2002). 
1.2 H. PYLORI RELATED CLINICAL 
MANIFESTATIONS 
H. pylori colonisation of the gastric mucosa induces gastritis in all infected 
individuals, but only a minority of infections develop clinical signs. It is estimated 
that infected patients have a 10-20% risk of developing peptic ulcer disease and 1- 
2% risk of developing gastric cancer, (Ernst & Gold, 2000; Kuipers, 1999). The 
risk of developing disease is dependent on a variety of host, bacterial and 
environmental factors (Kuipers, 1999). 
In some circumstances, clearance of the infection can occur, although this is rare 
with seroreversion rates ranging between 5-10%. It is not known if this clearance 
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is spontaneous, or as a result of antibiotic use for treatment of other conditions 
(Everhart, 2000). 
Once colonisation is established in the gastric mucosa, H. pylori persistently 
colonises resulting in chronic inflammation of the gastric mucosa, which can 
progress to atrophic gastritis and occasionally gastric carcinoma. A close 
correlation exists between the level of acid secretion and the pattern of gastritis 
that develops, and differences in the distribution of gastritis are crucial in 
determining H. pylori related disease outcome (discussed further in section 1.2.1). 
1.2.1 Peptic ulcer disease (PUD) 
Peptic ulcer disease is a major health concern to the world population, with high 
rates of morbidity and substantial mortality (Sonnenberg, 2006). The disease 
encompasses both gastric and duodenal ulcers, and symptoms include epigastric 
pain, often accompanied by other dyspeptic symptoms including nausea, 
heartburn, and bloating. The most common and severe complication of the disease 
is bleeding, occurring in 50-170 per 100,000 cases, with the highest risk to those 
older than 60 years of age (Longstreth, 1995; Rockall et al., 1995). 
Epidemiological studies have revealed a strong association between peptic ulcer 
disease (PUD) and H. pylori infection. Colonisation of the gastric mucosa with 
this bacterium is reportedly the cause of approximately 95% of duodenal ulcers 
and 85% of gastric ulcers worldwide (Kuipers et al., 1995a). However, recent 
reports have revealed a lower incidence of 81% for H. pylori associated duodenal 
ulceration, suggesting other factors are driving the development of the disease 
(Gisbert & Calvet, 2009). This causal relationship is strengthened by studies 
which demonstrated that eradication of the bacterium greatly reduced the risk of 
recurrent ulceration (Rauws & Tytgat, 1990). 
The underlying mechanism by which H. pylori contributes to peptic ulcer disease 
is thought to involve a combination of host genetic predisposition, bacterial 
virulence factors, and damage of the mucosa (Cohen, 2000). 
1.2.1.1 Duodenal ulcer disease (DUD) 
Acid production and the distribution of inflammation in the gastric mucosa are 
key factors in determining the development of PUD. In antral-predominant H. 
pylori-associated gastritis, both basal and stimulated acid output are increased, 
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and even more so in patients with duodenal ulcers (Schultze et al., 1998) which 
appear in the duodenal bulb (Kusters et al., 2006). Stomach acidity is regulated by 
a number of hormonal responses. Under normal conditions low pH in the antrum 
is detected and stimulates the release of somatostatin from D cells, which exhibits 
inhibitory control over gastrin secretion from adjacent G cells, and hence acid 
production from parietal cells in the corpus. H. pylori infection impairs the 
inhibitory effects of somatostatin through the activity of its urease enzyme, which 
neutralises local acidity and prevents D cells from detecting the true level of 
acidity in the antrum. This leads to reduced levels of somatostatin secretion (Moss 
et al., 1992), resulting in hypergastrinemia, and consequently excessive acid 
secretion (El-Omar et al., 1995; Graham et al., 1993; Olbe et al., 1996) (Figure 
1.1). Gastrin was previously suggested to act as a specific growth factor for H. 
pylori, effectively creating a positive feedback-loop (Chowers et al., 2002). 
However, such effects on bacterial growth were later disputed (Doherty & 
Atherton, 2009). 
As a protective response to the resulting gastric acid hypersecretion and acid 
overload in the duodenum, gastric metaplasia develops in the duodenum. Such 
changes are required to support the growth of H. pylori which specifically and 
exclusively colonises gastric epithelial cells (Khulusi et al., 1996; Ohkusa et al., 
2003). 
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Figure 1.1: Patterns of gastritis involved in the development of PUD. 
The patterns of gastritis associated with acid secretion and disease outcome. (a) H. 
pylori induced antral-predominant inflammation impairs somatostatin inhibitory 
control of gastrin release from adjacent G cells. Increased gastrin levels signal the 
release of acid from parietal cells located in the corpus, resulting in 
hypergastrinaemia. This leads to the development of DUD. (b) H. pylori induced 
pan-gastritis impairs acid output through direct inhibition of parietal cells, and 
indirect inhibition of histamine release from enterochromaffin-like (ECL) cells. 
This inflammatory profile is associated with the development of GUD. Continual 
proliferation of parietal cells increases the risk of developing gastric cancer 
(Taken from Blaser & Atherton, 2004). 
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1.2.1.1 Gastric ulcer disease (GUD) 
Gastric ulcers predominantly appear in the lesser curvature of the stomach, 
particularly at the point of transition from corpus to antrum mucosa (Kusters et 
al., 2006). In gastric ulcer disease (GUD), inflammation affects the antrum and 
corpus to similar extents (Schultze et al., 1998). Unlike in DUD, acid secretion in 
GUD can be reduced due to the more severe involvement of the acid secreting 
corpus, although a crucial amount of acid is always maintained. With a corpus- 
predominant gastritis or pan-gastritis, H. pylori-induced inflammatory mediators 
suppress acid production both directly through inhibition of parietal cell function, 
or indirectly by inhibiting the secretion of histamine, a stimulant for acid secretion 
from parietal cells, from enterochromaffin-like cells (ECL cells) (Beales & 
Calam, 1998; Fox et al., 2000). The resultant reduction in acid production further 
augments gastrin output, which, although it has little effect on raising acid 
production from the inflamed corpus, provides a stimulus for the proliferation of 
gastric epithelial cells (Figure 1.1). Continuing proliferation and inflammation has 
effects on epithelial cell cycle characteristics (Beales & Calam, 1998; Peek et al., 
2000) probably leading to loss of gastric glands and these changes may increase 
the risk of developing gastric adenocarcinoma (Kuipers et al., 1995c; Peek & 
Blaser, 2002). However, reduced acid levels do show a protective role against 
duodenal ulceration (Koike et al., 2001; Yamaji et al., 2001). 
1.2.1.2 Other factors contributing to PUD 
Most non-H. pylori related PUD is thought to be a result of non-steroidal anti- 
inflammatory drug (NSAID) use. Environmental factors such as smoking and 
excessive alcohol use have been described to contribute to the development of 
ulcer disease, but these factors have not been identified as individual ulcerogenic 
agents (Kato et al., 1992; Rosenstock et al., 2003). Emotional stress has been 
suggested to contribute to ulcer disease, but there is little evidence to support this 
role (Medalie et al., 1992; Peters & Richardson, 1983). 
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1.2.2 Gastric adenocarcinoma 
Gastric adenocarcinoma is the 2`d leading cause of cancer-related death 
worldwide, and is responsible for over 700,000 deaths each year (Peek & Blaser, 
2002). Since the discovery of H. pylori, numerous studies have reported a strong 
association between the disease and H. pylori infection, supported by 
geographical associations between the prevalence of H. pylori and the incidence 
of gastric cancer (Forman et al., 1990). These studies demonstrated that H. pylori 
infection increased the risk of developing gastric cancer (GC) by approximately 
10-fold, and the bacterium was later designated a class I carcinogen by the WHO. 
This risk association was later found to be higher in case-control studies (Ekstrom 
et al., 2001), and was supported in Mongolian gerbil studies, in which H. pylori 
infection induced atrophic gastritis and GC (Honda et al., 1998; Rieder et al., 
2005; Watanabe et al., 1998). Some case-control studies failed to show such a 
strong risk association with developing GC (Huang et al., 1998), and it is now 
understood that the rate of H. pylori infection was underestimated due to loss of 
the bacterium as the gastric mucosa undergoes pre-malignant transformation, a 
change that no longer supports growth of the bacterium. 
Despite the number of gastric cancer associated deaths, the rate of GC occurrence 
in developed countries has been declining, and the reason for this is now believed 
to be associated with the decreasing prevalence of H. pylori, particularly in 
western countries. However, GC is still the 4th most common cancer worldwide 
as the disease is still prevalent in many developing countries (Figure 1.2). 
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Figure 1.2: Geographical variations in GC death rate. 
Age standardised world gastric cancer death rate is given per 100,000 (Parkin, 
2004). 
Despite a similar rate of infection among most Asian countries, the rate of GC is 
considerably lower in India and Thailand at 8-10 per 100,000 (Miwa et al., 2002). 
Such a phenomenon is also observed in Africa, and has been described as the 
"African Enigma". It was hypothesised that the decreased rate of gastric cancer on 
this continent was due to common co-infections with helminths which drive aT 
helper 2 (Th2) immune response in contrast to the damaging T helper 1 (Th 1) 
response that has been associated with the progression of H. pylori associated 
disease (Frenck & Clemens, 2003; Kuipers & Meijer, 2000) (The immune 
response to infection is described further in section 1.7). However, this was 
disputed in subsequent studies that demonstrated GC occurred at similar rates as 
seen in western countries, and it is believed that previous observations may have 
been a result of low life expectancy. Therefore death by other causes may occur 
before GC became apparent in the infected individual. Lack of medical facilities 
and insufficient assessment of disease may also be a contributing factor (Agha & 
Graham, 2005). 
Gastric adenocarcinomas are defined as either well differentiated (intestinal-type) 
that are characterised by a corpus-predominant gastritis with atrophy and 
intestinal metaplasia, or undifferentiated (diffuse-type) which are characterised by 
pan-gastritis and no atrophy (Mbulaiteye et a/., 2009). Although the mechanisms 
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involved in the development of H. pylori-associated GC are still not completely 
understood, chronic inflammation is widely accepted as a major cancer-inducing 
factor. The mechanism of tumourigenesis is thought to involve DNA damage by 
cytokines and free radicals released during chronic inflammation (Hocker et al., 
1998; Scheiman & Cutler, 1999). Chronic inflammation can ultimately cause 
destruction of the normal gastric mucosa, which increases the risk of developing 
gastric adenocarcinoma by 90-fold (Kuipers et al., 1995c). The histological 
changes that occur in the gastric mucosa during progression to intestinal-type GC 
are better characterised than for diffuse-type GC. Intestinal-type tumours evolve 
through stages of chronic gastritis, atrophy, intestinal metaplasia, dysplasia, and 
cancer, known as the Correa pathway (Figure 1.3) (Correa, 1995; Fox & Wang, 
2001). Both atrophy and intestinal metaplasia (IM) are distinct steps in the 
pathway. Atrophic gastritis is defined as the loss of specialised glands (Genta, 
1997b), whereas IM is defined as the replacement of gastric-type tissue with 
intestinal-type tissue, often diagnosed by the presence of tubular crypts lined with 
goblet cells (Correa et al., 2010). 
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Figure 1.3: Proposed Correa pathway of pathological events in gastric 
adenocarcinoma, with histological presentation of stages involved. 
Normal: Histology of the body of the stomach. Chronic gastritis: Moderate to 
severe inflammation. Atrophic gastritis: Chronic inflammation with focal fibrosis 
and complete loss of oxyntic parietal and chief cells. Intestinal metaplasia: Gastric 
epithelial metaplasia to an intestinal phenotype characterized by columnar 
elongation, goblet cells, and production of mixed acidic (blue, intestinal-type) and 
neutral (red, gastric-type) mucins as shown by pH 2.5 Alcian blue/PAS stain 
(inset). Dysplasia: High-grade glandular dysplasia characterised by irregular size 
and shape. Cancer: Gastric intraepithelial neoplasia, here with intramucosal 
invasion (arrow). Scale bars: 160 mm (first panel); 400 mm (second and third 
panels); 80 mm (fourth panel; inset, original magnification, x400); 40 mm (fifth 
panel); 800 mm (sixth panel). (Fox & Wang, 2007) 
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Bacterial factors have been associated with H. pylori-related carcinogenesis. The 
most pathogenic strains of H. pylori are widely accepted as determinants in GC 
development (Prinz et al., 2001). The role of these factors in disease progression 
is discussed later (section 1.6). 
More recently, studies have proposed preferential damage to parietal cells by the 
bacterium, thereby altering the maturation of the stem cell (Correa & Houghton, 
2007). Others have reported that H. pylori-induced inflammation leads to 
recruitment of peripheral or bone-marrow derived stem cells into the gastric 
mucosa, which then transform into malignant cells. Furthermore, bone-marrow 
derived stem cells were identified as the origin of malignancy in a mouse model 
(Houghton et al., 2004), and H. pylori has also been identified inside gastric stem 
cells (Giannakis et al., 2008). These studies have demonstrated an important 
factor in the development of gastric cancer and describe another possible 
mechanism by which H. pylori induces GC. 
Genetic polymorphisms in genes coding for inflammatory cytokines also 
contribute to the progression of disease to GC. Interleukin-13 (IL-1 ß) is a crucial 
inflammatory mediator upregulated in the presence of H. pylori that is important 
in amplifying the inflammatory response to infection, and is a potent inhibitor of 
gastric acid secretion (El-Omar, 2001). IL-i 3 is key to the development of gastric 
cancer as it is capable of modulating the function of several gastric epithelial cell 
types, inducing the release of gastrin from G cells and inducing the release of 
histamine from ECL cells (Mahr et al., 2000; Prinz et al., 1997). The importance 
of IL-1 ß acid secretion was demonstrated by Takashima et al, who found IL-1 ß 
stimulation decreased acid output in a Mongolian gerbil model, and the addition 
of an IL-1R antagonist restored gastrin levels and acid output (Takashima et al., 
2001). This was also demonstrated in a transgenic mice model in which IL-l(3 
overproduction was targeted to the stomach. These mice developed severe 
gastritis and adenocarcinoma in the absence of H. pylori, and infection with the 
bacterium accelerated the appearance of pathology, which was prevented by the 
inclusion of IL-1 receptor antagonist (Tu et al., 2008). 
Three polymorphisms in the 1L1ß gene, leading to increased IL-10 production, 
have been described at positions 
-511, -31 and +3954 (El-Omar et al., 2000). All 
have been associated with an increased risk of developing GC in a number of 
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populations tested (El-Omar et al., 2000; Figueiredo et al., 2002; Machado et al., 
2001). In addition, a polymorphism in the IL-1 receptor, IL-1RN*2, has also been 
identified that results in prolonged responses to inflammatory stimuli and 
increases the risk of developing disease (Hsu et al., 2004). Furthermore, the risk 
of developing disease is compounded with the presence of multiple 
polymorphisms (Figueiredo et al., 2002; Machado et al., 2001). However, 
numerous studies have failed to show a correlation between polymorphisms of the 
IL1 fi gene and GC. Such discrepancies have been attributed to genetic differences 
between populations, to genetic polymorphisms in the gene promoter and 
transcription factors (Chen et al., 2006a; Lee et al., 2007b), or diet (Shen et al., 
2007). 
After the identification of polymorphic ILIß, other cytokine genes were also 
demonstrated to display polymorphisms in the gene. Tumour necrosis factor-a 
(TNFa) is also a known inhibitor of acid production, although much weaker than 
IL-lß. Several polymorphisms in the TNF-a gene have been associated with 
increased risk of developing H. pylori-associated gastroduodenal disease (El- 
Omar et al., 2003). The most studied is the TNFa 
-308 polymorphism, which is 
associated with high TNFa transcription and found to correlate with increased 
risk of developing gastric cancer (Rad et al., 2004). This association was also 
observed with the TNFa 
-238 polymorphism in children (Wilschanski et al., 
2007), and with the combination of the TNFa 
-857, -863 and -1031 
polymorphisms, all of which confer high transcriptional promoter activity 
(Sugimoto et al., 2007). 
IL- 10 is an anti-inflammatory cytokine involved in down-regulation of IL-lß and 
TNFa, as well as other inflammatory mediators. Three single nucleotide 
polymorphisms in the IL10 gene have been identified at positions 1082 (G to A), 
819 (C to T) and 592 (C to A). 8 possible haplotypes exist, of which the GCC 
haplotype is associated with a higher expression level of IL10, which favours an 
anti-inflammatory response. However, the ATA haplotype is associated with 
reduced IL10 expression and consequently leads to a THI-driven hyper- 
inflammatory response which causes excessive damage to the gastric mucosa (El- 
Omar et al, 2003). Importantly, some studies have failed to show an association 
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between ILIO polymorphisms and increased risk of developing disease (Garcia- 
Gonzalez et at, 2007; Hellmig et at, 2005). 
Many studies have shown that although polymorphisms in a single gene are 
associated with a two-three fold increased risk of developing gastric cancer, the 
presence of polymorphisms in multiple genes, which result in proinflammatory 
responses, substantially increases the risk by 27-fold (El-Omar et al, 2003). 
1.2.3 Mucosa-associated lvmahoid tissue (MALT) lymphomas 
MALT lymphomas are also associated with H. pylori infection, occurring in less 
than 1% of infected individuals. MALT is not present in the uninfected stomach 
and appearance of this tissue type is dependent on the presence of H. pylori. The 
bacterium stimulates the infiltration of B cells in the mucosal stroma, which 
slowly proliferate. In some cases they develop into a low grade MALT lymphoma 
and may sometimes undergo transformation to large-cell B cell lymphoma (Zucca 
et al., 1998). The risk factors associated with the development of MALT 
lymphoma are not well understood, but appear most commonly in the presence of 
pan-gastritis (Miehlke et al., 2001). Almost all MALT lymphoma patients are 
infected with H. pylori, and significant studies have shown that eradication of the 
bacterium with antibiotic treatment can cause complete regression of the 
lymphoma in 70-90% of cases, although this is not the case for high-grade 
lymphomas (Morgner et al., 2000). 
1.2.4 Other H. avlori associated diseases 
There is increasing evidence for potential beneficial roles of H. pylori infection in 
the human host, with the absence of infection being associated with an increased 
risk of developing various diseases. One of these is the inverse association 
between H. pylori infection and gastroesophageal reflux disease (GERD), 
Barrett's oesophagus, and oesophageal adenocarcinoma (Islami & Kamangar, 
2008; Vaezi et al., 2000; Vicari et al., 1998). One hypothesis for this relationship 
is that infection with H. pylori leads to reduced gastric acidity, making refluxate 
less damaging to oesophageal epithelium than that of an uninfected individual. It 
is also possible that infection alters the expression of gastric hormones that may 
have effects on oesophageal tissue. However, the exact mechanisms involved in 
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this association are still poorly understood. It is thought that inflammation of the 
corpus induced by H. pylori colonisation suppresses acid production and hence 
protects against GERD development (Francois et al., 2008; Roper et al., 2008). 
This protective role of H. pylori was noted particularly with more virulent cagA 
positive strains (Fallone et al., 2000; Lai et al., 2005). However, many other 
studies were unable to report similar trends (Ferrandez et al., 2006; Tsukada et al., 
2005). 
Another intriguing finding is the rising incidence of asthma and related disorders 
as the rate of H. pylori infection has declined. Asthma is generally considered as a 
disorder arising from dysfunctional immune responses to common allergens. The 
absence of the bacterium has been associated with increased incidence of 
childhood onset allergies, but was not found to be related to later-onset of disease. 
This association was found to be strongest with cagA positive infections (Blaser et 
al., 2008; Chen & Blaser, 2008). One hypothesis for this inverse association is 
that during H. pylori infection, populations of T-cells, including regulatory T- 
cells, are recruited that affect the activities of T cells present at other mucosal sites 
(Harris et al., 2008; Robinson et al., 2008). Also, regulatory T-cell responses, 
which are important for suppression of autoimmunity, allergy and inflammation 
(Thompson & Powrie, 2004), are notably induced during H. pylori infection, and 
may explain the protection against allergy observed with this infection (Robinson 
et al., 2008). The relationship between H. pylori and the immune response is 
discussed further in Chapters 4,5 and 6. 
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1.3 DIAGNOSIS OF H. PYLORI INFECTION 
Many diagnostic tools exist for the detection of H. pylori, and are classified as 
either invasive if they require detection of the bacterium in gastric tissue obtained 
during endoscopy, or non-invasive if they are based on peripheral samples, such 
as blood, breath or stool samples (Table 1.1). The decision as to which technique 
to employ is based on a number of factors including patient convenience and 
safety, reliability, cost, and time taken to perform the test. The choice of 
diagnostic method may vary between clinics, but generally for hospital-based 
care, many patients undergo endoscopy which is then combined with either 
histology or a rapid urease test for the detection of H. pylori. 
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1.4 TREATMENT 
Current treatment regimens specify that patients infected with H. pylori are treated 
with antibiotics and acid suppressants. Presently, 1g` line therapy consists of two 
antibiotics, commonly clarithromycin and either metronidazole or amoxicillin, 
and a proton pump inhibitor (PPI) drug (Chey & Wong, 2007; Malfertheiner et 
al., 2007). Eradication rates with 15t line therapy were reported to be greater than 
90% in 2000 (Kearney & Brousal, 2000). However, recent studies have estimated 
these rates to have fallen as low as 70% in many areas, and even down to 60% in 
some regions (Kadayifci et al., 2006). Reduced efficacy of ist line therapy is 
likely due to increasing resistance to antibiotics. In the case of clarithromycin 
resistance, 1St line therapy is reported to be effective in as little as 18% of treated 
patients (Megraud, 2004). Increased use of clarithromcycin for the treatment of 
respiratory infections is the likely cause of H. pylori resistance to clarithromycin 
(Boyanova, 2009; Romano et al., 2008). Metronidazole resistance is also 
common, and eradication rates have been reported to fall as low as 47% in areas 
with high levels of antibiotic resistance (Gerrits et al., 2006). 
Generally, 1$` line therapy is reported to fail in approximately 20% of treated 
patients, highlighting the need for 2"d line therapy (Ford et al., 2008). Many 2°d 
line therapies are in use, the most common involve treatment with bismuth-based 
quadruple therapy consisting of a PPI, bismuth, tetracycline and metronidazole, a 
combination reported to be effective in 70% of patients that failed to respond to 0 
line therapy (Hojo et al., 2001). 
Treatment is very effective for the management of PUD, but the protection against 
gastric cancer probably depends on whether infection is treated early and the 
extent of mucosal damage at the time of treatment (Rauws & Tytgat, 1990). 
1.5 VACCINES 
H. pylori is successfully treated with current treatment regimens; however, 
antibiotic resistance is an increasing problem (Megraud, 2004). Therefore the 
development of a vaccine would be of great benefit, and numerous approaches 
have been investigated to develop effective vaccination against H. pylori. 
1-19 
Among the H. pylon antigens investigated, the Urease B subunit (UreB) has been 
extensively studied in a number of vector systems. Subcutaneous immunisation 
with UREB138, a region of the gene known to be important for urease activity, 
was found to reduce bacterial density in the gastric mucosa of mice (Morihara et 
al., 2008). Vaccination with a recombinant fusion peptide of the urease B epitope 
and the cholera toxin B subunit encapsulated in liposome was found to protect 
mice from H. pylori infection both prophylactically and therapeutically. 
Furthermore, urease specific mucosal IgA was also detected in mice treated with 
the vaccine (Zhao et al., 2007). Importantly, long-lasting immunity is also 
dependent on host factors. Prophylactic immunisation with recombinant H. pylori 
HpaA and cholera toxin was found to reduce bacterial density in BALB/c mice 
but not in C57BL6 mice, demonstrating the influence of host genetics in effective 
vaccination (Sutton et al., 2007). However, vaccine models have yet to produce 
sterilising immunity. 
1.6 H. PYLORI COLONISATION FACTORS AND 
VIRULENCE DETERMINANTS 
Infection with H. pylori requires a complex interaction between both host and 
bacterial factors. Much diversity is observed for H. pylori leading to the existence 
of strains that vary in pathogenicity. The aggressiveness of the inflammatory 
response varies consequently, and a range of clinical manifestations can develop. 
This section reviews bacterial virulence factors that mediate colonisation and 
survival of the bacterium in the human host (Atherton, 2006; Blaser & Atherton, 
2004). 
1.6.1 Factors involved in colonisatlon 
Successful chronic infection with H. pylori is dependent on colonisation and 
persistence of bacterial infection in a dynamic environment. Several bacterial 
factors have been implicated as essential for both initial and persistent 
colonisation of the gastric mucosa by the bacterium. Of interest are factors that are 
involved in initial colonisation of the acidic stomach by a bacterium that is not 
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considered acidophilic, and that expresses enzymes essential for bacterial survival 
that are susceptible to the acid environment (Sachs et at, 2002). 
H. pylori is known to colonise the protective mucous gel, which exhibits a pH 
gradient whereby increased pH is observed near the gastric epithelium, and a 
lower pH is seen towards the luminal side of the mucous gel. H. pylori tend to 
colonise close to the less acidic epithelium, and moves rapidly towards this layer 
by means of chemotactic motility using this pH gradient. Studies in Mongolian 
gerbils demonstrated that the bacterium was capable of orientating themselves 
within pH gradients, and in the absence of these gradients, the bacteria were found 
throughout the mucous layer (Schreiber et al., 2004). These observations suggest 
H. pylori are capable of sensing and responding to changes in local acidity, and 
signal to the flagellar. Furthermore, the H. pylori genome encodes three 
membrane-spanning chemoreceptors (T1pA, T1pB and T1pC) that are thought to 
be essential for sensing changes in pH. Of these, T1pB was found to be essential 
for effective colonisation in a mouse model (Croxen et at, 2006). 
Essential to H. pylori acid tolerance is the urease enzyme. Urea, which is released 
as a result of the urea permease activity of the vacuolating cytotoxin A (discussed 
in section 1.6.4), is converted to ammonium and bicarbonate. This effectively 
neutralises cytoplasmic pH which buffers the periplasm and allows for survival in 
acidic conditions. Studies have demonstrated the importance of the enzyme in 
colonisation as knocking out the urease genes lead to failure of colonisation 
(Eaton & Krakowka, 1994). 
1.6.2 H. avlori adhesins and outer membrane proteins 
Once in the gastric mucous, H. pylori may adhere to the gastric epithelium, which 
is mediated by a number of bacterial factors. 
1.6.2.1 BabA 
Lewis b antigens (Leb) expressed on gastric epithelial cells have long been known 
to play a key role in H. pylori pathogenesis (Lee et al., 2006). Studies 
demonstrated specific binding of H. pylori to Leb which was found to be a 
receptor for a H. pylori-specific adhesin (Boren et al., 1993; Falk et al., 1993) 
named blood group antigen-binding adhesin (BabA) (Ilver et al., 1998). BabA 
may also mediate the adhesion of H. pylori to the gastric mucin MUC5AC (Van 
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de Bovenkamp et al., 2003), a secretory mucin expressed in gastric surface and 
glandular mucous cells, which is an important constituent of the protective 
mucous gel (Ho et al., 1995). Additional receptors may be involved in the 
adhesion of H. pylori as BabA-positive strains attach to the epithelium in the 
absence of Leb expression (Walz et al., 2005). 
The adhesin is encoded by the babA gene, of which 2 alleles exist; babAl and 
babA2. The babAl allele lacks the ATG start codon due to a 10 base pair insertion 
in the signal sequence, and therefore does not encode a functional protein. A 
functional protein is only encoded by the babA2 allele (Backstrom et al., 2004). A 
number of mechanisms are predicted for the regulation of babA, the main 
mechanism involving chimera formation between bab genes in different loci 
present in the H. pylori genome; babA, babB, and babC (Backstrom et al., 2004; 
Pride & Blaser, 2002). 
The prevalence of babA2 positivity varies between 30 and 70% in western 
countries, although recent large scale studies demonstrated only 9.8% of western 
strains to be babA2 negative (Fujimoto et al., 2007). In contrast, studies in Taiwan 
and Japan found 100% prevalence of the gene in H. pylori isolates (Sheu & Wu, 
2008; Yamaoka et al., 2002b). babA2 negative strains have been associated with 
mild gastritis and lower bacterial density compared to strains testing positive for 
the virulence factor (Fujimoto et al., 2007). BabA has also been strongly 
associated with peptic ulcer disease and gastric cancer (Azevedo et al., 2008; 
Gerhard et al., 1999). 
1.6. Z2 SabA 
The adhesion of a H. pylori strain that had a babA deletion and was still able to 
colonise in the presence of Leb antigen suggested that other adhesins were 
expressed on the surface of the bacterium. Sialyl-Lewis x and a (sLe" and sLea) 
were later demonstrated to serve as receptors for H. pylori adherence through 
interactions with the sialic acid binding adhesin (SabA) (Mahdavi et al., 2002). 
The expression of sLe" and sLe° is sparse on epithelial cells of normal, uninfected 
gastric tissue. However, a chronic inflammatory response to infection with H. 
pylori elicits sialylation of these Lewis antigens, increasing the level of sLe" and 
sLea and hence adhesion through SabA interactions. 
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Expression of the sabA gene is regulated by a slipped strand mispairing 
mechanism and is thought to be mediated by the number of CT repeats in the 5' 
region of the gene, which create "on" and "off' patterns that confer functionality. 
However, later studies found that varying numbers of CT repeats did not correlate 
with SabA production (Lehours et al., 2004; Sheu et al., 2006). The ability of H. 
pylori to switch sabA status may implicate this gene in immune evasion during 
infection. Mahdevi et al. (2002) suggested a model for SabA binding, whereby H. 
pylori infection triggers sialylation of Le" and Leb allowing binding. At sites of 
intense inflammation, "on/off' switching results in loss of adherence, allowing the 
bacterium to escape the immune response and thus contributing to chronicity of 
infection (Mahdavi et al., 2002). The prevalence of sabA varies geographically, 
with 80% of strains carrying the gene in Taiwanese populations (Sheu et al., 
2006), 86% in French populations (Lehours et al., 2004), and 93% in Dutch 
populations (de Jonge et al., 2004b). 
Infection with sabA-positive strains has been associated with gastric cancer, 
intestinal metaplasia and atrophy, but was negatively associated with DUD and 
neutrophil infiltration. In a study examining patients from Columbia and the US, 
sabA was found to be the only predictor of gastric cancer in comparison of babA 
and oipA (an outer membrane protein [Section 1.6.2.3]) (Yamaoka et al., 2006). 
However, sabA prevalence was not associated with H. pylori related disease in all 
populations tested, which may reflect global differences in the relationship 
between the virulence factor and disease status (Sheu et al., 2006). SabA positive 
strains have been associated with increased bacterial density (Sheu et al., 2003). 
Interestingly, this relationship was observed only in patients expressing sLe" with 
little Leb expression, but not in patients that expressed moderate levels of Leb. 
This suggests that SabA has little impact on bacterial density when Leb expression 
is strong allowing adhesion by BabA, but enhances colonisation in patients with 
weaker Leb expression (Sheu et al., 2003). 
L&2.3 OipA 
OipA is an additional outer membrane protein expressed by H. pylori. As with 
sabA, gene status is described as "on" or `off', and gene regulation is modulated 
by phase variation dependent on CT nucleotide repeats in the 5' region of the 
gene. ofpA has been associated with increased expression of IL8 both in vivo and 
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in vitro (Yamaoka et at, 2000). The adhesin oipA has been associated with the 
vacuolating cytotoxin (VacA) and BabA, but most strongly with the cytotoxin 
associated gene A (CagA) which is a strong inducer of IL8. Therefore, the 
association observed between OipA and IL8 expression may be a result of its 
association with CagA positivity. Importantly, mutagenesis of the gene reduced 
bacterial adherence but did not affect IL-8 secretion in vitro (Dossumbekova et 
al., 2006). The prevalence of oipA differs between populations. 100% positivity 
was reported in Tunisian patients, 51% in Iran, and 33% in Turkish populations 
(Ben Mansour et al., 2010; Dabiri et al., 2009). oipA-positive status has been 
linked with duodenal ulceration and gastric cancer, but this may again be a result 
of the close association between oipA and other virulence determinants (Yamaoka 
et al., 2000). 
1.6.3 The Cytotoxln associated gene A (Ca¢A) and Cae natho¢enicity 
island (Caa PAD. 
After the discovery of H. pylori as a causal agent in the development of ulcer 
disease (Marshall & Warren, 1984), numerous studies attempted to identify the 
bacterial agent involved in inducing disease in some infected individuals. Early 
studies described strains of the bacterium that were capable of inducing cellular 
rearrangements in gastric epithelial cells, which were also associated with more 
aggressive inflammatory responses in the infected host. The cytotoxin associated 
gene A (CagA) secreted by the bacterium was identified as a major bacterial agent 
responsible for these observations and was associated with increased risk of 
developing severe disease during chronic infection with H. pylori (Blaser et al., 
1995; Crabtree et al., 1991b; Segal et al., 1999). 
CagA is a 120-140kDa highly immunogenic protein encoded by the cagA gene 
localised at one end of the cag Pathogenicity Island (cagPAI) and acts as a marker 
for the presence of the island (Tummuru et al., 1993). The cagPAI is a 40kb DNA 
segment consisting of 27-31 genes, thought to have been acquired by H. pylori 
through horizontal transfer from an unknown origin (Akopyants et at., 1998). 
Most genes in the island code for proteins with sequence similarity to components 
of type N secretion systems, forming a syringe-like structure capable of 
penetrating gastric epithelial cells and allowing translocation of CagA into cells 
(Censini et al., 1996). The entire island can be lost or restored through natural 
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transformation and is flanked by 39bp direct repeats. Strains of H. pylori that do 
not possess the cag PAI have a single copy of the flanking repeat in the glutamate 
racemase gene (Kersulyte et at, 1999). More than 90% of East Asian H. pylori 
strains and roughly 60% of Western strains carry the cag PAI (Parsonnet et at, 
1997). Importantly, CagA varies in size and toxicity, and differences in the 
biological activities of bacterial strains isolated from patients in East Asia 
compared to Western isolates relates to the difference in gastric cancer incidence 
between these two geographical regions (Figure 1.2). 
Translocation of CagA into the host cell is followed by tyrosine phosphorylation 
of the protein, which occurs at small repetitive motifs comprising a five amino 
acid sequence of Glu-Pro-Ile-Tyr-Ala (EPIYA). These motifs are present in 
multiple copies in the C-terminal variable region of the protein. Sequence analysis 
of the regions immediately flanking these motifs identified 4 distinct EPIYA 
segments in the CagA protein 
- 
EPIYA-A, 
-B, -C and -D. Western strains of H. 
pylori possess EPIYA-A, 
-B and -C segments, whereas East Asian strains consist 
of an EPIYA-D region in place of the C motif characteristic of Western strains 
(Higashi et al., 2002b; Yamaoka et al., 1998) (Figure 1.4). Most strains express 
CagA proteins with a conserved EPIYA segment core consisting of a single copy 
of each motif. However, many isolates express CagA proteins with multiple 
duplications of the EPIYA-C motif, and in some cases duplication of the EPIYA- 
A, 
-B or -D motifs have been reported (Higashi et at, 2002b; Yamaoka et al., 
1998). Phosphorylation of these sites plays a critical role in the cellular responses 
that transpire after CagA translocation, including the induction of cellular 
morphological changes known as the "hummingbird" phenotype (Discussed 
further in section 1.6.3.1) (Argent et at, 2004). 
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Figure 1.4: Structure of the EPIYA motifs of the cagA gene. 
Repetitive Glu-Pro-Ile-Tyr-Ala (EPIYA) motifs are found at the C-terminal 
region of the cagA gene. Sequence analysis of DNA flanking these motifs 
identified four distinct segments. EPIYA-A, 
-B, and -C motifs are found in 
Western strains of the bacterium. The presence of multiple EPIYA-C motifs is 
common and related increased risk of developing H. pylori-associated disease. 
East Asian strains of the bacterium carry the EPIYA-D motif in place of EPIYA- 
C, and are highly associated with the development of gastric adenocarcinoma. In 
some cases, duplication of the EPIYA-A and B motifs has also been reported. 
Once translocated into the host cell, host kinases phosphorylate the toxin at 
tyrosine residue in EPIYA motifs. Phosphorylated CagA is specifically bound by 
kinases Csk (at EPIYA-A and 
-B motifs) and SHP-2 (at EPIYA-C and -D 
motifs). (Adapted from Hatakeyama, 2008) 
1.6.3.1 Cellular effects of CagA 
Translocation of CagA into the host cell is followed by localisation of the protein 
to the inner surface of the plasma membrane. Mutagenesis of the EPIYA regions 
demonstrated an essential role of these motifs in localisation of CagA (Higashi et 
al., 2005). Membrane-associated CagA is subsequently phophorylated at the 
tyrosine site in EPIYA-C motifs by the host Srk family protein tyrosine kinase, c- 
Src (Selbach et al., 2002; Stein et al., 2002). Activity of c-Src is regulated through 
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two tyrosine phosphorylation sites present in the c-Src protein; one conferring 
activity through auto-phosphorylation of the Y419 residue, and the other 
repressing activity after phosphorylation of residue Y530 by a C-terminal Srk 
kinase (Csk) (Selbach et al., 2002; Stein et al., 2002). Importantly, 
phosphorylated CagA (CagA-P) was found to interact at Src homology-2 (SH2) 
domains present in the Csk sequence. This interaction stimulates Csk activity and 
subsequently represses c-Src (Tsutsumi et al., 2003). CagA phosphorylation, and 
hence activity, is therefore negatively regulated by the accumulation of CagA-P, 
which may represent a means of maintaining the bacterial infection in the host 
through modulating CagA production and consequently the inflammatory 
response that leads to cellular damage. A second host tyrosine kinase, c-Abl, was 
later discovered to also phosphorylate CagA, and is thought to maintain activation 
of CagA at late stages of infection (Tammer et al., 2007). 
The degree of CagA phosphorylation is dependent on the number of EPIYA-C 
motifs, with increased phosphorylation associated with multiple EPIYA-C motifs. 
The number of tyrosine phosphorylation sites also determines the biological 
activity of CagA, inducing more cytoskeletal rearrangement that leads to a severe 
"hummingbird" phenotype in more cells compared to strains expressing CagA 
proteins with fewer tyrosine phosphorylation sites. Extensive phosphorylation is 
also associated with an increased risk of developing GC (Argent et at., 2004). 
CagA-P interacts with proteins possessing Src homology-2 (SH2) domains. 
Noteably, CagA-P directly binds SH2 domain-containing protein tyrosine 
phosphatase (SHP-2), a bonafide oncogene, in gastric epithelial cells. This 
specific interaction activates SHP-2 phosphatase activity through a 
conformational change that relieves catalytic site inhibition (Higashi et at., 2002a; 
Higashi et al., 2002b). In most cases, SHP-2 is important in the regulation of 
signals involved in cell growth and cell motility (Neel et al., 2003). SHP-2 
interaction with CagA-P induces prolonged activation and dysregulation of the 
ErkfMAPK signal pathway, leading to induction of cyclin Dl and promotion of 
GI to S phase progression. Dysregulation of such pathways represents a potential 
pathway involved in driving H. pylori induced gastric adenocarcinoma (Higashi et 
al., 2002a; Higashi et al., 2002b). Activation of this pathway is also mediated 
through binding of the adapter protein Growth factors receptor bound 2 (Grb2) to 
non-phosphorylated CagA (Mimuro et al., 2002). The CagA-P-SHP-2 complex 
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also dephosphorylates Focal adhesion kinase (FAK) and inhibits the kinase 
activity of the enzyme, leading to disruption of focal adhesion points and 
increased cell motility, as well as cell elongation characteristic of the 
hummingbird phenotype (Tsutsumi et al., 2006). 
CagA-SHP-2 interactions are essential for induction of morphological changes in 
cells, giving cells the characteristic "hummingbird" phenotype. Importantly, the 
SH2 domains of SHP-2 bind with highest affinity to a consensus sequence that 
perfectly matches the sequence flanking the EPIYA-D motif in East Asian strains 
of H. pylori. However, a single amino acid mutation in the flanking sequence of 
EP1YA-C motifs reduces binding affinity. Consequently, EPIYA-D containing 
strains exhibit stronger binding and have a greater ability to induce hummingbird 
phenotypes (Higashi et al., 2002a). 
Hummingbird phenotypes are also induced through actin cytoskeletal 
rearrangements and polymerisation. These cellular changes were shown to be 
induced through dephosphorylation of actin binding proteins such as cortactin 
through CagA mediated inactivation of c-Src (Selbach et a!., 2003), or by 
activation of Rac1 and subsequent stimulation of WAVE protein and Arp2/3 
complexes (Brandt et a!., 2007; Tammer et al., 2007). However, the induction of 
the hummingbird phenotype by these interactions is controversial as a recent 
study demonstrated such cellular changes to be independent of Racl and Arpl/2 
complexes (Bourzac et al., 2007). 
CagA also induces cellular responses independent of tyrosine phosphorylation, 
including the disruption of tight junctions and cell polarity in the epithelial layer 
(Amieva et al., 2003). Tight junctions are essential for maintaining cell polarity 
by limiting the diffusion of integral membrane proteins between apical and 
basolateral membranes. CagA disruption of this activity involves direct interaction 
with partitioning-defective-1 (PARI)/microtubule affinity regulating kinase 
(MARK) (Saadat et al., 2007). PARI is thought to act as a master regulator of cell 
polarisation, and polarity is maintained by localisation of PARI to the basolateral 
membrane and localisation of the atypical protein kinase C (aPKC)/PAR3/PAR6 
complex to the apical membrane, with tight junctions forming where the two 
proteins face each other. The kinase activity of PAR! is essential for destabilising 
aPKC complexes that gather at the basolateral membrane and thus maintaining 
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tight junctions (Hurov et al., 2004; Suzuki et al., 2004a). Interaction with CagA 
inhibits this kinase activity causing junctional and polarity defects. Furthermore, 
H. pylori were found to preferentially adhere at junctions, and relocalisation of 
apical junction proteins zonula occludens-1 (ZO1) and transmembrane protein 
junctional adhesion molecule (JAM) to the site of bacterial adhesion was 
demonstrated (Amieva et al., 2003). Cellular rearrangement of these proteins 
disrupted barrier function, and is thought to be related to the inhibition of PARI 
through CagA binding (Saadat et al., 2007). 
Unmodified CagA was also demonstrated to activate nuclear factor of activated T 
cells (NFAT) in gastric epithelial cells (Yokoyama et al., 2005). Nuclear 
translocation of this transcription factor induces the transcription of genes 
involved in cellular differentiation. Notably, the induction of p21c'Pl cyclin- 
dependent kinase inhibitor, which is involved in cell cycle inhibition, is thought to 
contribute to the induction of intestinal metaplasia (Crabtree & Olson, 2002). 
Direct interaction of CagA with c-Met effector phospolipase Cy (PLCy) either 
alone or as a complex with c-Met may activate the PLCy-Cat+-calcineurin 
pathway, which leads to the activation of NFAT (Churin et al., 2003). 
Unphosphorylated CagA was also demonstrated to induce transcription of ß- 
catenin-dependent genes, including cyclin D1. The transmembrane protein E- 
cadherin forms a complex with ß-catenin, localising the protein to cell junctions 
where the complex plays a crucial role in maintaining cellular architecture, and 
also plays a role in signalling pathways involved in regulating cell growth and 
differentiation (Jamora & Fuchs, 2002; Takeichi, 1991). CagA was demonstrated 
to directly interact with E-cadherin, inhibiting E-cadherin/ ß-catenin complexes 
from forming (Murata-Kamiya et al., 2007). This results in cytoplasmic and 
nuclear accumulation of ß-catenin, and subsequent activation of ß-catenin- 
dependent genes and signalling, including the Wnt/ß-catenin pathway which is 
involved in colorectal cancer (Segditsas & Tomlinson, 2006). 
In addition, CagA has also been found to induce activation of the transcription 
factor NF-KB activation via the MAP kinase pathway. The activated transcription 
factor induces transcription of genes involved in proinflammatory immune 
responses, including IL8 (Brandt et al., 2005). However, studies reported the 
involvement of CagA in IL-8 induction to be controversial as cagA mutant H. 
pylori strains induced IL-8 secretion (Fischer et al., 2001; Sharma et al., 1998). It 
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was later shown that CagA was involved in late induction of IL-8 secretion, which 
may be dependent on polymorphisms in the CagA gene upstream of the EPIYA 
motifs (Brandt et al., 2005). In vitro analyses demonstrated IL-8 secretion to be 
largely dependent on a functional cagPAI. Viala et al. (2004) reported the 
delivery of H. pylori peptidoglycan via a functional cagPAI, and subsequent 
recognition of the bacterial component by the intracellular receptor Nodl. This 
was followed by the activation of NF-KB and upregulated expression of IL8. 
Peptidoglycan was shown to induce IL-8 secretion during early infection, and the 
exact mechanisms involved in NF-KB activation are yet to be determined. 
Overall, CagA activates numerous signalling pathways leading to cellular 
damage. However, regulation of CagA phosphorylation and other cellular proteins 
involved in CagA-induced cellular damage limits the potential damage to host 
cells and contribute to chronic infection with H. pylori. The cellular interactions 
of CagA are summarised in Figure 1.5. 
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1.6.3.2 CagA associated disease 
There is a strong correlation between cagA positive strains of H. pylori and 
increased risk of developing peptic ulcer disease and gastric cancer (Blaser & 
Crabtree, 1996) ( 
Figure 1.6). Morphological transformation of cells and the loss of normal cellular 
architecture induced by chronic infection with cagA positive strains are likely to 
disrupt the gastric mucosa and induce inflammation. Furthermore, CagA induces 
cell proliferation and differentiation, which is likely involved in the development 
of gastric cancer. As mentioned, the risk of developing gastric cancer is notably 
higher in patients harbouring East-Asian strains due to the high affinity binding of 
EPIYA-D motifs to SHP-2. Interestingly, patients infected with East-Asian CagA- 
positive strains show varying degrees of gastric atrophy, suggesting other factors 
contribute to the development of disease (Azuma et al., 2004). Increased numbers 
of EPIYA tyrosine phosphorylation sites are also associated with risk of 
developing gastric cancer (Argent et al., 2004). 
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Figure 1.6: CagA association with the development of gastric cancer. 
CagA seropositivity was significantly higher in patients with gastric cancer (GC) 
compared to controls, demonstrated for all age groups (Konturck et a/., 2009). 
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1.6.4 Vacuolatin2 Cvtotoxin A (VacA) 
Soon after the discovery of H. pylori, broth culture filtrates of the bacterium were 
reported to induce vacuolation in the cell cytoplasm of cultured mammalian cells 
(Leunk et a!., 1988). The toxin responsible was later purified from culture 
supernatants and named the Vacuolating cytotoxin A (VacA) (Cover & Blaser, 
1992). The vacA gene, which encodes the toxin, varies in size between strains, but 
is roughly 3.9kb and encodes a protoxin approximately 139kDa in size (Cover et 
a!., 1994). All strains of H. pylori have the vacA gene and most secrete VacA 
protein, however not all strains are able to induce cytoplasmic vacuolation of 
epithelial cells in vitro (Harris et al., 1996). The reason for this is that vacA is 
naturally polymorphic, and the three main diverse regions are the signal (s) 
region, the intermediate (i) region, and the mid (m) region (Figure 1.7). All 
regions exist in two main allelic forms. The s-region was observed to play a role 
in vacuolating activity through altering channel formation in lipid bilayers in 
vitro, with sl-type strains having most activity whilst s2-type strains are non- 
vacuolating (McClain et al., 2001). Analysis of the N-terminal region identified 
an additional hydrophilic 12 amino acid extension in s2-type toxins that was not 
observed in the hydrophobic N-terminus of sl-type VacA. Addition of this 12 
amino acid extension to sl-type VacA blocked vacuolating activity, and removal 
of this region in s2-type VacA established vacuolating activity in the bacterial 
strain (Letley & Atherton, 2000; Letley et a!., 2003). Analysis of the s-region 
sequence determined further variations in sl-type strains, identifying three 
subtypes: sla, slb and sic. No correlation with respect to geographic distribution 
of sla and sib subtypes was found; although the slc subtypes were isolated from 
East Asian strains (van Doom et al., 1998). Variations in the mid-region were 
found to be important for cell specific targeting of vacuolation. In studies using 
various cell lines, ml-type vacA was found to bind and vacuolate RK13 and HeLa 
cells, whilst m2-type vacA was only capable of binding to and inducing 
vacuolation of RK13 cells. This difference in cell binding was attributed to 
differences in cell specific targets or receptor binding by ml and m2-type VacA 
(Ji et al., 2000). Receptor targets are discussed further below (Section 1.6.4.1). As 
with the s-region, sequence analysis of the m-region identified further 
polymorphic variation in m2-type VacA, giving rise to m2a and m2b subtypes of 
the toxin, the latter isolated in East Asian strains (van Doom et al., 1998). 
A variation in a third region of the vacA gene located between the signal and mid 
region was recently observed and was termed the intermediate-(i-) region. The i- 
region type was also identified as a determinant of vacuolating activity, and was 
found to influence epithelial cell-type specificity similar to the m-region (Rhead et 
al., 2007), although the mechanism for this effect is unknown. 
Natural mosacism is observed for vacA, leading to the existence of all 
combinations of s-, m- and i-region type strains. This gives rise to strains with 
varying vaucolating capability (Atherton et al., 1995; Letley et al., 1999; Rhead et 
al., 2007). Infections with strains of H. pylori which express active forms of the 
VacA cytotoxin have been highly associated with disease progression. In many 
populations, vacA sl/ml type strains have been associated with peptic ulceration 
and gastric cancer (Atherton et al., 1995; Basso et al., 1998; Figueiredo et al., 
2001; Rudi et al., 1998). This association was also observed for bacterial strains 
isolated from East Asian countries. However, vacA s1 /m 1 type strains are 
predominant in these regions, and some cancer patients were found to be infected 
with m2-type strains (Ito et al., 1997; Shimoyama & Crabtree, 1998). 
Alternatively, of the 3 polymorphic regions of vacA, only the i-region was found 
to be a significant and independent marker of GC associated strains within an 
Iranian population studied (Rhead et al., 2007). This association was also 
observed in a later study, which also reported a correlation between i 1-type vacA 
and PUD (Basso et al., 2008). In addition, il-type strains were found to be 
associated with GU disease in an Iraqi population (Hussein et al., 2008). 
Overall, VacA induces cellular responses that lead to cell damage, and expression 
of the most virulent form of the toxin is associated with disease progression. 
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Figure 1.7: VacA protein processing 
Schematic representation of the VacA cytotoxin. The vacA gene encodes a 
protoxin approximately 139kDa in size. An autotransporter domain in the C- 
terminus, and the N-terminal signal sequence are cleaved during secretion of the 
toxin, leaving the mature toxin ranging in size between 87-95kDa. Further 
processing can produce the p37 and p58 domains, which remain non-covalently 
associated. The mature toxin forms oligomeric structures, with hydrophobic 
regions and p37 domains forming the core that acts as a channel. The p58 domain 
is orientated towards the outside of the flower shaped structure (Adapted 
from Sewald et al., 2008a). 
1.6.4.1 Structure of VacA 
As mentioned, the vacA gene encodes a protoxin of approximately 139kDa, which 
is secreted by the bacterium using an autotransporter (type V)-secretion system. 
Processing of the protein begins during secretion, during which a 33kDa 
autotransporter domain in the C-terminus, and 33 amino acid N-terminal signal 
region are cleaved. Further processing of the secreted VacA toxin results in 
cleavage of a l2kDa C-terminal fragment (Bumann et al., 2002) that is thought to 
share similar properties as the a-protein of the autotransporter Neisseria 
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gonorrhoeae IgAl Protease (Pohlner et al., 1987). This protein is known to 
stimulate T-helper cell responses in peripheral blood monocytes (Jose et al., 
2000). However, the role of the cleaved VacA fragment of H. pylori is not 
known. The mature 87-95kDa toxin consists of an N-terminal domain (p37) where 
the signal and intermediate polymorphic regions are located, and a C-terminal 
domain (p58) consisting of the m-region (Figure 1.7). The two domains may be 
cleaved at an exposed protease-sensitive loop between them, but remain non- 
covalently associated. Studies suggest that the interaction between these two 
domains is important for VacA toxicity (Torres et al., 2004). 
The native VacA protein exists as a large oligomeric structure arranged as a 
flower-shaped complex, which is thought to consist of one or two rings, each 
comprising six to seven VacA molecules. Monomers in the complex are arranged 
to form a hydrophobic central anion selective channel, with p37 domains located 
near the central ring. The p58 domains are orientated towards the outside of the 
VacA oligomer (Figure 1.7). Purified oligomeric VacA has poor vacuolating 
activity in vitro, however under acidic conditions the structure dissembles and 
vacuolating activity of the toxin increases. Interestingly, at pH 2.0 VacA is highly 
resistant to proteolytic cleavage by the digestive enzyme pepsin (de Bernard et al., 
1995). Dissociated monomers can then form membrane-associated hexamers on 
the epithelial cell surface that act as anion-selective pores, causing egress of 
anions and urea from host cells (Cover et al., 1997; Lupetti et al., 1996) (Figure 
1.8). 
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Figure 1.8: Oligomeric structure and membrane assembly of VacA. 
A schematic view of the secreted oligomeric VacA toxin. Individual VacA 
monomers arrange to form a flower shaped complex consisting of 6-7 monomers, 
which has poor activity. Acid or alkali exposure results in the breakdown of the 
structure, releasing individual molecules that are biologically active. VacA active 
toxin monomers form a membrane-associated anion selective channel that allows 
for vacuolation (Wada et al., 2004). 
1.6.4.2 VacA binding to epithelial cells 
Binding of VacA to specific cell targets is crucial for toxicity. A number of 
potential receptors have been suggested for binding of VacA. Numerous studies 
have identified transmembrane receptor-like protein tyrosine phosphatases a 
(RPTP(x) and P (RPTP 3) as VacA-specific receptors on epithelial cell surfaces 
(Yahiro et al., 1997; Yahiro et al., 2003). Furthermore, glycosylation of a five 
amino-acid sequence of RPTP1 was found to be essential for VacA binding 
(Yahiro et al., 2004). Recently, a T-cell receptor, the 02 integrin subunit of 
lymphocyte function-associated antigen-1 (LFA-1), CD18, was also identified as 
a VacA specific receptor (Sewald et a!., 2008b). The polymorphic m-region of 
VacA accounts for cell-type specific binding of the toxin. Whilst mI 
-type VacA 
was found to induce vacuolation in both rabbit kidney (RK 13) and HeLa cell 
lines, vacuolation was not observed in HeLa cells with m2-type VacA (Ji et a!., 
2000; Pagliaccia et a!., 1998). Analysis of the toxin sequence revealed amino 
acids 460-496 were involved in this cell-specific binding of ml-type VacA, and 
an insertion of 23 amino acids at position 475 was identified in the m2-type (Ji et 
al., 2000). 
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L6.4.3 Va-4 functsons 
Cellular vacuolation was one of the first characterised cytotoxic activities of 
VacA (Leunk et al., 1988). VacA is internalised at lipid raft structures via a 
clathrin-independent pathway of endocytosis which requires cellular components 
such as the small GTPase Cdc42 (Ricci et al., 2000). Once internalised, VacA 
monomers form an anion selective channel in endosomal membranes and are 
carried along the endocytic pathway to vacuolar-type ATPase (V-ATPase) 
positive late endosomes and lysosomes. Both late endosomal and lysosomal 
markers are found in vacuole membranes, suggesting that VacA may disrupt 
membrane trafficking at the level of late endosomes (Molinari et al., 1997). The 
formation of vacuoles requires the full activity of V-ATPase, which acidifies the 
compartment and is potentiated by the presence of weak bases such as ammonium 
chloride (Cover et al., 1993). VacA channels allow for an influx of chloride 
anions into the endosomal compartment, which results in a reduced membrane 
potential. This stimulates an increase in the proton concentration inside the 
vacuole through V-ATPase. An influx of weak bases through the vacuole 
membrane in response to the acidification of the compartment follows. These 
weak bases react with protons which prevents their escape. The resulting 
imbalance in osmotic pressure leads to the influx of water and swelling of the 
vacuole (Cover & Blaser, 1992). Rab7, a membrane traffic regulator, and Rac1, 
an actin-cytoskeleton associated protein, are small GTP-binding proteins that have 
also been recognised in playing a role in vacuole formation and are thought to be 
associated with VacA-induced vacuoles (Hotchin et al., 2000; Papini et al., 1997). 
In addition to forming anion selective channels that induce vacuolation in 
endosomal compartments, VacA also increases epithelial permeability through 
formation of these channels at the apical surface of the gastric epithelium. This 
allows for ions and small neutral molecules to diffuse through epithelial cells 
towards the stomach lumen, particularly bicarbonate ions and pyruvate (Tombola 
et al., 1999). Channel formation also penneabilises the membrane to urea, which 
is the essential substrate for the urease enzyme required for increasing local pH 
for protection of the bacterium (Tombola et at., 2001). Weakening of tight 
junctions has also been suggested as a result of VacA toxicity, allowing the 
release of essential nutrients for bacterial growth (Papini et al., 1998). 
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VacA has also been shown to localise to mitochondria resulting in disruptive 
effects on energy metabolism, including a decrease in mitochondrial membrane 
potential and reduced cellular ATP levels. An important response to VacA is the 
release of cytochrome c into the cytosol, an initiator of cellular apoptosis 
(Galmiche et al., 2000), through the activation of Bax and Bak which are pivotal 
regulators of cytochrome c release (Yamasaki et al., 2006). 
Studies have implicated VacA as a key component in interfering with antigen 
processing and presentation. Two pathways exist for the generation of T-cell 
epitopes, either in early endosomes for loading on recycling MHC II molecules 
(the invariant chain [Ii]-independent pathway) or after antigen degradation in late 
endosomes for loading on newly synthesised MHC II molecules (Ii-dependent 
pathway). VacA was demonstrated to selectively inhibit the Ii-dependent pathway 
of antigen presentation, resulting in an impaired T cell response due to defective 
antigen production (Molinari et al., 1998). 
VacA also impairs T cell proliferation via a mechanism that leads to inhibition of 
IL2 expression, a cytokine essential for T cell viability and proliferation. This 
mechanism involves blocking nuclear translocation of the transcription factor 
NFAT, which is essential for IL2 expression (Boncristiano et a!., 2003). 
Activation of NFAT is induced through two independent pathways, one involving 
the influx of calcium and the other through the activation of stress related tyrosine 
kinases (Rao et al., 1997). VacA was found to block NFAT activation by 
interfering with both pathways. The formation of VacA anion selective channels 
disrupts plasma membrane potentials, which likely drives decreased calcium ion 
influx. Alternatively, a channel-independent activation of the stress activated 
kinase p38 was found to inhibit NFAT activation, triggered by VacA association 
with a cell surface receptor (Boncristiano et al., 2003). 
It is clear that VacA is involved in numerous mechanisms to avoid and suppress 
an immune response. However studies have suggested a proinflammatory 
response that is elicited by this cytotoxin. Boncristiano et at (2003) reported that 
VacA treatment of both macrophages and neutrophils showed substantial 
activation of p38 that consequently increased the expression of cyclooxygenase-2 
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(Cox-2), which contributes to inflammation by production of proinflammatory 
prostanoids. Increased COX-2 expression also induces gastrointestinal 
tumorigenesis through several mechanisms including the inhibition of apoptosis 
(Fujimura et al., 2006). Hence, VacA may play a role in H. pylori induced gastric 
inflammation. The cellular effects of VacA are summarised in Figure 1.9. 
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Figure 1.9: VacA intracellular interactions. 
VacA interacts with cellular processing via a number of mechanisms that aid 
chronic colonisation of H. pylori. (1) VacA binds to cell membrane receptors and 
initiates a proinflammatory response; (2) the toxin is taken up by cells and 
trafficked to the mitochondria where it induces apoptosis; (3) Pore formation in 
cellular compartments reduces membrane potential and increased proton 
concentrations, leading to water influx and vacuolation; (4) membrane channel 
formation, resulting in leakage of nutrients to the extracellular space; and (5) 
VacA passes through tight junctions and inhibit T-cell activation and 
proliferation. (Adapted from Kusters et al., 2006). 
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1.6.5 The nlasticity region 
The H. pylori genome is highly diverse, with the highest degree of variability in a 
DNA segment of the genome referred to as the plasticity region. This region is 
approximately 45kb in H. pylori strain J99 and 68kb in strain 26695, accounting 
for 3-4% of chromosomal DNA (Alm et al., 1999). Almost half of the H. pylori 
strain-specific genes are found within this region. Analysing the prevalence of J99 
strain-specific genes present in the plasticity region over 72 H. pylori strains 
demonstrated the true variability of this region, with gene prevalence ranging 
from 13 to 100% amongst different strains (Yamaoka, 2008). A number of open 
reading frames (ORFs) in the plasticity region encode proteins homologous to 
genes encoding known functional proteins. These include vir factors that are 
required for functional secretion systems (jhp0917 and jhp0918), DNA 
topoisomerase I which is important in DNA replication (jhp0919, jhp0920 and 
jhpO931), and integrase/recombinase genes important for DNA modification, 
recombination and repair (jhp0941 and jhp0951) (Yamaoka, 2008). Studies have 
identified a relationship between the prevalence of certain genes in the plasticity 
region and H. pylori-associated disease. JhpO947 has been associated with peptic 
ulcer disease and gastric cancer in a number of studies (de Jonge et al., 2004a; 
Occhialini et al., 2000; Santos et al., 2003; Yamaoka, 2008). Although other 
genes were also observed to be prevalent in patients with these disease profiles, 
such an association was not observed in different populations tested and little is 
known with respect to the plasticity region and clinical outcomes in East Asian 
strains (de Jonge et at, 2004b; Rizwan et al., 2008; Santos et al., 2003). 
1.6.6 Duodenal ulcer-uromotina gene A (DuDA) 
In a recent study, the prevalence of genes jhp0917 and jhpO918 were found to be 
significantly higher in patients diagnosed with DUD. Furthermore, the prevalence 
of both genes was closely associated, with only 2% of tested strains being 
negative for just one gene. In this study, aI base pair insertion (C or T) at the 3' 
region of jhp0917 was found which resulted in a frame shift leading to a 
continuous gene with jhp0917 and jhpO918. This gene was named the duodenal 
ulcer promoting gene A (dupA) (Lu et al., 2005). Bioinformatic analysis showed 
the gene encoded an intact virB4 homologue, with the N-terminus (encoded by the 
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C-terminal region of jhp0917) showing homology to members of the 
FtsK/SpoIIIE family, a putative ATP-binding P-loop motif that has been 
implicated in intercellular chromosomal DNA transfer. The central domain of 
dupA (encoded by jhp0917 and N-terminal region of jhp0918) shares homology 
with the TraG/TraD family, which are NTP hydrolases thought to be essential for 
DNA transfer in bacterial conjugation (Lu et al., 2005). 
The functions of DupA are not fully understood, but based on its homology to the 
ATPase VirB4, DupA is hypothesised to play a role in the correct assembly of 
another type IV secretion apparatus, or the delivery of effector molecules through 
such a system. Lu et al. (2005) also demonstrated increased IL-8 secretion with 
dupA positive strains in vivo and in vitro. Recently, dupA was found to be 
polymorphic with varying gene size in different H. pylori isolates. Analysis of the 
function of these isolates demonstrated the extended dupAl allelic form to induce 
IL-12 secretion in peripheral blood mononuclear cells (PBMCs) which was not 
observed with dupA2 type strains as used by Lu et al. (2005). Furthermore, IL8 
expression was found to be increased for dupA positive strains in gastric tissue, 
but not for gastric epithelial cell lines, suggesting DupA may directly stimulate 
IL-8 secretion from other cell types, or may indirectly induce the expression of 
other cytokines known to stimulate epithelial cell IL-8 secretion (Hussein et al., 
2010). Importantly, it is not known which of the dupA alleles encode functional 
proteins. 
The original study describing dupA demonstrated an association between the 
presence of this gene and duodenal ulceration. In addition, a possible protective 
role of dupA in the development of gastric cancer was suggested (Lu et al., 2005). 
Evaluation of dupA and clinical outcome of infection has been studied further in a 
number of populations. An association between dupA positivity and DUD was 
confirmed in North India (Arachchi et al., 2007), Iraq (Hussein et al., 2008), and 
China (Zhang et al., 2008). However, this was not the case in patients examined in 
Iran (Douraghi et al., 2008; Hussein et al., 2008), Belgium, South Africa, China 
and North America (Argent et al., 2007). Interestingly, these studies did confirm 
the protective association between dupA and the development of gastric cancer 
(Argent et al., 2007; Douraghi et al., 2008). However, no association was found in 
other populations (Gomes et al., 2008), demonstrating distinct geographical 
1-43 
variations in the prevalence of the dupA gene and its association with the clinical 
outcome of infection. 
1.6.7 H. Mori neutronhil-activatine protein (HP-NAP) 
H. pylori neutrophil-activating protein (HP-NAP) is an oligomeric protein of 
150kDa, with a central cavity for iron accumulation. It was initially identified as a 
promoter of endothelial adhesion of neutrophils, and also found to be a possible 
adhesin to mucin (Namavar et al., 1998). The napA gene is found in all H. pylori 
strains, and differences in the level of gene expression may explain the differing 
ability of individual strains to induce inflammation. However, HP-NAP synthesis 
was found in 80% of H. pylori strains, regardless of whether patients presented 
with disease or not (Thoreson et al., 2000). Overall, cellular effects of HP-NAP 
lead to the induction of T helperl polarised immune responses that play a major 
role in maintaining chronic infection. This virulence determinant drives the 
inflammatory response through a number of mechanisms (illustrated in Figure 
1.10). HP-NAP is capable of crossing the epithelial layer to the underlying tissue 
where it comes into contact with a number of leukocytes. An important feature of 
HP-NAP is the ability of the virulence factor to induce extravasation of rolling 
leukocytes across the endothelial layer through direct contact with cells. 02 
integrin expression, essential for tight adhesion of leukocytes to endothelial cells, 
is also upregulated through contact with HP-NAP, leading to the recruitment of 
inflammatory cells towards the site of infection (Polenghi et al., 2007; Satin et al., 
2000). HP-NAP was also found to stimulate mast cells and macrophages to 
secrete TNFa, which is important for increasing the adhesiveness of endothelial 
cells, representing an indirect mechanism by which HP-NAP induces the 
recruitment of leukocytes (Amedei et al., 2006; Montemurro et al., 2002). 
In addition to these functions, HP-NAP was also found to stimulate monocytes 
and dendritic cells to promote an IL-12 and IL-23 rich milieu known to drive 
differentiation of antigen-stimulated T-cells towards a proinflammatory Th 1 
phenotype (Oppmann et al., 2000; Trinchieri, 2003). Furthermore, HP-NAP was 
shown to drive naive T cells (ThO cells) to express a Thl polarised profile and 
also downregulate the Th2 antibody response (Amedei et al., 2006; D'Elios et al., 
2009). 
1-44 
re lymphocytes 
-,. A- 
PMNs 
endothel8I ceNs 
-® A 0. A -A'16 
6 
IL-12. IL-23 
ChemokInos 
T Lymphocytes 
S®-ý 
ý^ý 
ýý ge5lnt spowhal eels 
Figure 1.10: Cellular effects of H. pylori HP-NAP. 
Schematic representation of HP-NAP functions in driving the inflammatory 
response to H. pylori infection. Once secreted by the bacterium, (1) HP-NAP 
crosses the gastric epithelial lining and (2) the endothelium, and (3) stimulates the 
adherence of leukocytes to endothelial cells, (4) followed by extravasation of 
cells. (5) HP-NAP also stimulates the secretion of cytokines IL-12 and IL-23 from 
activated neutrophils and monocytes, (6) thus creating an IL-12/IL-23-enriched 
milieu which is responsible for driving the differentiation of T helper cells 
towards the Th1 phenotype (Adapted from de Bernard & D'Elios, 2009). 
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1.7 THE IMMUNE RESPONSE TO H. PYLORI 
The immune system uses a complex array of mechanisms to eliminate pathogenic 
microbes, whilst controlling inflammation to avoid responses that produce 
excessive damage to self-tissue. The immune response to infection can be 
categorised as innate immunity, which involves rapid responses by non-specific 
recognition of infecting particles and represent the initial response to infection, or 
adaptive immunity, which involves highly specific immune responses that come 
into play later over the course of an infection. Synergy between innate and 
adaptive immunity is essential for a fully effective immune response capable of 
eliminating microbial infections. 
1.7.1 Innate immune responses to H. uvlori 
Innate immunity is central to the immune response to H. pylori infection, and acts 
as a front line defence against the bacterium. A number of components are 
involved and are discussed below. 
1.7.1.1 Epithelial cells 
The epithelial surface provides the first line of defence against infection. Tight 
junctions between these cells create an effective seal against the external 
environment. Mucosal epithelia are further protected by the expression of surface 
mucins, a collection of glycoproteins that create a thick gel covering the cell 
surface that is constantly shed and replaced. These cells also secrete antimicrobial 
peptides (Section 1.7.1.6). In this way, bacterial adhesion is greatly hindered. 
However, H. pylori have developed to bypass this protective barrier by means of 
flagella, along with the helical shape of the bacterium, to effectively burrow 
through the mucous gel to the epithelial cell surface, and also through down- 
regulation of certain antimicrobial peptides (Chapter 8, section 8.1). Evasion of 
this protective barrier is followed by adhesion to the cell surface through non- 
specific receptors that recognise common bacterial components. 
Importantly, epithelial cells also secrete cytokines in response to infection, which 
are essential in the initiation of innate and ultimately adaptive immune responses. 
One of the key responses to H. pylori infection, and specifically to the presence of 
CagPAI is the induction of IL8 expression (Brandt et al., 2005), which is 
1-46 
important for the recruitment for the recruitment of neutrophils to the lamina 
propria. 
1.7.1.2 Cell surface receptors 
Attachment to gastric epithelial cells induces an inflammatory response via a 
number of mechanisms. Activation of such responses depends on recognition of 
small conserved molecular motifs on microbes known as pathogen-associated 
molecular patterns (PAMPs), which include LPS and peptidoglycan. These 
microbial components act as ligands for cell surface pattern recognition receptors 
(PRRs) such as Toll-like receptors (TLRs), activation of which is followed by 
induction of intracellular signalling pathways that lead to the activation of 
transcription factors such as NF-xB essential for inflammatory cytokine gene 
expression (Netea et al., 2004). 
Studies addressing the role of TLRs in mediating gastric inflammatory responses 
have been conflicting. Several lines of evidence have demonstrated the roll of 
TLR4, which recognises bacterial LPS, in H. pylori immune recognition. TLR4 
RNA was detected in human gastric epithelial cell lines (Su et al., 2003) and in 
human gastric pit cells (Ishihara et al., 2004). However, other studies have 
demonstrated TLR4 not to be important in recognising H. pylori (Backhed et al., 
2003; Mandell et al., 2004). In any case, H. pylori LPS is a poor activator of 
innate immune responses compared to other Gram-negative bacteria (Moran, 
1999; Muotiala et al., 1992). H. pylori recognition was found to be predominantly 
mediated by TLR2, which recognises peptidoglycan, rather that TLR4 (Mandell et 
al., 2004). Furthermore, TLR2 was found to be important in H. pylori induced 
NFKB activation, demonstrating the importance of this receptor for immune 
recognition of the bacterium (Smith et al., 2003). As with TLR4, evidence for the 
role of TLR2 in H. pylon recognition is controversial. TLR2 expression was not 
detected in human gastric tissue (Mandell et al., 2004). 
TLR5, important for the detection of flagellin, has also been implicated in H. 
pylori infection (Smith et al., 2003). However, other studies have found little, if 
any, stimulation of this receptor. Such discrepancies in the reported involvement 
of TLR5 may relate to variable receptor expression patterns on different gastric 
cell lines (Gewirtz et al., 2004; Lee et at., 2003). 
1-47 
Nuclear-binding oligomerisation domain proteins I (NOD! ) and 2 (NOD2) are 
intracellular PRRs which recognise cytosolic PAMPs and are expressed primarily 
in antigen presenting cells (APCs) and epithelial cells. These receptors are 
responsible for activating NF-uB pathways, which ultimately initiate transcription 
of inflammatory responses. NOD I is a key component in activating inflammation 
during H. pylori infection in response to peptidoglycan injected by the CagPAL In 
particular, NOD1 activation in epithelial cells is associated with up-regulation of 
IL8 expression (discussed in section 1.6.3.1) (Viala et al., 2004). 
1.7.1.3 Neutrophils 
Neutrophils are phagocytic, multi-lobed leukocytes normally found in the blood, 
which migrate into tissue to sites of infection in response to chemotactic factors. 
These cells function to internalise and kill microbes, releasing bactericidal 
peptides and reactive oxygen metabolites. In the gastric mucosa, epithelial cells 
are stimulated in a CagPAI-dependent manner to secrete IL-8, a chemokine 
important in recruitment of neutrophils to the site of infection (Suzuki et at, 
2004b). Stimulation of neutrophils by H. pylori results in further release of IL-8 
from these cells which leads to recruitment of more neutrophils in the gastric 
mucosa (Shimoyama et al., 2002). Numerous studies have shown H. pylori 
infection to induce an active inflammation, characterised by infiltrating 
neutrophils (example slides given in appendix 11.1) (Basso et al., 2008; 
Demirturk et al., 2001). Neutrophilic activity is dependent on the generation of 
reactive oxygen species (ROS) for effective killing of phagacytosed bacteria 
(Sawyer et at, 1989). Enhanced ROS production in the gastric mucosa is highly 
associated with the development of H. pylori-associated disease (Suzuki et at, 
1996; Zhang et at, 1996), and furthermore, correlates with CagA positive 
infections and increased neutrophil infiltration of the gastric mucosa (Danese et 
at, 2001). Increased neutrophilic infiltration is also induced by H. pylori secreted 
HP-NAP (discussed in detail in section 1.6.7). Therefore, the phagocytic activity 
of neutrophils along with degranulation of stored proteins (e. g. metalloproteinases 
and serine proteases) that are capable of tissue damage (Rautelin et al., 2009), 
contribute to the immune response against H. pylori. 
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1.7.1.4 Macrophages 
Macrophages patrol the tissue for microbial infection. They are phagocytic cells 
and therefore, like neutrophils, are essential for initial responses to infection. 
These cells express a wide range of PRRs which are key for the recognition of 
microbes. Resistance to phagocytic killing by H. pylori has been observed in 
macrophages. In vitro studies demonstrated elayed phagocytosis in macrophages, 
and the accumulation of viable bacteria in large megasomal structures, protecting 
intracellular bacteria. The survival of H. pylon in megasomes was shown to be 
dependent on the cagPAI (Allen, 2001). 
Macrophages' activity is also dependent on the release of nitric oxide (NO) 
through activation of inducible nitric oxide synthase (iNOS), which aids in killing 
intracellular bacteria. H. pylori infection is associated with increased activation of 
iNOS in macrophages (Fu et al., 1999). This enzyme produces nitric oxide (NO) 
from the terminal nitrogen atom of L-arginine. However, H. pylori prevents NO 
synthesis by producing arginase, which converts L-arginine to urea and L- 
ornithine. In this way, H. pylori regulates NO production by competing for the 
substrate essential for its synthesis (Gobert et al., 2001; von Bothmer et al., 2002). 
Recently, activation of ERK signalling by H. pylori resulted in apoptosis of 
machrophages through the activation of c-Myc and ornithine decarboxylase 
(ODC) in vitro and in macrophages of the gastric mucosa, thus demonstrating a 
further mechanism by which H. pylori may interfere with host immune response 
(Asim et al., 2010). 
In addition, macrophages play an essential role in bridging the innate and adaptive 
immune response by presenting processed antigen on their cell surface, ready for 
recognition and activation of naive T-cells. Stimulation of macrophages by H. 
pylori induces the production of pro-inflammatory cytokines IL-6, IL-10 and 
TNFa (Crabtree et al., 1991b; Gionchetti et al., 1994). Furthermore, in vitro 
stimulation of macrophages resulted in the secretion of IL- 12 (which stimulates T 
cells to secrete IFNy) (Rad et at., 2007), and IL-23 (which stimulates Th17 cell 
secretion of IL-17 (discussed in section 1.7.2.3)) (Amedei et al., 2006), both of 
which are important to the immune response to H. pylori infection. The migration 
inhibitory factor (MIF), which is secreted by macrophages and other cell types, is 
associated with increased expression of chemokines, and therefore increases the 
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migration of macrophages to the site of infection. Recently, increased expression 
of MIF was observed in H. pylori infected mice, suggesting a role for this 
cytokine in the development of gastritis (Wong et al., 2009). The importance of 
these cells in gastric inflammatory responses was also demonstrated after 
depletion of macrophages in mice reduced gastritis after H. pylori infection 
(Kaparakis et al., 2008). 
1. Z1.5 Dendritßc cells 
Like macrophages, dendritic cells (DCs) act as phagocytic cells, and are critical 
for the activation of adaptive immune responses though their ability to present 
antigen on the cell surface. They are found in tissue as immature cells, and mature 
on antigen stimulation of PRRs. Human dendritic cells were found to be activated 
by H. pylori in culture, and may produce a host of cytokines, including IL-6, IL-8, 
IL-10, IL-12, IL-10 and TNFa (Hafsi et al., 2004; Kranzer et al., 2004; Kranzer et 
al., 2005). The cytokine profile produced by activated DCs determines the nature 
of the immune response. H. pylori infection has also been reported to induce IFN7 
and IL-17 which drive a Thl7, and hence, a pro-inflammatory response to 
infection (Khamri et al., 2010). Recently, H. pylori were found to be ingested by 
dendritic cells (Rad et al., 2007), and furthermore, were shown to reduce DC 
function in a CagA-dependent manner in vitro, with reduced ability to recognise 
LPS and reduced naive T cell differentiation to a Thl phenotype (Tanaka et al., 
2010). Therefore, dendritic cells are essential for development of adaptive 
immune responses to H. pylori, and the bacterium has developed to inhibit such 
responses in dendritic cells. 
1.7.1.6 Antimicrobial peptides 
In order to fight potentially harmful microbes, multi-cellular organisms have 
developed specific defence mechanisms to evade such infections. Many species 
have evolved to produce and secrete small peptides known as antimicrobial 
peptides (AMPs) which are cationic peptides that exhibit a wide range of 
antimicrobial activity against Gram-positive and Gram-negative bacteria, fungi, 
protozoa and viruses implicating them as direct effectors of the host immune 
response, acting as an early barrier in host defence. A number of different AMPs 
exist that are heterogeneous with respect o their primary and secondary structure, 
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tissue distribution, their effects on host cells, and antimicrobial potential. The 
expression of the mature peptide may be constitutive or inducible depending on 
species, tissue type and cellular lineages (Islam et al., 2001; Selsted & Ouellette, 
2005). 
The most extensively studied families of AMPs are the defensins and 
cathelicidins, which are structurally and evolutionarily distinct, but similar in 
distribution and abundance (Chen et al., 2006b). 
1.7.1.61 Defensins 
The defensin family of AMPs are small, arginine-rich peptides with molecular 
weight of 4-5kDa. They contain 6-8 conserved cysteine residues that form 3-4 
disulfide bonds, and are categorised based on the position of the cysteine residues 
as well as gene sequence. The family is subdivided into the a-, ß- and 6-defensins 
based on the distribution of cysteine residues (Ganz, 2003). 
Of the 6 identified a-defensins, HNP 1-4 were isolated from neutrophil cells, and 
constitute between 5-7% of neutrophil protein content, acting intracellularly with 
phagolysozomes to kill engulfed bacteria (Ganz & Lehrer, 1994). The second 
major source of a-defensins are intestinal Paneth cells, which in humans, express 
HD5 and HD6 (Jones & Bevins, 1992; Jones & Bevins, 1993), although other 
intestinal cells have been reported to express HD5 (Cunliffe et al., 2001). 
The ß-defensin subfamily consist of three ß-strands flanked by an a-helical 
segment in the N-terminal fragment of the protein (Pazgier et al., 2006). The first 
isolated human ß-defensin was hßB1 (Bensch et al., 1995), for which expression 
was subsequently detected in numerous epithelial cells including the 
gastrointestinal tract. As with h3B1, hJB2 and h3B3 expression is abundant in 
numerous epithelial cells (Table 1). Recently, h3D4 was identified and found to 
be expressed highly in testis and the gastric antrum. Subsequent studies observed 
expression of this defensin in lung, kidney and uterus, as well as neutrophils 
(Garcia et al., 2001). The hJD5 and hOD6 peptides were isolated in 2002, and 
found to be expressed specifically in human epididymis (Yamaguchi et a!., 2002). 
Importantly, a number of other human ß-defensin genes have been identified by 
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sequence analysis, although functional proteins are yet to be isolated (Schufte et 
at, 2002). 
The 6-defensins are structurally dissimilar to the a- and ß-defensins as they are 
cyclised. They have been isolated in several species of Old world monkeys, but 
not in humans (Nguyen et al., 2003). Although mRNA orthologs have been 
identified, mutations that introduce stop codons in the sequence abolish peptide 
production (Cole et al., 2002). 
1.7.1. ä2 Cathelicidins 
Cathelicidins are a large family of AMPs commonly found in mammalian species. 
These AMPs are not characterised based on structure, but rather by the way in 
which they are produced and stored in cells. All members of the family are 
synthesised as a large precursor peptide with the antimicrobial activity ascribed to 
the C-terminal portion of the protein. Heterogeneity in the C-terminus yields 
peptides with varying secondary structure and hence bactericidal activity. These 
AMPs are categorised broadly into 3 groups, the most common being the a- 
helical amphiphatic structure, whist the other groups are flat ß-sheet structures 
that are stabilised by disulphide bonding. The only homologue that has been 
described in humans is the a-helical LL-37 (Agerberth et al., 1995). LL-37 is 
processed from the proprotein hCAP-18 encoded by the camp gene 
(Gudmundsson et al., 1996). LL-37 was initially identified in granules of myeloid 
cells, but has since been detected in epithelial layers of the skin, respiratory tract 
and gastrointestinal tract (Frohm et at., 1997; Hase et at., 2003). LL-37 is actually 
stored as the proprotein in these cells until activated by serine protease cleavage, 
and after cleavage of hCAP-18, the N-terminal domain may also exhibit 
antimicrobial activity (Zaiou et al., 2003). LL-37 has been found to be active 
against a broad range of microbes with a wide overlap in specificity (Durr et al., 
2006). Apart from the antimicrobial functions of LL-37, immunomodulatory 
functions have also been described (Durr et al., 2006). 
The role of defensins and cathelicidins in H. pylori infection is discussed further 
in chapter 8. 
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1.71.6 3 Mechanism of action of AMPs 
Although known to have immunomodulatory properties (Yang et al., 1999), the 
key function of AMPs is their antimicrobial activity. The cationic characteristics 
and amphipathic nature of AMPs allows them to target a fundamental difference 
between membranes of microbes and multicellular organisms, that is the 
electrostatic charge of the outer membrane. Electrostatic interactions act over a 
relatively long distance, therefore explaining their specificity for bacterial anionic 
phospholipids in the outer most lipid bilayer of bacterial cells, compared to the 
zwitterionic amphiphiles present in mammalian membranes (Zasloff, 2002). 
Analysis of the primary structure of hOD 1-3 indicates a considerable variation in 
the net charge between defensins, with the more positively charged h3D3 having 
the greatest antimicrobial activity. The importance of the overall charge of these 
peptides was revealed in mutational studies which found no difference in 
antimicrobial activity when single amino acid substitutions did not alter the net 
charge or hydrophobicity of the peptide, although bacterial susceptibility and the 
rate of killing were altered (Hoover et al., 2003; Kluver et al., 2005). Increasing 
the net charge and hydrophobicity increases activity, whereas peptides with 
reduced charge and hydrophobicity were virtually inactive (Kluver et a!., 2005). 
The structure of AMPs is also considered important to function, given the 
conserved spacing between cysteine residues. 
AMPs are thought to kill target microbes by disrupting their membrane integrity 
via a mechanism known as the "Shai-Matsuzaki-Huang model". This model 
involves association of the peptides with the outer membrane of the bacterium, 
followed by displacement of the lipid bilayer resulting in membrane disruption 
and pore formation, leading to cell leakage and death (Figure 1.11). 
The importance of these AMPs in defence becomes apparent when regulation or 
function is disrupted, as describing in a growing list of diseases. This includes 
Crohn's disease, which is associated with a decreased expression of a-defensins 
(Wehkamp et al., 2007), and psoriasis which is associated with increased 
expression of AMPs (Lande et al., 2007; Yamasaki et al., 2007). 
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Figure 1.11: The Shai-Matsuzaki-Huang model for antimicrobial peptide 
mediated bacterial lysis. 
The proposed mechanism for antimicrobial peptide action by the Shai-Matsuzaki- 
Huang model involves (a) the attachment of peptides to form a carpet on the outer 
membrane of the bacterium. (b) This is followed by the integration of the peptide 
into the membrane and thinning of the outer leaflet. The surface area of the outer 
leaflet expands, resulting in strain within the bilayer (jagged arrows). (c) This 
allows for pore formation, (d) and transport of lipids and peptides into the inner 
leaflet. (e) This leads to destruction of intracellular targets once peptides have 
diffused into the intracellular space, (f) or can result in the collapse of the 
membrane and cell destruction (Zasloff, 2002). 
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1.7.2 Adaptive Immune response 
The adaptive immune response, in contrast to the non-specific innate immune 
response, is highly specific in targeting pathogenic microbes and clearing 
infections that have breached the innate response. Humoral and cell-mediated 
responses constitute the adaptive immune response, both of which are activated 
during H. pylori infection. However, despite this vigorous response, adaptive 
immunity is ineffective at clearing the infection. Instead, a severe chronic gastritis 
develops, which is associated with an increased risk of developing disease (Blaser 
& Atherton, 2004). H. pylori plays a central role in regulating these immune 
responses through virulence determinants expressed by the bacterium, which have 
been discussed previously. 
1.7.2.1 Priming of the adaptive immune response 
As mentioned, stimulation of epithelial PItRs ultimately results in the recruitment 
of leukocytes to the site of infection. In the case of H. pylori infection, these cells 
are recruited to the lamina propria (Crabtree, 1996; Mori et al., 2001). 
Macrophages and DCs come into contact with H. pylori antigen, and are essential 
for activation of adaptive immunity. However, as H. pylori is generally considered 
a non-invasive pathogen present only in the mucous gel and attached to the 
epithelial cells, it is unclear how these APCs "sample" antigen. The loosening of 
tight junctions by H. pylori virulence determinants may disturb the integrity of the 
epithelial layer so that antigen can pass through to the underlying lamina propria 
and hence the patrolling APCs. However, non-virulent strains of H. pylori also 
induce gastritis on infection. Some studies have demonstrated an invasive 
capability of H. pylori, finding intracellular bacteria in patients with gastritis and 
H. pylori-associated disease (Genta et al., 1996; Necchi et al., 2007; Noach et al., 
1994b), and in naturally infected rhesus monkeys (Dubois et al., 1994). Indeed, 
engulfed bacteria have been found within compartments of macrophages (Allen, 
2001), and DCs were shown to bind and ingest H. pylori (Rad et al., 2007). 
Antigen sampling in the intestine is mediated through specialised aggregations of 
lymphoid tissue called Peyer's patches, which are not present in the stomach. The 
significance of these structures in the immune response towards H. pylori 
infection has been demonstrated in mice that lack Peyer's patches. These mice did 
not develop gastritis when infected with H. pylori (Nagai et al., 2007). 
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Furthermore, Peyer's patches were found to be important in the humoral response 
as well as cell-mediated responses (Kiriya et al., 2007). It was also found that 
DCs activated by H. pylori in Peyer's patches instruct naive T-cells to 
differentiate into gut-homing T-cells, thus suggesting that the intestine is in fact a 
major source of antigen sampling and immune priming in H. pylori infection 
(Mora et al., 2003). 
There is now evidence to suggest that DCs are present at the gastric epithelial 
layer during H. pylori infection. Kao et al. (2010) found DCs near the surface of 
the epithelium in mice, and showed cytoplasmic projections of DCs extending 
between cells where they can sample luminal bacteria. In addition, DC-like cells 
have been identified in the H. pylori colonised human gastric epithelium (Necchi 
et al., 2009), therefore providing evidence that priming of the adaptive immune 
response may occur in the stomach. 
1. Z2.2 Humoral immune response 
Humoral immunity is mediated by secreted antibodies produced by the cells of the 
B lymphocyte lineage (B cells). These cells also act as APCs, and activation of 
naive B cells is mediated by the Th2 subset of T cells. Once activated, they 
differentiate into plasma cells capable of secreting large amounts of antibody. 
The role of B cell responses to H. pylori infection is controversial. Although a 
strong IgG and IgA response has been demonstrated both systemically and in the 
gastric mucosa (Hayashi et al., 1998; Mattsson et al., 1998), the role of humoral 
immunity is marginal in protective immunity against the bacterium. In addition, it 
was shown that colonisation in B-cell deficient mice was normal during early 
infection, but bacteria were cleared in later weeks, demonstrating the importance 
of T-cell immunity for protective immunity. Furthermore, mice with normal B 
cell function were extensively colonised by H. pylori and developed mild gastritis 
during late infection, suggesting B-cell immunity was in fact detrimental to 
elimination of the bacteria and impaired the gastric inflammatory response 
(Akhiani et al., 2004; Akhiani et al., 2005). 
1.7.2.3 Cell-mediated immune response 
The T lymphocyte cell lineage (T-cells) is central to cell mediated immunity. T 
cells express the T cell receptor (TCR) and undergo clonal expansion upon 
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recognition of peptide fragments that are bound to major histocompatibility 
complex (MHC) class I or II molecules on antigen-presenting cells. T cells are 
classified according to the co-receptor expressed at the cell surface. Cells carrying 
the CD8 co-receptor (CD8+ cells) bind to antigen-MHC class I complexes. As 
MHC class I binds antigen processed in the cytosol, CD8+ cells are important in 
host defence against intracellular pathogens. These cells are capable of inducing 
apoptosis in host cells, mediated by releasing granzymes and perforin. CD8+ cells 
are therefore referred to as cytotoxic T cells (Tc cells) (Castellino & Germain, 
2006). 
T cells expressing the CD4 co-receptor (CD4+ cells) recognise antigen complexed 
with MHC class II molecules and, through cytokine secretion, promote and 
enhance the immune response of other cells. They are therefore referred to as T 
helper cells (Th cells) (Castellino & Germain, 2006). A number of Th subsets can 
develop from circulating naive CD4+ cells and changes in the local 
microenvironment are important for determining which cell phenotype should 
arise. Proliferation of naive T cells through stimulation of TCR in an IL-12 rich 
environment gives rise to a Thl phenotype (Figure 1.12). Thl cells are 
characterised by the secretion of IFNy, IL-2, and TNFa, and promote the 
functions of other immune cells including macrophages and neutrophils. Effector 
functions of ThI cells are typically associated with the destruction of intracellular 
pathogens (Murphy & Reiner, 2002). Alternatively, TCR stimulation in an IL-4 
rich environment is necessary for induction of Th2 cells (Figure 1.12). These cells 
typically secrete IL-4, IL-5, IL-9, IL-13, and IL-10, and promote humoral 
immunity inducing B cells to produce antibodies. Th2 cells are also associated 
with eosinophil activation and mast cell degranulation (Le Gros et at., 1990; 
Murphy & Reiner, 2002; Swain et al., 1990). These two subsets are commonly 
referred to as opposing arms of the immune response, and evidence suggest that 
chronic immune responses in humans are polarised to either Thl or Th2 (Del 
Prete, 1998). Cytokines secreted by both subsets of cells have autocrine growth 
factor function on their secretive cells, and they simultaneously inhibit the 
expansion of the other subset, a function shown to be crucial to their regulation 
(Fernandez-Botran et al., 1988; Gajewski & Fitch, 1988). 
1-58 
Naive 
D4+ 
Th1 
IL-U, T-bet IFNy STAT-4 
Th2 
.* 
U() 
IL-4 
TGFP, iTre 
retinolc acid Tolerance to self 
FOXP3 io, TGF 
antigens, suppression of 
v! IL- ß inflammation 
Cell mediated immunity, 
e. g. against intracellular 
bacterial Infections 
Humoral Immunity, 
allergy, Immunity to 
intestinal parasites 
TGFO, IL-6, 
IL 23 Cn7 Chronic Inflammation, 
IL-17A, IL-17F immunity to fungal and bacterial infections 
Figure 1.12: The differentiation of naive T cells. 
Naive T cells can differentiate into a number of different effector T cells 
depending on the cytokine milieu during activation of the naive cell. In the 
presence of IL-4, they differentiate into Th2 effector cells important in humoral 
immunity, and secrete IL-4. They characteristically express the GATA-3 
transcription factor and signal through STAT-6 dependent pathways. IL-12 is a 
potent inducer of the Th 1 phenotype, which are characterised by the expression of 
the T-bet transcription factor, activation of STAT-4, and secretion of IFNy. Th17 
depend on TGF3, IL-23 and IL-6, and secrete IL17. Tregs also require TGFO for 
differentiation and secrete TGFß and possibly other cytokines to mediate the 
function of this subset of CD4" cells (Adapted from Robinson & Atherton, 2010). 
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The mucosal inflammation induced by H. pylori is widely believed to be polarised 
towards a Thl-dominated phenotype (D'Elios et al., 1997; Mohammadi et al., 
1996). Lymphocytes isolated from H. pylori infected mucosa were shown to have 
a Th i cell phenotype, and gastric T cells produced little IL-4, demonstrating the 
dominance of Thl cells (Bamford et al., 1998). A number of factors contribute to 
Thl immune dominance. The production of IL-8 is upregulated in epithelial cells 
during H. pylori infection, particularly in response to CagPAI (Viala et al., 2004). 
IL-8 is essential in the initial response to H. pylori for the recruitment of IL-12 
secreting neutrophils, which creates a cytokine milieu that induces Thl 
differentiation, and strong production of IL-12 in H. pylori infected gastric 
biopsies has been found (Karttunen et al., 1997). Furthermore, as discussed 
previously (section 1.6.7), HP-NAP is capable of inducing Thl responses and 
down-regulating Th2 response (Amedei et al., 2006). The Thl response has been 
demonstrated to be specific for CagA, with the majority of gastric Thl cells 
having specificity for this antigen, with prominent production of IFN-y, but not 
IL-4 (D'Elios et al., 1997). However, infections with non-virulent strains of the 
bacterium also induce an inflammatory response. Recently, H. pylori infection 
was found to activate dendritic cells and promote their maturation in a cag PAI- 
and VacA-independent manner (Kranzen et al., 2005). Overall, cell-mediated 
immunity to H. pylori infection is believed to be polarised towards a Thl 
phenotype, which contributes to the development of H. pylori-related disease 
profiles (D'Elios et al., 2003). 
More recently, a novel subset of T effector cells that differentiate from naive T 
cells was identified. These cells produce a range of cytokines including IL-6 and 
TNFa, but most abundantly secrete IL17 and were named Th17 cells (Aggarwal 
& Gurney, 2002). Th17 cells are a distinct population of T cells that are induced 
under the influence of IL-23, IL-6 and TGFf (Figure 1.12) (Bettelli et al., 2006). 
IL- 17 has a number of biological roles, and is believed to stimulate a number of 
cells including fibroblasts, endothelial cells, epithelial cells, and macrophages to 
secrete chemokines for the recruitment of other cells (Aggarwal & Gurney, 2002; 
Ye et al., 2001). Therefore, although Th17 cells are considered as cells of the 
adaptive immune response, cytokines secreted by these cells are important for the 
activation of innate immunity. IL-17 has been demonstrated to be upregulated 
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with H. pylori infection (Luzza et al., 2000; Mizuno et at, 2005). Importantly, IL- 
17 was found to be upregulated in the gastric mucosa and to stimulate the 
production of IL-8. Furthermore, up-regulation of IL-8 was observed in a gastric 
cell line, and neutrophil infiltration was observed in response to increased 
secretion of IL-8 (Luzza et al., 2000). IL-17 may therefore be important in H. 
pylori-induced gastritis. 
1.7.2.4 Regulatory Response 
In recent years, there has been renewed interest into the regulation of immune 
responses, and it is now clear that a subset of T cells with regulatory functions is 
responsible for modulating these responses. These regulatory T cells (Tregs) are 
critical for the regulation of immune responses, maintenance of immunological 
self-tolerance and immune homeostasis, and the control of autoimmunity and 
cancer surveillance (Sakaguchi & Powrie, 2007). Tregs represent a minor 
subpopulation of CD4+ T cells and are divided into two subpopulations which are 
defined as naturally occurring Tregs (nTregs) or inducible Tregs (iTregs). 
Natural Tregs originate directly from the thymus and constitute 5-10% of the T 
cell population in the peripheral blood. They express high levels of CD25, the 
alpha-chain of the IL-2 receptor, and FOXP3 (Forkhead box P3), a transcriptional 
repression factor of the forkhead-winged helix family of transcription factors 
(Sakaguchi et al., 2006), which, as discussed later, are markers that are 
characteristic of Tregs (Bluestone & Abbas, 2003). There is some evidence to 
suggest that nTregs are particularly important in maintaining tolerance to self- 
antigen (Hsieh et al., 2006; Pacholczyk et al., 2006). 
Recently, it was found that the Treg cell response can also be shaped in the 
periphery, and naive T cells differentiate into functional iTregs following 
stimulation in the presence of antigen and a specific cytokine milieu such as TGF- 
ß, IL-10 and IL-4 (Figure 1.12) (Chatenoud & Bach, 2006). In vitro stimulation of 
naive T cells in the presence of TGF-ß was found to induce the development of 
FOXP3+ cells with the suppressive characteristics of Tregs (Sakaguchi & Powrie, 
2007; Zheng et al., 2007). In addition, expansion of Treg cells was also 
demonstrated after TCR stimulation in vivo (Walker et al., 2003; Yamazaki et al., 
2003). 
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Heterogeneity exists in the iTreg population, with numerous lineages that are 
characterised according to the cytokine expression profile of the cells. Trl cells 
have regulatory function and secrete high levels of IL-10 (O'Garra et al., 2004; 
Thompson & Powrie, 2004). They can be generated from stimulation of naYve T 
cells that have been stimulated by antigen and APCs. This cell line differs from 
"conventional" Tregs as they are believed to be FOXP3 negative (Zhu & Paul, 
2010). TGF-ß producing Th3 cells are also iTregs (Weiner, 2001), and are 
believed to play a role in the induction of oral tolerance and prevent autoimmune 
disease after stimulation with self-antigen (Zhu & Paul, 2010). However, it is as 
yet unclear if these populations of cells are truly distinct. Many publications have 
described these populations but their classification overlaps. 
As mentioned, Tregs are characterised by the expression of FOXP3 (Sakaguchi et 
al., 2006), which was shown to be important for both the development and 
function of Tregs (Chatila et al., 2000; Khattri et al, 2003; Ziegler, 2006). The 
function of FOXP3 involves its physical association with the Rel family 
transcription factors, NFATs and NF-icB, and in doing so, blocks their ability to 
induce expression of their target genes including key cytokine genes (Bettelli et 
al., 2005). The importance of FOXP3 to Treg functionality becomes apparent with 
the autoimmune disease immune dysregulation, polyendocrinopathy, enteropathy, 
and X-linked syndrome (IPEX) in humans, which results from mutations in the 
FOXP3 gene (Bennett et al., 2001). 
In addition to FOXP3, Tregs are also characterised by the high expression of 
CD25 (Sakaguchi et al., 1995), and their survival and expansion is dependent on 
the presence of IL-2 (Setoguchi et al., 2005). T cells expressing high levels of 
CD25 are considered regulatory (Baecher-Allan et al., 2001). The CD25hi 
population of Tregs include both iTregs and nTregs, making it difficult to 
distinguish between the two subsets (Horwitz et al, 2008b). Based on the 
expression of CD25 on the surface of Tregs, it is believed that a possible 
mechanism by which Tregs execute their suppressive capability is through the 
scavenging of IL-2, which is also essential for the differentiation of other T cells 
(Pandolfi et al., 2000). 
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Cytotoxic T-lymphocyte antigen-4 (CTLA-4), is also highly expressed on the 
surface of Tregs, and is constitutively expressed on Tregs that express FoxP3. 
Furthermore, the relationship between TGFI, CTLA-4 and FoxP3 was shown to 
be important in the generation of iTreg, but not nTreg (Horwitz et al., 2008a). 
CTLA-4 is believed to block the differentiation of T cells through direct binding 
to the costimulatory molecules CD80 (B7-1) and CD86 (B7-2) expressed on 
APCs, which bind to CD28 on naive T cells for differentiation to effector T cells. 
CTLA-4 binds with higher affinity than CD28, therefore inhibiting the second 
signal, necessary for immune activation (Engelhardt et al., 2006). Further 
evidence for the immune suppressive function of CTLA-4 was provided in vivo 
through blockade of CTLA-4, which resulted in spontaneous development of 
chronic organ-specific autoimmune diseases (Takahashi et al., 2000). 
Natural regulatory T-cells have been shown to act via the production of regulatory 
cytokines IL- 10 and TGF-ß (Annacker et al., 2001; Asseman et al., 1999; Hara et 
al., 2001; Kingsley et al., 2002; Mills & McGuirk, 2004; Suri-Payer & Cantor, 
2001), and function through limiting effector T-cell function, and inhibiting 
recruitment of inflammatory cells such as neutrophils and monocytes (Rudensky 
& Campbell, 2006). The inhibitory roles of IL-10 and TGFI are discussed further 
in Chapter 7 (section 7.1). 
As H. pylori colonisation is persistent and provokes a chronic infection, the role 
of Tregs in suppressing the host immune response is of great interest. This 
concept is supported by the inability of H. pylori to maintain an infection in mice 
lacking Treg cells (Rad et at, 2006; Raghavan et at, 2003). Furthermore, elevated 
levels of both CD4+CD25h' cells and FOXP3 transcript can be found in the gastric 
mucosa of infected patients (Hida et al., 1999; Lindholm er al., 1998; Lundgren et 
al., 2005a; Robinson et al., 2008). Tregs were also found to home and accumulate 
in H. pylori-infected gastric tissue (Lundgren et al., 2005b), demonstrating the 
importance of Tregs in the immune response mounted during infection with this 
bacterium. The regulatory response to H. pylori is discussed further in Chapter 7 
(section 7.1). 
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1.8 AIMS 
The chronicity of infection that develops in response to H. pylori infection is 
driven by a combination of host and bacterial factors. The interaction between 
these factors results in what may be considered as an equilibrium between the 
toxicity of the bacterium and the immune response that is mounted against the 
infection. In this balance, a shift towards an aggressive immune response may 
lead to reduced bacterial numbers, whereas a shift towards colonisation with less 
virulent strains of the bacterium may dampen the damaging inflammatory 
response. Due to the complexity of the host-H. pylori relationship, questions still 
remain about the driving forces that lead to lifelong infection. To address the 
question of factors that influence colonisation, the specific aims of this study were 
to: 
" 
Design a quantitative assay for accurate assessment of H. pylori densities 
in the gastric mucosa. 
9 Determine the relationship between bacterial load and disease outcome in 
infected individuals. 
" Determine the impact of bacterial virulence factors on bacterial load. 
" 
Investigate proinflammatory host immune responses and their impact on 
H. pylori density. 
" 
Investigate regulatory immune responses in relation to H. pylori density 
and disease profiles. 
" Determine the influence of antimicrobial peptides on colonisation density. 
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Chapter 2 
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2. MATERIALS AND METHODS 
2.1 SAMPLE COLLECTION 
Gastric biopsies were donated with permission by patients attending a routine 
upper gastrointestinal endoscopy at the Queens Medical Centre, Nottingham 
(mean age=53.7, age range=33-86 years, male: female ratio=4.76). Donors 
attending the clinic were referred based on a number of dyspeptic symptoms 
including acid reflux and chronic indigestion, but were otherwise healthy. Clinical 
endoscopic observations and disease severity were noted. Patients were 
discounted from the study if antibiotics, proton pump inhibitors (PPIs) or non- 
steroidal anti-inflammatory drugs (NSAIDs) were taken in the 2 weeks prior to 
endoscopic analysis. Tissue specimens from the antrum and corpus were taken 
with informed patient consent and Nottingham University Hospital Ethics 
Committee approval. Biopsies taken for this study are summarised in Table 2.1. 
BIOPSIES STORAGE CONDITIONS 
TAKEN 
1x antrum Isosensitest glycerol (15% v/v) For culture 
lx corpus medium, stored at 
-80°C 
For CLO test and Ix antrum 
- 
rapid urease test 
Immediately fixed in formol-saline. 
1x antuen For histology Biopsies were paraffin wax embedded 
Ix corpus 
and 4µm sections were prepared 
For gPCR and Ix antrum RNALater RNA stabilising reagent 
RT-PCR 1x corpus (Qiagen), stored at 
-80°C 
Sterile RPMI640 medium 
supplemented with 2% foetal bovine 
For FACs analysis 4x antrum serum (FBS), 100U/ml penicillin G, 
100µg/ml streptomycin sulphate and 
250ng/ml amphotericin B. 
Table 2.1: Biopsies donated by patients during routine upper GI endoscopy, 
and storage conditions. 
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2.2 BACTERIAL STRAINS AND CULTURE 
2.2.1 H. nvlori strains and culture 
H. pylori clinical isolates were cultured from human gastric biopsies. Both clinical 
isolates and laboratory strains were cultured on Columbia blood agar plates 
containing 5% (v/v) horse blood (Oxoid) at 37°C in a 5% CO2 humidified 
atmosphere. Isolated strains were stored at 
-80°C in isosensitest medium (Oxoid) 
containing 15% (v/v) glycerol, prepared according to manufacturer's 
recommendations of 23.4g media in 1L distilled water. The medium was sterilised 
by autoclaving at 121 °C at l5psi for 15mins. Laboratory strains used are 
summarised in Table 2.2. 
H. pylori Relevant strain characteristics Reference 
strain 
Tx30a Wild-type (ATCC 51932) 
Leunk et al., 1988 
vacA s2/m2, cagPAI- 
60190 Wild-type (ATCC 49503) 
Leunk et al., 1988 
vacA sl/ml, cagAPAI+ 
601900vacA As 60190 but disrupted by insertion of 
chloramphenicol/kanamycin resistance marker in Argent et al., 2008 
the vacA gene 
6019OAcagA As 60190 but disrupted by insertion of 
chloramphenicol/kanamycin resistance marker in Argent et al., 2008 
the cagA gene 
601900cagE As 60190 but disrupted by insertion of 
chloramphenicol/kanamycin resistance marker in Argent et a!., 2008 
the cagE gene 
11637 Wild-type (ATCC 43504) Constructed 
vacA sl/ml, cagA+ previously in our 
group 
11637AcagE As 60190 but disrupted by insertion of Constructed 
chloramphenicol/kanamycin resistance marker in previously in our 
the cagE gene group 
84183 Wild-type (ATCC 53726) Perez-Perez & 
vacA sl/ml, cagA+ Blaser, 1987 
84183AcagE As 60190 but disrupted by insertion of Argent et a!., 2008 
chloramphenicol/kanamycin resistance marker in 
the cagE gene 
Table 2.2: H. pylori laboratory strains used. 
2-67 
2.2.2 Escherichia coil culture 
The Novablue E. coli strain (Novagen) was cultured on Luria-Bertani (LB) agar 
plates supplemented with carbenicillin (50gg/ml), Isopropyl ß-D-1- 
thiogalactopyranoside (IPTG, 80µM), and X-gal (70gg/ml) as appropriate. LB 
broth was prepared with lOg tryptone (Oxoid), 5g yeast extract (Oxoid), and lOg 
sodium chloride (Sigma-Aldrich), made up to 1 litre with distilled water. The 
medium was sterilised by autoclaving at 121°C at 15psi pressure for 15 minutes. 
LB agar plates were made by the addition of Bactoagar (1.5% w/v [Oxoid]) to the 
broth. 
2.3 GASTRIC CELL LINES 
AGS cells, a human gastric epithelial cell line (ATCC CRL-1739T'''`), were grown 
in F12 Ham's nutrient mixture medium (supplemented with L-glutamine, 
Invitrogen) with 10% FBS (Invitrogen), at 37°C in a 5% CO2 humidified 
atmosphere. Once fully confluent, cells were washed twice with sterile phosphate 
buffered saline (PBS), and then treated with Trypsin-EDTA (Invitrogen) to 
release cells from the flask. F12 medium was added to the cells to wash away any 
remaining Trypsin-EDTA. Cells were collected by centrifugation (1500rpm, 
3mins, at 21 °C) and resuspended in F 12 medium to appropriate dilutions, passed 
into new flasks with fresh medium, and incubated as before. 
2.4 CELL QUANTIFICATION 
2.4.1 H. Mori Cens 
The concentration of H. pylori cells in a suspension was estimated 
spectrophotometrically using the Pharmacia Novaspec II, where an OD55o of 0.1 
is equivalent to Ix 108 colony forming units (CFUs)/ml (determined previously 
in our group). 
2.4.2 Gastric cells 
1 volume of gastric cells were stained with 3 volumes of Trypan blue solution (0.4 
% w/v; Sigma) and quantified using a haemocytometer. 
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2.5 DNA PURIFICATION, MANIPULATION AND 
ANALYSIS 
2.5.1 Purification of H. Mori genomic DNA 
H. pylori cells cultured for 24 hours were harvested from blood agar plates and 
resuspended in lml sterile PBS. Cells were centrifuged (13000 rpm, 20°C, 5 
minutes) and pellets were resuspended in 100µl of TE buffer (l0mM Tris-Cl, 
1mM EDTA, pH 8.0). 5001i1 GES reagent (5M Guanidine thiocyanate, 0.5M 
EDTA, 10% w/v Sarkosyl) was added and incubated for 5mins at room 
temperature before being transferred to ice. 250µ1 ice cold ammonium acetate 
(7.5M) was then added before further incubation on ice for 5mins. 650µ1 
chloroform was added, mixed thoroughly and the layers separated by 
centrifugation (13000 rpm, 20°C, 5 minutes). The top aqueous layer was 
transferred to a clean 1.5m1 microcentrifuge tube and the chloroform extraction 
repeated. Isopropanol was added to one volume of the aqueous layer, mixed 
thoroughly and incubated at room temperature for 5mins to precipitate DNA, 
which was then collected by centrifugation as before. DNA pellets were washed 
twice with 70% ethanol and allowed to air dry. Once dry, DNA was resuspended 
in 1001i1 nuclease free water (Invitrogen). 
2.5.2 Purification of DNA & RNA from gastric bloDsies 
The All Prep DNA/RNA Mini Kit (Qiagen) was used, which allowed for the 
simultaneous purification of genomic DNA and total RNA from the same tissue 
sample. Thawed biopsies which had previously been treated with RNALater and 
stored at 
-80°C were transferred to RLT lysis buffer containing ß-mecaptoethanol 
(350µl) and homogenised for 30 seconds using a T8 Ultra Turrax rotor-stator 
homogeniser (IKA, Werke & Co. Freiburg, Germany). Nucleic acids were then 
extracted according to the manufacturer's instructions. Briefly, DNA was first 
isolated by passing the tissue homogenate through an A1lPrep DNA spin column, 
and then through an RNeasy spin column to selectively isolate RNA. DNA was 
eluted in TE buffer (100µ1), and RNA in 30µl nuclease free water (Qiagen). 
Nucleic acid concentration was quantified using a NanoDrop ND-1000 
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spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA). The quality 
of extracted nucleic acids was assessed by the A260/A2xo ratio. 
2.5.3 cDNA svntbesis 
cDNA synthesis of 100ng mRNA transcript was performed using 200U 
SuperScript II RNase H reverse transcriptase, lx first strand buffer (250mM Tris- 
HCL, 375mM KC1,15mM MgC12, pH 8.3 at room temperature), 10mM DTT, 
1.25µM oligo(dT) primer (Invitrogen, Paisley, Scotland) and 200µM each 
deoxynucleotide triphospate (Roche) in a final volume of 20µl. Purified RNA 
extracted from gastric biopsies was quantified using a NanoDrop ND-1000 
spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA). 
As a control for DNA contamination, first stage RT-PCR samples produced 
without reverse transcriptase were also synthesised. 
2.5.4 Polymerase chain reaction (PCR) conditions and end Doint analysis 
Reactions were prepared in a 50gl volume and contained 1xPCR Buffer 
(containing 1.5mM MgCl2; Qiagen); 1.25U Hotstar Taq polymerase (Qiagen); 
200µM each deoxynucleotide triphosphates (Roche); 0.1 µM each of forward and 
reverse primer (provided by Sigma-Aldrich); up to 300ng of DNA template, and 
nuclease-free water to volume. Reactions were performed in a PCRexpress 
thermal cycler (Hybaid). Primers used in this study are listed in Table 2.3. PCR 
cycling conditions are shown in Table 2.4. 
H. pylori strain genotyping was performed for cagA, vacA s-, m- and i-region, and 
dupA gene according to previous reports (referenced in Table 2.3). 
PCR products were analysed on 2% (w/v) agarose gels, which were prepared with 
lx Tris-acetate-EDTA buffer (TAE [40mM Tris-acetate, 2mM EDTA, pH 8.0]), 
and gels contained ethidium bromide (0.5gg/ml) for visualisation. 
Samples were prepared with 6x loading buffer (0.25% bromophenol blue, 20% 
glycerol in TE, 0.1% SDS), and run at 70V (constant volume) and visualised 
under UV light. 
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Primer Primer Sequence Product Reference 
Size (E) 
GAPDH: 
hGAPDHI GGTCCGAGTCACCGCCT 118bp In this study (N/A) 
hGAPDH2 TGGCGACGCAAAAGAAGATG 
16S rRNA: 
16S rRNAF CGATGAAGCTTCTAGCTTGC 164bp Narayanan, (N/A) 2005 
16S rRNAr ATAGGACATAGGCTGATCTC 
cagA: 
cag2 GGAACCCTAGTCGGTAAATG 
450bp Rudi et al., 
(N/A) 1998 
cag4 ATCTTTGAGCTTGTCTATCG 
vac. 4 s region: sl=259bp 
A3436 ATGGAAATACAACAAACACAC s2=286bp 
Atherton et 
al, 1995 
C1226 CTGCTTGAATGCGCCAAAC (N/A) 
vacA m region: m1=290bp 
VAGF CAATCTGTCCAATCAAGCGAG m2=352bp 
Atherton et 
al., 1995 
VAGR CTAGCGTCAAAATAATTCCAAGG (N/A) 
vacA i region: 
VACF1 GTTGGGATTGGGGGAATGCCG it- 426bp Rhead et aL, 
C1R TTAATTTAACGCTGTTTGAAG i2= 432bp 2007 (N/A) 
OR GATCAACGCTCTGATTTGA 
dupA: 
DupAF113 GACOATTGAGCGATGGGAATAT 1018bp Argent et aL, 
(N/A) 2007 
DupAR1083 CTGAGAAGCCTTATTATCTTGTTGG 
FOXP3 
Forward CAGCACATTCCCAGAGTTCCT (2.07) Robinson et 
a!.. 2008 
Reverse GCOTGTGAACCAGTGGTAGAT 
TGFB1 
Forward CAGAAATACAGCAACAATTCCTGG (2.86) Robinson et 
a!., 2008 
Reverse TTGCAGTGTGTTATCCCTOCTGTC 
ILIO 
Forward GCTGGAGGACTTTAAGGGTTACCT (1.94) Robinson et 
a!., 2008 
Revue CTTGATGTCTGGGTCTTGGTTCT 
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IL8 
Forward CTCTTGGCAGCCTTCCTGA (2,07) Robinson et 
al., 2008 
Reverse AGTTCTTTAGCACTCCTTGGCA 
GAPDH 
Forward CCACATCGCTCAGACACCAT (1.92) Robinson et 
al., 2008 
Reverse GGCAACAATATCCACTTTACCAGAGT 
Table 2.3: Primer pair sequences used for qPCR reactions and strain 
genotyping (E= reaction efficiency). 
Step Temperature 
(°C) 
Length of 
time 
Number of 
Cycles 
Initialisation 95 15mins 1 
Denaturation 95 30secs 
Annealing 56 60secs 35 
Elongation 72 30secs 
Final 
Elongation 
72 10mins I 
Table 2.4: PCR cycling conditions for amplification of 16S rRNA and 
quantification of H. pylori density by RT-PCR. 
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2.5.5 Quantitative Real-Time PCR (aPCR) 
2.5.5.1 Quantification of H. pylori colonisation density 
Absolute quantification of H. pylori copy numbers was determined using standard 
curves (described in more detail in Chapter 3). Reaction mixtures contained 2.5µl 
of forward and reverse primers (0.1µM, provided by Sigma-Aldrich), 5µ1 of DNA 
template, and 12.5jil of 2xQuantiTect SYBR Green PCR Master Mix (included 
HotStarTaq DNA Polymerase, QuantiTect SYBR Green PCR Buffer, dNTP mix, 
SYBR Green I dye, and ROX dye [Qiagen]). Reaction mixtures were made up to 
25pl with nuclease-free water and were carried out using the Rotor-Gene 3000 
system. Cycling conditions are listed in Table 2.4 with the addition of a final melt 
curve analysis between 72-95°C, increasing by 1 °C for each step, to ensure primer 
specificity. No template controls (NTCs) were included in each run. Data was 
analysed using the Rotor-Gene 6 program, with melt curves showing single peaks 
for each gene amplified. 
2.5.5.2 Reverse Transcriptase PCR (RT-PCR) 
Quantification of mRNA transcripts was carried out using 4µ1 of cDNA template 
(prepared as previously described in section 2.5.3). Reactions were performed 
using a DyNAmo HS SYBR green qPCR kit (New England Biosciences, UK). 
Reaction mixtures contained 2.5µl of forward and reverse primers, and 10µl of 
DyNAmo HS SYBR green PCR Master Mix. Reaction mixtures were made up to 
201Ll with nuclease-free water. Amplification was carried out over 45 cycles of 15 
seconds at 95°C, 30 seconds at 62°C, and 30 seconds at 72°C. No template 
controls were included in each run, and a melting curve analysis was performed as 
described above (section 2.5.5.1). First stage RT-PCR samples, produced in the 
absence of reverse transcriptase from each RNA sample were tested in parallel to 
ensure that products were not amplified from contaminating genomic DNA. 
Samples were run in duplicate and the results were analysed according to the 
method described by Pfaffl (Pfaffl, 2001). Relative gene expression levels were 
determined by normalising against GAPDHmRNA levels, and data was presented 
as a fold difference in comparison to a reference sample obtained from uninfected 
donors. For this uninfected comparator, cDNA was synthesised from purified 
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RNA pooled and extracted from biopsies donated by 10 H. pylori negative 
patients. A commercial human cDNA standard (BD Biosciences) was included as 
a positive control in all assays. Reaction efficiencies were measured with a 
standard curve developed using a 4-fold dilution series of a commercial human 
cDNA standard (BD Biosciences). Real-time PCR was performed on a Rotor- 
Gene 3000 (Corbett Research, Cambridge, UK). 
Commercial primers were used for the quantification of human hBDI and LL37 
expression (Qiagen), and normalised with commercial GAPDH primers (Qiagen). 
Amplification was carried out over 40 cycles of 15s at 94°C, 30s at 55°C and 30s 
at 72°C. Reaction efficiencies were determined as previously mentioned 
(hBD1=1.97, LL37=1.83, GAPDH=1.93). 
2.5.6 Preparation of human GAPDH plasmid construct pSAP1 
An 118bp fragment of the human GAPDH gene was amplified by PCR using the 
hGAPDHI and hGAPDH2 primer pair (Table 2.3) and the above protocol (Table 
2.4). The PCR reaction was separated by agarose gel electrophoresis, and the 
corresponding band was excised from the agarose gel and weighed. The DNA 
fragment was then purified using the Wizard SV Gel and PCR Clean up System 
(Promega) according to manufacturer's instructions. DNA was eluted in 501A of 
nuclease-free water. 
The purified PCR fragment was then cloned into the pGEM-T Easy Vector 
System (Promega) according to the manufacturer's recommendations. Insert and 
vector were used in a 3: 1 molar ratio. The amount of insert used was determined 
using the equation: 
Vector concentration (ng) x Product size (kb) 1x insert: vector molar ratio Size of vetor (kb) 
lOµ1 reaction mixtures contained lx ligation buffer (Promega), pGEM-T Easy 
vector (50ng), and T4 DNA Ligase (3 Weiss units). Positive control reactions 
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containing control insert DNA (8ng; Promega), and vector only control reactions 
were also set up. Reaction mixtures were left to incubate at 4°C overnight. 
1 µl of the ligation reaction was transformed into E. coli Novablue competent cells 
(Novagen) according to manufacturer's recommendations. Cells were plated onto 
LB agar plates containing carbenicillin (50pg/ml), IPTG (80µM), and X-gal 
(70µg/ml), and incubated overnight at 37°C. 
To test for the presence of the correct plasmid construct, white E. coli 
transformants were used to inoculate individual 5m1 LB broth cultures 
supplemented with carbenicillin (50gg/ml) and incubated overnight at 37°C with 
shaking. Cells were harvested by centrifugation (4000 rpm, Smins), and plasmid 
extraction was performed using the Qiaprep Spin Miniprep Kit (Qiagen) 
according to the manufacturer's recommendations. Plasmid DNA was eluted in 
50µ1 of Buffer EB (10 mM Tris"Cl, pH 8.5). 
Restriction digestion was carried out using the Not! endonuclease nzyme (New 
England Biolabs), which cuts either side of the insertion site, and excision sites 
were not present in the expected insert. Reaction mixtures were set up as follows: 
5µl restriction buffer, 5 t1 BSA, l tl restriction enzyme, 6µl DNA and 33µl 
nuclease free water (final volume of 5011) Reactions were incubated at 37°C for 2 
hours, and fragments were visualised by agarose gel electrophoresis (2% w/v) 
(section 2.5.4). 
Positive clones were identified and verified by DNA sequencing at the 
Biopolymer Synthesis and Analysis Unit (Queen's Medical Centre, University of 
Nottingham). Sequence data was analysed using DNAstar software. A clone with 
the correct GAPDH insert was selected and named pSAP1 
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2.6 CO-CULTURE ASSAYS 
All cells were cultured as described in section 2.3, trypsinised and seeded into 
flat-bottomed 24 well tissue culture plates at 5x 104 cells/well, which were then 
incubated at 37°C, 5% C02 for 24 hours. At 80% confluence, media was replaced 
with media containing 24 hour grown H. pylori cultures at an MOI 100. Cultures 
were incubated for a further 24 hours. 
AGS cells were infected with H. pylori mutant and wildtype strains which were at 
the same passage number. After 24 hours of co-culture, cells were removed by 
scraping and treated with 1% Saponin (diluted in sterile PBS) to ensure a 
homogenous suspension of cells. A 10-fold dilution series was created in sterile 
PBS, and bacterial colony foaming units (CFU) were determined by spotting lOµ1 
volumes of the diluted suspensions onto Columbia horse blood agar plates, which 
were incubated as described above in section 2.2.1. Five 10µl spots were plated 
for each dilution, and CFUs were enumerated once colonies were visible, usually 
after 4 days incubation. 
2.6.1 Cvtokine assay 
AGS cells were cultured and infected with H. pylori as described in section 2.6. 
For cytokine treatment, commercial recombinant protein was added at the time of 
infection at a concentration of 5Ong/ml unless otherwise stated. Cytokines used 
included IL-10, TNFa, TGFß, IL-22 (all from Peprotech), IL-10 and IL-17 
(AbSerotech). Untreated cultures were included as controls, as well as uninfected 
AGS cytokine stimulated controls. After 24 hours of culture, supernatants were 
harvested by pipetting and stored at 
-80°C for assessment of IL-8 secretion levels. 
2.7 ELISA ASSAYS 
IL-8 levels were assayed using a Biosource human IL-8 Cytoset" enzyme linked 
immunosorbent assay (ELISA) kit (Invitrogen), according to the manufacturer's 
instructions. A standard curve was included on each plate and samples were 
measured in duplicate, diluted at half their original concentration. Serum gastrin- 
17, pepsinogen I and pepsinogen II levels were assessed using Biohit ELISA kits 
(Biohit). Optical densities were measured using a microplate reader (LabSystems 
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iEMS reader MF) at 450nm and 620nm and the concentration of cytokine in each 
sample was calculated by reference to the local standard curve. 
2.8 HISTOLOGY 
Gastric biopsy sections were prepared and stained by Dr Abed Zaitoun (Division 
of Histopathology, University Hospital, Nottingham) with either Haemotoxilin 
and eosin stain used to assess the degree of inflammation, activity, atrophy and 
intestinal metaplasia, or Toluidine blue stain which was used to assess the grade 
of H. pylori density. Scoring was carried out using the Sydney scoring system 
(Genta & Dixon, 1995; Genta, 1996; Price, 1991) and was done independently 
under the supervision of Dr Abed Zaitoun. Example slides are shown in appendix 
11.1. 
2.9 FLOW CYTOMETRY ANALYSIS 
Four antral gastric biopsies were dissociated by rubbing through a sterile 
disposable 100 µm nylon cell strainer (BD Biosciences, Oxford, UK), washed and 
re-suspended in RPMI 1640 culture medium supplemented with 10% FCS, 
100µg/ml penicillin and 100gg/ml streptomycin sulphate (all from Sigma) at Ix 
106 per ml. H. pylori whole-cell sonicated antigen from the SS1 strain (Lee et al., 
1997) was added to give a final concentration of 25gg/ml as described previously 
(Robinson et al., 2005). As a positive control, PMA and ionomycin were added to 
give final concentrations of 20ng/ml and 1 µM respectively. Negative control 
tubes received no antigens or mitogens. The cultures were incubated for 1 hour at 
370C in 5% CO2 before adding Brefeldin A (BFA) (Sigma) at 10 µg/ml and then 
replaced in the incubator for a further 14 hours. The positive control 
PMA/ionomycin tubes were incubated for only a further 5 hours after adding 
BFA. 
Cells were pelleted at 250xg for 5 minutes at 4°C in preparation for staining with 
combinations of the following conjugated monoclonal antibodies for 30 minutes 
on ice: anti-human-CD4-phycoerythrin-Texas Red (ECD), anti-CD45- 
phycoerythin-cyanin 5.1 (PC5), and anti-human-CD25-PE (Miltenyi Biotech). 
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The cells were washed three times with iml of ice-cold PBA buffer (PBS 
containing 0.1% BSA and. 0.05% sodium azide) supplemented with 2% FBS 
before fixing in 0.5m1 0.5% formaldehyde in PBS at 4°C overnight. The cells 
were then washed with Iml PBA, and permeabilised by washing in lml 
PBA/0.1 % saponin. Cells were washed with PBA/0.1 % saponin/ 10% FCS before 
staining with anti-IL-10-FITC (R&D Systems) for 2 hours at 4°C. The cells were 
washed three times with PBS/0.1% saponin before fixing in 0.5% formaldehyde. 
The data on 100,000 events were acquired using a Coulter EPICS Altra flow 
cytometer, unstained cells and cells stained separately with each fluorochrome- 
labelled antibody were included to optimise compensation settings. Data analysis 
was performed using WinMDI version 2.8 (http: //facs. scripps. edu/) or WEASEL 
v. 2 (developed by Walter and Eliza Hall Institute of Medical Research). CD45+ 
events were then analysed for CD4, CD25 and IL-10 staining with reference to 
appropriate isotype control antibody conjugates. Analysis of cell counts was 
assessed by a colleague, Darren P Letley. 
2.10 PROGRAMS AND WEBSITES USED 
All programs and websites used for data or sequence analysis are listed in Table 
2.5. 
Website or program used Web address 
Lasergene software by DNASTAR Inc. Was 
used for sequence data analysis 
Ensembi website used for GAPDH gene analysis www. ensembl. org 
Netprimer website for primer design www. premierbiosoft. com/netRrimer 
BLAST search www. ncbi. nim. nih. gov/BLAST 
Table 2.5: Programs and websites used. 
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2.11 STATISTICAL ANALYSIS 
Statistical analyses and box-and-whisker plots were prepared using MINITAB 
Release 14 software. Boxes represent the first to third quartiles, the median values 
are shown as horizontal lines within the bars, and the whiskers depict the lowest 
and highest observations within 1.5 times the first to third interquartile range. 
Statistical tests of unpaired data were carried out using the Mann-Whitney U-test, 
unless otherwise stated. Correlations were examined using the Spearman's rank 
correlation test. Analysis of in vitro data was tested using the Student T-test. A 
significant difference was taken at p: 50.05 
2-79 
Chapter 3 
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3. DEVELOPMENT OF A QUANTITATIVE 
ASSAY FOR H. PYLORI FROM HUMAN 
GASTRIC TISSUE 
3.1 INTRODUCTION 
The quantification of bacterial load has many applications, including monitoring 
the effectiveness of treatment regimes and vaccines. A number of techniques are 
available for measuring bacterial burden in gastric tissue with varying degrees of 
accuracy, making some techniques semi-quantitative at best. 
3.1.1 OuantitatIve culture 
The use of quantitative culture has been utilised in a number of studies with 
varying degrees of success. Previous comparative studies have investigated the 
accuracy of quantification of H. pylori density by culture in comparison to other 
quantitative tools such as histology and qPCR. However, the degree of correlation 
between different assays varies between studies, with some reports showing a 
strong correlation (Atherton et al., 1996; Janzon et al., 2009), whilst others have 
not (Auroux et at, 1998; Tummala et al., 2007). Furthermore, studies that have 
shown a good correlation between bacterial loads found reduced bacterial 
numbers with culture in comparison to qPCR (Janzon et al., 2009; Nayak & Rose, 
2007). The accuracy of quantitative culture is of course dependent on the viability 
of the bacteria in the sample, illustrating the importance of an optimal transport 
system and rapid processing of tissue after collection. Culture conditions may also 
impact the accuracy of quantification. A homogenous biopsy suspension is 
necessary as a cluster of organisms will grow as a single colony rather than 
several, leading to an underestimation of bacterial density, and an overgrowth of 
other organisms may be a problem if selective media are not used (Goodwin et at, 
1985). This may explain the differences in the efficiency of quantitative culture 
observed between comparative studies. 
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3.1.2 Ouantiffcation by UBT 
The urease breath test (UBT) has also been used for the quantification of H. 
pylori. Previous studies have noted a positive correlation between the change in 
13C02 and H. pylori colonisation density measured by qPCR (Perri et al., 1998; 
Zagari et al., 2005). Although the difference in 13C02 may give an indication of 
bacterial load, UBT does not provide absolute quantification. The UBT is non- 
invasive and measures density in the entire stomach, which may prove useful as a 
quick and easy method for monitoring treatment of the infection. However, UBT 
will not be appropriate for determining bacterial load in different anatomical sites 
of the stomach. This may be due to uneven intragastric distribution of the urea 
solution, which may result if the protocol for UBT is not strictly followed, 
including the positioning of the patient (Atherton, 1997). Also, urease activity of 
individual H. pylori strains may differ by several-fold, and therefore, urease 
activity can not accurately reflect bacterial density. Not surprising, studies have 
failed to show a correlation between bacterial load and UBT (Graham & Klein, 
2000; Logan et al., 1991; Tummala et al., 2007). 
3.1.3 Quantification by histoloi v 
Overall, histological estimation of H. pylori density is most commonly used. H. 
pylori can be visualised microscopically with several special stains including 
Toluidine blue and silver stains, which allow for better contrast between bacteria 
and the mucous in comparison to the standard hematoxylin-eosin (H&E) stain. 
Measure of bacterial load is usually based on the semi-quantitative Sydney system 
of classification (Dixon et al., 1996). Some previous comparative studies have 
demonstrated reasonable correlation in quantification between histology and 
culture (Atherton et al., 1996), as well as qPCR (Kobayashi et al., 2002). 
However, quantification is dependent on the expertise of the examining 
pathologist and so estimations of bacterial load by histology can be subjective. 
3.1.4 Quantification of nucleic acids 
Bacterial density can also be quantified using molecular methods. Probe 
hybridisation methods, with the use of target-specific non-radioactive labelled 
probes such as digoxigenin (DIG), can be used. However, the sensitivity of 
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detection may be poor as large amounts of DNA are required (Tsai et al, 2003). 
The use of PCR increases the sensitivity of detection as theoretically, a single 
copy of the target gene can be detected. Bacterial density can be estimated from 
band density of PCR products on acrylamide gel, and accuracy can be increased 
by normalising band density of the target gene against the density of a reference 
gene such as Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (discussed 
further in section 3.1.5.2). However, PCR has inherent limitations (von 
Wintzingerode et al., 1997). A major drawback in analysing PCR amplicons after 
completion of the final PCR cycle (termed "end point" analysis) is that the 
number of amplicons detected may not reflect the actual proportion of the target 
gene. This results from biases introduced into the reaction that are associated with 
the amplification of a target from a mixed DNA template (Suzuki & Giovannoni, 
1996). Moreover, it may be difficult to distinguish small differences between 
samples based on band intensities, making quantification by such methods 
limited. 
To overcome the limitations of quantification observed with standard PCR, 
competitive PCR was developed, which has also been utilised for the 
quantification of nucleic acids (Becker-Andre & Hahlbrock, 1989). This 
technique uses an internal standard, which is co-amplified using the same primer 
set as the target template. The standard harbours a mutation that will result in a 
PCR product of different size to the template, making the two amplicons easily 
distinguishable. As the amount of competitive template added to the reaction is 
known, it is easy to calculate the amount of target product in the reaction. 
Competitive PCR was previously shown to be a reliable method for the 
quantification of H. pylori (Furuta et al., 1996; Monteiro et at, 1997). The use of 
an internal standard for quantification reduces well-well variations in PCR 
amplification. In addition, although quantification involved assessing band 
intensity of PCR products on acrylamide gel, the inclusion of internal standards 
provided a means for absolute quantification (Furuta et at, 1996). However, the 
DNA standard may also alter the final result through competing for reagents and 
primers during the PCR. 
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As mentioned, estimating bacterial load by end point analysis may not be 
sufficient for accurate quantification as the kinetics, and hence the efficiency of 
the reaction drops over the course of amplification, eventually leading to a plateau 
in the amount of PCR product produced. Ideally, the efficiency of a reaction 
should be 100%, which can be described as the synthesis of two complete 
molecules from every one template, and the number of detected amplicons is 
directly proportional to the initial number of target sequences. This occurs in the 
exponential phase of the reaction (Heid et al., 1996). The sensitivity of PCR is 
due to the exponential amplification nature of the procedure (Equation 1). 
Equation 1: 
Nn =No x (1 + E)° 
Where N is the number of DNA molecules after n cycles of PCR, No represents 
the initial number of template molecules, and E is the efficiency of amplification. 
The efficiency of a reaction is dependent on a number of factors including the 
length and the sequence of the DNA to be amplified, primer design, concentration 
of reaction buffer, and temperature, and even a minor change in E can result in 
dramatically different amplification kinetics. The efficiency begins to approach 
zero as PCR reaches the plateau phase. For this reason, it is difficult to directly 
quantify No by measuring N. at the end of the reaction (Heid et al., 1996). Real- 
time PCR overcomes this problem by determining No during the exponential 
phase of the reaction. 
3.1.5 Real-time PCR 
Real-time PCR is a kinetics-based quantitative technique which exploits 
fluorescence technology for the detection of newly synthesised PCR products. 
Fluorescence emission is detected at each PCR cycle throughout the reaction. 
During the initial few cycles of the reaction, where PCR products are too few to 
quantify accurately, very little change in the fluorescence signal is detected. This 
represents the baseline of the reaction. As the PCR progresses, the build up of 
newly synthesised amplified product results in increasing amounts of fluorescence 
emission (Heid et al., 1996). The difference between the signal at each time point 
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and the signal of the baseline is calculated, and is described as ORn (Gibson et al., 
1996). Real-time PCR plots display this change in fluorescence emission against 
the cycle number (Figure 3.1). 
For nucleic acids quantification, the fluorescence data are converted into 
numerical values. The fluorescence level at a defined threshold, typically 10 times 
the standard deviation of the average signal of the baseline fluorescence signal, is 
used (Ct). The Ct value is inversely proportional to the logarithm of the initial 
template concentration and is always in the exponential phase (Gibson et al., 
1996). 
3-85 
2000000 
1800000 
1600000 
1400000 
1200000 
C 1000000 
800000 
400000 
- 
- 
200000 
t 50000 
-a-12500 
-3125 
+781 
-195 
-6-49 
- 
NTC 
Linear phase 
2000001 Threshold 
Baseline 9 18 27 
Plateau 
36 45 
-2000OO ,Ct 
cycle number 
Figure 3.1: An example PCR plot illustrating the stages of the amplification 
reaction. 
Amplification plots for a five-fold serial dilution of template cDNA, amplified by 
real-time PCR. The change in fluorescence (ARn) between the baseline signal and 
the signal detected at each cycle is plotted. The initial cycles of the reaction show 
little changes in fluorescence, and represent the baseline of the reaction. ARn 
increases as the reaction progresses, and crosses the threshold in the exponential 
phase of the reaction. The point at which 4Rn crosses the threshold is referred to 
as the Ct value, and is used to calculate the initial concentration of the template. 
The reaction then proceeds through a log phase, before increases in ARn slow 
down and eventually reach the plateau phase. Serial dilutions demonstrate the 
impact of the initial template concentration on Ct values, with higher 
concentrations of template having lower Ct values (Taken and adapted 
from Giulietti et al., 2001). 
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ILS. I Detection chemistries 
The use of fluorescence-based detection increases the sensitivity of quantification, 
and enables the detection of gene number at a much wider range than end point 
analysis. Detection using fluorescence chemistry is largely based on fluorescence 
resonance energy transfer (FRET), which involves light emission from an excited 
reporter dye, which is absorbed and activates an acceptor dye that may emit light 
as a result. A number of different fluorescent technologies exist for real-time 
PCR. These are categorised into: 
a) Primer-dye based signalling systems: 
This technology involves a fluorescent reporter that is attached to the 
primer. After binding to the target gene, amplification leads to the release of 
the fluorescent signal. With the LUX system, for example, the reporter is 
attached at the 3' end of the oligonucleotide. A 4-6 base pair extension at 
the 5' of the oligonucleotide binds to an internal sequence near the 3' end, 
effectively creating a stem loop structure that quenches fluorescence of the 
reporter dye. Following the melting and annealing of the primer to the 
template, the primer is made linear and incorporated into the newly 
synthesised DNA strand, which frees the reporter and results in an increase 
in fluorescence of up to 10-fold over the background (Nazarenko et al., 
2002). This technology allows for high specificity; however, the quality of 
the assay is dependent on the specificity of the primers for the target gene. 
b) Probe based signalling: 
These assays involve a third oligonucleotide that also binds to the target 
sequence. The probe is bound by both the reporter dye and also the acceptor 
dye that quenches the fluorescence of the reporter. Annealing of the probe 
must occur before the binding of the primers. Taq polymerase binds 
immediately after and begins extension of the target gene. The 5' nuclease 
activity of the polymerase cleaves the probe that is bound and releases the 
reporter from the quencher, allowing emission of light which is detected 
(Holland et al., 1991). A number of different probe-based technologies 
exist, including the Taqman system and molecular beacons. Multiple 
reporter dyes can be used with a variety of quenchers. These systems benefit 
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from the added specificity of using a third primer, making them useful for 
detection of target genes with low copy number. In addition, there is no 
detection of primer dimers. However, the addition of an extra primer 
increases the cost of the assay and complicates assay design (Giulietti et al., 
2001). 
c) Free dye systems: 
These systems incorporate a free dye into a newly synthesised double- 
stranded DNA product. This was initially demonstrated with ethidium 
bromide (Higuchi et at, 1993). The most commonly used dye for real-time 
PCR is now SYBR green I (Schneeberger et at, 1995). This dye is ideal as 
it has low background fluorescence, and when bound to the minor groove of 
double-stranded DNA, a dramatic increase in fluorescence output of almost 
2000 times the initial unbound signal is seen. This system is beneficial as it 
is relatively cheap and the assays are easy to develop. However, this system 
is limited as all double-stranded DNA products will be susceptible to 
detection by SYBR green. This includes primer-dimers and any non-specific 
amplicons generated during the course of the reaction. Therefore, excellent 
primer design is necessary to minimise non-specific amplification. The use 
of heat dissociation analysis is also beneficial for determination of non- 
specific fluorescence detection. This involves incremental heating of the 
PCR product at the end of the reaction (Ririe et at, 1997). The dissociation 
of double-stranded products as a result releases the dye and causes a 
decrease in fluorescence intensity. A negative first derivation curve of 
fluorescence intensity shows the melting temperature of the products in the 
reaction. Ideally a single peak should be present representing the specific 
PCR product that is amplified (see Figure 3.3C). Melting temperatures 
measured at the point of dissociation should be similar to the predicted 
melting temperature of the PCR amplicon, therefore making primer-dimers 
easy to identify, as their short oligonucleotide sequence will have a low 
melting temperature. The use of HotStart DNA polymerase may also help to 
eliminate extra-assay signals. The use of SYBR green at high concentrations 
has been shown to inhibit PCR, illustrating the need to optimise assays 
(Giglio et at, 2003). 
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The choice of which technology to use is dependent on many factors. The need 
for high specificity would call for the use of probe based systems such as Taqman. 
However, these technologies can be expensive and low cost favours the use of 
SYBR green. 
31.5.2 Normalisation of PCR assays and reference genes 
Although quantification by real-time PCR is highly sensitive and specific, a 
number of errors can be introduced at various stages of the protocol. These 
include variations in the amount of DNA in the reaction, which may differ as a 
result of varying sizes of tissue samples, variability in the extraction procedure, or 
simple pipetting errors. For the quantification of RNA, additional error may be 
introduced during cDNA synthesis (Bustin & Nolan, 2004). Consequently, an 
appropriate method of normalisation is required to minimise these experimental 
errors. 
The most basic and simple method for normalisation is correcting for sample size, 
for example by using tissue weight. However, correcting for sample size may not 
ensure that the samples contain the same cellular content. For example, adhesive 
cells used for in vitro culture assays can often clump together, making it difficult 
to obtain accurate cell counts. Therefore, this method of normalisation is not 
sufficient on its own. Correcting for the total amount of DNA extracted from 
samples may also be efficient. However, this is dependent on the accuracy of 
measuring DNA concentration. For the quantification of RNA, it is essential to 
use consistent concentrations of RNA for cDNA synthesis. However, this does not 
account for errors introduced during the synthesis of cDNA (Bustin & Nolan, 
2004). 
Normalisation to a reference gene is currently the most acceptable method to 
correct for minor errors. In theory, normalisation by amplification of a reference 
gene is the most accurate method as the reference gene will be subject to the same 
variation that affects the gene of interest. Ideally, reference genes are expressed 
constitutively in all cells and at different times of development. These genes are 
often termed housekeeping genes, and the most commonly used include ß-actin, 
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GAPDH, and hypoxanthine-guanine phosphoribosyl transferase (HPRT) (Giulietti 
et al., 2001). Importantly, the expression of the housekeeping gene must not be 
affected by the experimental procedure. There is evidence to suggest hat both 0- 
actin (Foss et al., 1998) and GAPDH (Bustin, 2000; Freeman et al., 1999) 
expression is influenced by the experimental treatment or conditions. It is now 
thought that use of multiple reference genes in an assay may reduce the error that 
may occur as a result of using a single reference gene (Vandesompele et al., 
2002). However, this may increase the cost of the experiment, and may not be 
suitable if a limited amount of sample is available for amplification. 
3.1.5.3 Methods of quantification 
Quantification of the results obtained by real-time PCR may be absolute or 
relative. Absolute quantification involves the use of standard curves. Standards 
can be based on a plasmid construct containing a portion of the gene of interest, 
synthetic oligonucleotides, or genomic DNA. Concentrations of the standard are 
measured by spectrophotometry, and copy numbers can be calculated using the 
molecular weight of the DNA or RNA. The design and development of a standard 
curve is essential for accurate quantification, as small variations between reactions 
in the initial phase are amplified greatly during PCR (Reid et al., 1996). The 
quality of the standard curve can be estimated from parameters determined by the 
software used for real-time PCR. The efficiency of the reaction (E) provides an 
indication of how well the PCR reaction has proceeded. The integrity of the data 
fit to the standard curve (r) is a measure of the accuracy of the dilutions and the 
precision of pipetting. Therefore, these parameters can be used to estimate the 
accuracy of the standard curve and hence, the accuracy of quantification (Souaze 
et al., 1996). 
Relative or comparative methods are often used for measuring small physiological 
changes in gene expression levels, and measure the relative change in mRNA 
levels. They can be used to measure difference in gene expression compared to a 
control group, for example, an untreated or uninfected control. This method does 
not require standard curves with known concentrations of transcript, but does 
require reaction efficiencies of both reference and target gene to be similar, which 
is often determined using a standard curve (Bustin, 2002). Quantification involves 
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the comparison of Ct values and the units used to express relative quantities are 
irrelevant (Livak & Schmittgen, 2001). 
3.1.5.4 Applications of Real-time PCR 
An accurate tool for of the quantification of H. pylori is beneficial in a clinical 
setting for monitoring the effectiveness of treatment regimes and vaccines. Real- 
time PCR was previously used to demonstrate the effectiveness of a urease based 
vaccination against H. pylori in mice (Mikula et al., 2003). Real-time PCR has 
also been used to determine the abundance and distribution of specific bacterial 
strains (Becker et al., 2000; Suzuki et al., 2000). Quantitative PCR is also 
important for assessing functional genes and their abundance within the 
environment (Denman et al., 2007; Henry et al., 2006; Okano et al., 2004). 
An accurate quantitative assay will be important for investigating the impact of H. 
pylori bacterial density on host responses and may also be useful in 
epidemiological studies on the acquisition and spread of H. pylori. Previous 
studies of bacterial colonisation density have reported an association with 
inflammation of the gastric mucosa (Blanchard et al., 2003; Chen et al., 2001), 
bacterial virulence factors and the presence of duodenal ulceration (Atherton et 
al., 1996). These data demonstrate that quantification of bacterial density in the 
gastric mucosa may be useful in determining the severity of infection, and its 
influence on histological changes and clinical outcomes, and the use of real-time 
PCR based assays should provide a highly accurate means for determining 
bacterial load. The association of colonisation density with both host and bacterial 
factors will be discussed in the following chapters. 
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3.1.6 Experimental aims 
" To develop a real-time PCR based quantitative assay for the accurate 
quantification of H. pylori from gastric tissue samples. 
9 To validate the assay developed, determine the accuracy of quantification, 
and the reproducibility of the assay. 
" To compare the accuracy of the assay to other quantitative tools in order to 
determine the efficacy of the assay developed. 
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3.2 RESULTS 
3.2.1 Development of a auantitatlve assay for detection of H. yvlori 
Absolute quantification of bacterial density was a requirement for this assay to 
provide the most accurate measure from human gastric tissue samples. A real-time 
PCR using SYBR green I fluorescence technology was employed. The 16S rRNA 
gene was chosen for quantification of H. pylori genome copy numbers in DNA 
extracted from gastric tissue biopsies, as it is well conserved amongst all strains. 
Gene specific primers were designed, and BLAST analysis of the primer 
sequences confirmed specificity to H. pylori only. Primer detection specificity 
was tested on 30 clinical isolates. All strains tested were PCR positive for the 
gene, and only a single PCR product was observed (Figure 3.2). 
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Figure 3.2: Gel images showing positive PCR amplification of 16S rRNA from 
multiple H. pylori strains. 
Clinical isolates of H. pylori were cultured from numerous gastric tissue biopsies 
donated by infected patients. The 16S rRNA gene fragment was amplified from 
each strain to validate primer specificity in multiple strains of H. pylori. All PCR 
reactions were amplified alongside a no template control (NTC). H. pylori strain 
60190 was used as a positive control, and a 1Kb ladder was included alongside. A 
product size of 164bp was expected. 
Lanes: 1. Ladder, 2. Empty, 3. Positive control, 4. NTC, 5. Q 16a, 6. Q36a, 7. 
Q55a, 8. Q64a, 9. Q102,10. Q173a, 11. Q201a, 12. Q249b, 13. Ladder, 14. 
Ladder, 15. Q255a, 16. Q265a, 17. Q274a, 18. Q241a, 19. Q256b, 20. Q223b, 21. 
Q187a, 22. Q182a, 23. Q215b, 24. Q173a, 25. Q247b, 26. Positive control, 27. 
NTC, 28. Ladder, 29. Ladder, 30. Q 136a. 31. Q 173b, 32. Q 117a, 33. Q 14a, 34. 
Q7b, 35. Q242b, 36. Q106a, 37. Q102b, 38. Q240b, 39. Q245b, 40. Q77b, 41. 
Empty, 42. Positive control, 43. NTC, 44. Ladder. 
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To allow for absolute quantification, standard curves were designed for inclusion 
in each PCR to reduce run-to-run errors. Genomic DNA from the J99 H. pylori 
strain was purified and used as a standard. A 5-fold dilution series was prepared 
ranging from 20ng/gl to 10.24fg/µl, and all samples were tested in triplicate for 
every real-time PCR performed. From this, the sensitivity of the assay was 
determined, and a standard curve within a smaller range of 4ng/ul-6.4pg/µl was 
designed which encompassed the range of detection of H. pylori from tissue 
samples (Figure 3.3A). Analysis of the melt dissociation curve showed a single 
peak at 80.3°C, again demonstrating primer specificity (Figure 3.3B). Analysis of 
the resulting standard curve demonstrated excellent linearity of data (? =0.997), 
with a gradient of 
-4.676. However the efficiency of the reaction was reduced 
(E=0.64) (Figure 3.3C). 
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Figure 3.3: Real-time PCR plots and standard curve for 16S rRNA using J99 
genomic DNA 
A standard curve was developed using a 5-fold serial dilution of J99 genomic 
DNA ranging from 4ng/pl-6.4pg/µl. A- PCR amplification plots display the level 
of fluorescence detected in each PCR cycle. The threshold was determined by the 
Rotorgene 6 software. 13- the dissociation curve shows the negative first 
derivation of fluorescence intensity versus temperature (dF/dT). Peaks represent 
the temperature at which PCR products dissociate. A single peak at 80.3°C was 
seen when using 16S rRNA specific primers. ('- a standard curve is plotted giving 
the Ct values obtained for each concentration of genome copy numbers, with 
r2=0.997, E=0.64, and a gradient of 
-4.676. 
"4ng/gl, 800pg/µl, " 60pg/gl, "32pg/µl, M6.4pg/µl 
3-98 
For absolute quantification of bacterial numbers, genome copy numbers in each 
dilution point of the standard curve were calculated using equation 2. A 
breakdown of this equation is provided in appendix 11.2 (taken from Roussel et 
al., 2007). DNA concentrations were determined spectrophotometrically using the 
NanoDrop. Genome copy numbers calculated using this equation were defined as 
"estimated copy numbers". 
Equation 2: 
Genome copies = DNA concentration (p 
-/µl) 1x8.85x 108 Template size x gene copy number 
After amplification, the Rotorgene 6 software was used to determine the number 
of target genes amplified, termed "actual copy number", for each dilution point in 
the standard curve. To assess the accuracy of detection, the percentage variation 
between estimated and actual values was calculated by the software using 
equation 3. 
Equation 3: 
% Variation =Absorbance x Measured Concentration 
Estimated concentration 
-I 
The degree of accuracy varied, ranging from 1.8 
- 
23.4%. However, a plot of 
estimated and actual copy numbers showed an excellent linearity (r2=0.998) 
(Figure 3.4). This demonstrated excellent accuracy of the dilutions prepared for 
the standard curve, and that little error was introduced during pipetting and 
preparation of reactions. However, this does not show the accuracy of measuring 
bacterial load in infected samples using real-time PCR. 
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Figure 3.4: Graphical representation of the accuracy of the 16S rRNA gene 
quantitative real-time PCR assay. 
A standard curve was developed using real-time PCR for DNA concentrations 
ranging between 4ng/µl-6.4pg/pl for 16S rRNA detection. The Rotorgcne software 
was used to calculate gene copy numbers for each reaction (actual copy number), 
and compared with the estimated values calculated from the concentration of 
DNA added to each standard (estimated copy number). For each dilution point, 
the gene copy number calculated by the Rotorgene 6 software after amplification 
was plotted (defined as actual 16S rRNA copy number). A trend line was added to 
demonstrate the accuracy of detection. A gradient of I and r2 value of 0.998 arc 
given. 
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3.2.2 Testing the accuracy of H. nvlori real-time PCR 
To test the accuracy of the real-time PCR assay, a culture of the J99 strain was 
diluted to give bacterial concentrations ranging between 1x104 to 1x108 colony 
forming units (CFU), estimated by optical density. Genomic DNA was extracted 
from the diluted bacterial suspensions, and bacterial load was determined using 
the real-time PCR assay. The detection limit of the assay was lx1 OS bacteria. 
Detected copy numbers from the PCR were roughly 50 times lower than the 
amount of bacteria initially estimated. However, the degree of error in detection 
was consistent over all samples tested, and 10-fold difference were observed with 
good linearity between samples (r2=0.999) (Figure 3.5). This suggests that the 
difference in bacterial load detected by PCR compared to the number of bacteria 
initially added to each bacterial suspension may be due to loss of bacterial DNA 
during the extraction process, demonstrating the impact of sample processing on 
the accuracy of quantification. However, it also suggests that the loss of bacterial 
DNA occurs in a highly linear and predictable manner. 
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Figure 3.5: Accuracy of bacterial genome copy detection using real-time 
PCR. 
A bacterial suspension of the J99 H. pylori strain was diluted to concentrations of 
1x104,1 x 105,1x106,1x107, and 1x108 colony-forming units (CFU), estimated by 
spectrophotometry. Bacterial genome copy number was assayed in triplicate using 
the 16S rRNA real time PCR system developed. The equation of the trendline is 
given with r2=0.9988. 
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As mentioned earlier (section 3.1.5.2), more accurate quantification benefits from 
normalising data for another measurable factor. For validation of the quantitative 
PCR, colonisation densities were therefore measured relative to the total amount 
of DNA in samples. An in vitro culture assay was developed, for which 1x106 
gastric epithelial cells (AGS) were infected with varying numbers of bacterial 
cells ranging from W05 105 to 1x108 CFUs. Bacterial genome copy numbers were 
measured in the resulting DNA extracted from AGS-bacterial cell mixtures. 
Normalised for total DNA, the PCR data showed approximately a5 to 10-fold 
reduction in the bacterial genome copy number (gradient of 0.009) compared to 
the bacterial CFUs initially added (gradient of 1). Measurements between 
replicates appeared to be fairly reproducible; however, there was increased 
variability between replicates at the lower limit of sensitivity (Figure 3.6). 
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Figure 3.6: Accuracy of the quantitative H. pylori PCR in epithelial cell- 
bacterial cell co-cultures when data were normalised for the total amount of 
DNA present. 
1x 106 gastric epithelial cells (AGS) were infected with a J99 H. pylori bacterial 
suspension at concentrations of lx 105,1 x 106,1 x 107, or 1x 108 CFU. Total DNA 
concentrations extracted from cell suspensions were determined by NanoDrop 
spectrophotometry. Bacterial genome copy numbers were measured for 6 
replicates by real time PCR and data normalised for the total amount of DNA 
present. The red broken line illustrates the bacterial copy number/total DNA from 
spectrophotometric estimation of CFUs added, and the black, solid line shows the 
actual density measured by real-time PCR. 
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To test the accuracy of quantification from gastric tissue samples, uninfected 
biopsies were spiked with a bacterial suspension at concentrations ranging from 
1x 105 to 1x 108 CFUs. As before, H. pylori genome copy numbers were calculated 
relative to the total DNA concentration. Again, lower densities were observed by 
PCR quantification (gradient of 19.5) in contrast to the initial number of bacteria 
added (gradient of 1). As bacterial load increased, the degree of error also 
increased, with more than a 10-fold difference at 1x108 CFU. In this case, the 
sensitivity of the assay was also reduced with a detection limit of 1x 106 (Figure 
3.7). 
These two experiments showed that normalising for total DNA in samples 
introduced considerable error. Alternative strategies for normalising were 
necessary as gastric biopsy specimens vary in size. This must be taken into 
account. 
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Figure 3.7: Detection of H. pylori in gastric biopsies in gastric tissue to 
determine the accuracy of quantification by real-time PCR. 
Biopsies taken from uninfected patients were infected with 0,105,106,107, or 108 
colony-forming units of H. pylori J99 bacterial cells. Biopsies were homogenised, 
DNA was extracted, and the bacterial copy number was measured in triplicate by 
PCR. Bacterial copy numbers detected in total DNA were plotted against the 
number of bacteria added (black solid line). A line showing the expected result is 
also shown (red broken line). 
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3.2.3 Normalising for human cell numbers in bloDsles 
As bacterial density measured relative to total DNA was inaccurate, an alternative 
strategy was required. Bacterial load would ideally be normalised against some 
measure of the number of human cells present in the tissue. For this, the human 
GAPDH gene was quantitatively co-amplified, thus giving a measure of bacterial 
load in terms of bacterial genome copy number per human genome copy number. 
Primers were designed with specificity confirmed by BLAST analysis of the gene 
sequence. Standard curves were developed using the pSAPI plasmid construct 
containing the GAPDH amplicon as a standard. Serial dilutions were prepared 
within a range of 32pg/µ1-10.24fg/µl (Figure 3.8A). A dissociation plot gave a 
single peak at 86.3°C illustrating the specificity of primers (Figure 3.8B). 
Standard curves demonstrated excellent linearity (r2=0.996), with a gradient of 
- 
3.237, and the reaction proceeded with an excellent reaction efficiency (E=0.96) 
(Figure 3.8C). 
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Figure 3.8: Real-time PCR plots and a standard curve for the GAPDH 
plasmid construct. 
The pSAP1 plasmid construct was used for developing a 5-fold serial dilution 
ranging from 32pg/µl-10.24fg/gl. A- PCR amplification plots represent the degree 
of fluorescence detected at each PCR cycle for three replicates. B- the dissociation 
curve shows the negative first derivation of fluorescence intensity against 
temperature (dF/dT). A single peak at 86.3°C represents the melting temperature 
of the PCR product. C- a standard curve was plotted giving the Ct values for a 
given concentration of genome copy numbers, with an efficiency of 0.96, r` value 
of 0.996, and a gradient of 
-3.237. 
I32pg/pl, 6.4pg/µl, "1.28pg/µl, "256fg/µl, "51.2fg/µl, "0.2fg/µl 
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The percentage variance between the estimated concentrations of DNA measured 
using NanoDrop spectrophotometry, and the actual DNA concentration 
determined by amplification of DNA standards was calculated using the 
Rotorgene 6 software. The variance ranged from 1.5-36.7% (Figure 3.9). The 
gradient was 1 and the r2 value 0.995, demonstrating a close fit between the data 
sets. 
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Figure 3.9: Graphical representation of the accuracy of GAPDH detection by 
the PCR assay. 
A standard curve was developed using pSAPI with DNA concentrations ranging 
between 32pg/gl-10.24fg/µl. The estimated gene copy number (calculated using 
equation 1) for each dilution point and the gene copy number calculated by the 
Rotorgene 6 software after amplification are plotted. Each dilution was tested in 
triplicate. A trend line is given with a gradient of I and r2 value of 0.995. 
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To test the accuracy of detection when measuring bacterial load relative to human 
GAPDH, known numbers of H. pylori J99 cells were added to AGS cells as 
described previously (Figure 3.6). The ratio of bacterial cells: human cells were 
calculated using the qPCR assay, this time normalising for GAPDH. This gave a 
much more accurate quantification, with bacterial loads measured by PCR 
(gradient of 0.84) agreeing closely with estimated densities initially added to the 
culture (gradient of 1) (Figure 3.10). Overall, quantification by real-time PCR was 
more accurate when data was corrected for the number of human cells rather than 
normalising against the total amount of DNA present. 
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Figure 3.10: Accuracy of bacterial load measured in samples of AGS cells 
mixed with known numbers of H. pylori J99, normalising for GAPDH. 
1x 106 gastric epithelial cells (AGS) were infected with either 1x 105,1 x 106,1 x 107, 
or 1x 108 bacterial CFUs. Bacterial genome copy numbers were measured by real 
time PCR and normalised against human GAPDH cell copy number for 6 
replicates. The red broken line shows the estimated bacterial: human cell ratio 
initially added, and the black, solid line represents the ratio of bacterial: human 
cells calculated after PCR amplification. 
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3.2.4 Testing the reproducibility of the real-time PCR assay 
It is possible that the results of the assay may be affected by slight differences in 
run conditions. This was addressed by including standard curves in each reaction 
carried out. To assess whether reproducibility between reactions was sufficient, 
standard curves developed for quantifying both bacterial and human genome copy 
numbers were tested in quadruplicate and compared. Successive reactions of 
DNA standards for both genes showed excellent reproducibility (Figure 3.11). 
Intra-run reproducibility was assessed using the Rotorgene 6 software which 
calculated the percentage variance between replicates within a run. Variability 
ranged between 3.7-12.9% for 16S rRNA standard curves, and 3.9-14.9% for 
GAPDH. 
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Figure 3.11: Analysis of standard curve reproducibility between successive 
PCRs. 
PCRs for standard curves based on A- H. pylori strain J99 chromosomal DNA for 
measuring 16S rRNA gene copy number, and B- the pSAP1 plasmid construct for 
measuring human GAPDH gene copy number were repeated in 4 successive 
reactions. Each data point represents the average Ct values of 3 replicate 
reactions, with bars representing standard deviation. 
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Although excellent inter-run reproducibility was found for standard curves, the 
percentage variability was measured using Ct values. The Ct scale is exponential 
in nature, and small differences in Ct values may translate to large variations in 
actual bacterial numbers. Therefore, it would be important to measure the 
percentage variance between detected copy numbers in biopsy samples. 
Colonisation density was measured in 10 H. pylori infected tissue samples, taken 
from either the antrum or corpus region of the stomach. For all samples, both 
GAPDH and 16S rRNA gene amplification was conducted in triplicate. Bacterial 
load was measured for the same sample in 2 individual reactions. The calculated 
bacterial load was found to be highly comparable between reactions, 
demonstrating good inter-run reproducibility (Figure 3.12). 
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Figure 3.12: The reproducibility of bacterial load measured in H. pylori 
infected tissue between PCRs. 
Colonisation density was measured in tissue samples taken from the antrum 
(denoted as "a") and corpus (denoted as "b") region of the stomach. Triplicate 
reactions for each sample were included in each PCR, and an average load was 
determined for each sample. PCRs were repeated using DNA samples that were 
left on ice between reactions. The average bacterial load for reaction one (light 
blue solid bars) and reaction 2 (dark blue solid bars) are given. Error bars depict 
the standard deviation amongst 3 replicates. 
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Of note was the observed effect of sample freeze-thawing on the quantification of 
bacterial load. Considerable variability was observed between reactions when 
samples were used after a single freeze-thaw cycle. (Figure 3.13). This illustrated 
the importance of using a consistent protocol for assessing colonisation density by 
PCR. 
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Figure 3.13: The effects of freeze-thaw on reproducibility of measured 
bacterial density. 
Bacterial load was measured in tissue samples taken from the antrum (denoted as 
"a") and corpus (denoted as "b") region of the stomach. Triplicate reactions for 
each sample were included in each PCR, and an average load was determined for 
each sample. PCR reactions were repeated after a freeze-thaw cycle of sample 
DNA. The average bacterial load for reaction one (light blue solid bars) and 
reaction 2 (dark blue solid bars) are given. Error bars depict the standard deviation 
amongst 3 replicates. 
,1 
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3.2.5 Comparison of quantitative PCR with semi-quantitative histolorv 
In the current study, it has been shown that gPCR is highly accurate and 
reproducible in determining bacterial load. As histology is commonly used for 
quantification of H. pylori, it was of interest to investigate whether this semi- 
quantitative tool is comparable to qPCR for the determination of bacterial load. 
Bacterial load was measured in gastric biopsies using the quantitative PCR assay 
developed here. Bacterial loads were stratified according to the grade of density 
measured by histology, with grades determined as mild (grade 1), moderate (grade 
2), and severe (grade 3). 
A weak positive association was found in the antrum between mild and severe 
colonisation (for score 1: median=0.3, n=9, IQR=0.03-0.60; for score 3: 
median=0.4; p=0.042, IQR=0.25-0.83). A trend towards a positive association 
was also observed in the corpus, although this was not statistically significant 
(Figure 3.14). Thus, quantification by the two methods agreed weakly, 
particularly in the antrum. Given the reproducibility of qPCR, this implies that 
histology is not a good method for quantifying bacterial load in the stomach. 
3-119 
B 
7- 
6- 
5- 
4- 
3- a 
ýo 
2- 
;; 
V 
.ý1 
0 
?3 
Bacterial load determined by Histology 
Figure 3.14: Comparison of bacterial load determined by histology and 
qPCR. 
Bacterial load was quantified by qPCR in 34 antral and 38 corpus biopsies. 
Bacterial density measured by PCR was stratified according to the histological 
grade of H. pylori density for comparison in A- the antrum and 13- the corpus. 
3-120 
Finally, histology and qPCR were compared as ways of measuring the pattern of 
bacterial colonisation in the stomach, as determined by calculating the 
antral: corpus ratio of colonisation. For histology, an antrat predominant 
colonisation was described as a higher bacterial load in the antrum compared to 
the corpus, giving an antral: corpus ratio of greater than 1, and a corpus 
predominant colonisation was described as having an antral: corpus colonisation 
density lower than 1. A pan-colonisation was described as having equal bacterial 
loads in both the antrum and corpus, therefore giving a ratio of bacterial density of 
1. Predicted patterns of colonisation by qPCR and histology were compared. 
Agreement was good, particularly for antral predominant colonisation where 12 
out of 15 samples gave the same result with both methods. However, there was 
less agreement for corpus predominant colonisation (3 out of 4 agreed) (Figure 
3.15). Thus, histology performs reasonably well for assessing whether 
colonisation is antral-predominant, corpus-predominant or pan-colonisation. 
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Figure 3.15: Comparison of the pattern of colonisation determined by PCR 
and histology. 
The pattern of colonisation was determined using histology and qPCR by 
calculating the antral/corpus ratio of bacterial load. An antral predominant 
colonisation was described as a ratio greater than 1, pan colonisation was 
described as having a ratio of 1, and corpus predominant having a ratio of less 
than 1. The ratio of density measured by qPCR for each histological grade of H. 
pylori density was plotted to show the agreement between methods for predicting 
patterns of colonisation. A reference line at I on the y-axis is shown to highlight 
equal density in the antrum and corpus. 
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3.3 DISCUSSION 
The relationship between H. pylori and the host is complex, with each having an 
impact on the other in many respects. It has been suggested that bacterial density 
may affect host responses (Blanchard et al., 2003; Chen et al., 2001), and be 
related to particular bacterial virulence factor profiles, as well as correlating with 
disease progression (Atherton et al., 1996). Further investigation into the 
importance of colonisation density is necessary in understanding the extent of the 
bacterial and host relationship, highlighting the value of an accurate tool for 
quantifying bacterial load. 
A quantitative assay based on real-time PCR was chosen. Previous studies using 
this tool have reported excellent sensitivity and specificity for diagnosis (He et al., 
2002; Kobayashi et al., 2002; Mikula et al., 2003). However other quantitative 
methods are still extensively used. The aim of this chapter was to assess the 
quantitative aspect of PCR. 
3.3.1 Development of a quantitative real-time PCR 
Successful amplification of all H. pylori strains requires amplification of a 
conserved gene that is specific to the bacterium. The 16S rRNA gene was chosen 
for amplification as it has been previously used successfully and is a highly 
conserved gene. 
Initial BLAST search analysis of primer sequences confirmed specificity to H. 
pylori strains only, as did PCR amplification of the gene from 30 clinical isolates. 
Primer specificity was confirmed by dissociation melt curves, which showed 
amplification of a single product, illustrating 16S rRNA to be an ideal candidate 
for specific detection of H. pylori. Homology of the 16S rRNA gene has however 
come under question as cross-reactivity with human tissue samples has been 
reported (Chong et al., 1996). A stretch of 546bp region was identified with H. 
pylori specificity, which was recommended for specific primer design (Liu et al., 
2008). Primers used in this study were designed in a region of the gene that had 
100% homology between H. pylori strains J99,26695, and 43504. The use of 16S 
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rRNA as a target gene for quantification has been successful in other studies, 
showing high sensitivity, as low as 101 copies, although reproducibility between 
replicates was reduced at the lower limit of sensitivity. Compared with other 
diagnostic tests, 100% specificity and sensitivity has been reported (Kobayashi et 
al., 2002; Roussel et al., 2007). 
Other target genes have been used for quantification of H. pylori with real-time 
PCR, for example genes coding for urease subunits and 23S rRNA. Specificity has 
previously been an issue with amplification in 16S rRNA based assays, as false 
positive detection has occurred, although sensitivity has been reported as good 
(He et al., 2002; Lascols et al., 2003; McDaniels et al., 2005; Mikula et al., 2003). 
Measuring bacterial load most commonly utilises absolute quantification with the 
use of standard curves, which was applied in this study. Standard curves can be 
based on a number of different templates including genomic DNA or plasmid 
vectors containing a fragment of the target gene. Importantly, the standard used 
must have similar reaction efficiencies to the sample DNA tested for accurate 
quantification. Most often, discrepancies in efficiency result from PCR inhibitors 
present in sample DNA, particularly when using tissue. However, this effect was 
found to be reduced when samples are diluted (Roussel et al., 2007). For this 
study, standard curves based on amplification of the 16S rRNA gene were 
designed using genomic DNA and gave excellent linearity between replicates 
(r2=0.997), although the efficiency of reaction was reduced (E=1.64). The range 
of detection reached a lower limit of 103 copies per reaction, which gave excellent 
sensitivity of detection. However, two samples tested in this data set were false 
negative results, which highlight the limit of sensitivity on occasion. Diluting 
samples may help to determine whether these false negatives were a result of PCR 
inhibitors. Although linearity was excellent, it is not a measure of accuracy in 
detection. Intra-run reproducibility was excellent, and comparison of the 
calculated copy number for standards against estimated standard values was 
excellent, demonstrating that low efficiency of the reaction did not greatly affect 
quantification of bacterial genome copy numbers. However, spiking of uninfected 
tissue with bacteria showed further reduction in sensitivity, raising the question of 
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PCR inhibitors in gastric tissue that may affect amplification efficiencies and 
hence quantification. 
Although accurate detection was observed within standard curves, bacterial load 
is always reported relative to another measureable factor. For example, this may 
be in terms of per gram of tissue, per total DNA, or per host genome copy 
number. Importantly, the accuracy in measuring this relative marker is essential 
for accurate final quantification. Measuring colonisation density relative to tissue 
weight is the least accurate as variability introduced during tissue processing is 
not accounted for. Therefore, normalising data against a measure of DNA is far 
more reliable (Roussel et al., 2007). Normalising bacterial load against the 
amount of total DNA proved to be inaccurate in the current study, reaching almost 
a 10-fold difference at the lowest limit of sensitivity. For this reason, bacterial 
loads were measured relative to the amount of host genomic DNA. 
For the amplification of host genomic DNA used for normalisation of bacterial 
copy numbers, the GAPDH housekeeping gene was chosen. Standard curves were 
designed using the pSAP1 plasmid construct consisting of an amplified portion of 
the human GAPDH gene. Reaction efficiencies may vary depending on the 
standard used. Amplifications using plasmid vectors are known to proceed with 
higher efficiency, in comparison to genomic DNA. As absolute quantification 
required knowing the whole genome size, a plasmid construct was used for 
definite template size. Standard curves showed excellent efficiency (E=1.04) and 
linearity (r2=0.993), and the measure of gene copy numbers for each standard 
point correlated well with estimated values. However, to determine the extent of 
the difference in reaction efficiencies as a result of using a plasmid construct, a 
standard curve based on human genomic DNA should have been tested for 
comparison; although the use of genomic standards has previously been shown to 
be comparable with plasmid standards (Roussel et al., 2007). 
Overall, reliable standards are essential for accurate quantification. The accuracy 
of DNA standards can be affected by a number of factors including the process of 
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purification and the presence of PCR inhibitors that may be co-purified with 
DNA. It has been suggested that providing standards are prepared in the same 
manner as test samples, PCRs will proceed with the same efficiency, making for a 
more accurate quantification (Dumonceaux et al., 2006). 
A clear complication in quantification of H. pylori relative to host genomic DNA 
is that colonisation is restricted to the mucosal surface. Host genomic DNA 
accounts for the number of cells throughout the tissue sample and final 
quantification may therefore be affected by the variable depth of tissue biopsies. 
Ideally, the best method for quantification would be to measure bacterial load 
relative to an epithelial specific marker. However this would require 
quantification of messenger RNA, and measure of a constitutively expressed host 
gene, which is yet to be characterised. This reflects back to quantification of 
bacteria per epithelial cell number by histopathology. 
H. Pylori infection is known to upregulate inflammatory responses, increasing the 
number of PCR targets, which may also impact final quantification. Hence, RNA 
quantification may be a more accurate measure of host cells. However, a reference 
gene for which expression is unchanged during inflammation is essential. It is also 
recommended that more than one reference gene is used for each assay. Other 
genes that have previously been used include fl-actin and SART 1, for which 
expression was found to be constitutive (Camilleri et al., 2007). 
3.3.2 Renroducibility of the quantitative assay 
Reproducible quantification is essential to determine efficacy of the assay. Good 
intra- and inter-run reproducibility was observed for standard curves in this study. 
However, reproducibility between test samples must also be measured. Here, 
samples were tested twice in subsequent PCR reactions, and excellent accuracy 
was observed in bacterial load measured in each reaction, as was observed with 
standard curves. Reactions that were repeated whilst DNA samples were left on 
ice between reactions showed extremely agreeable results. However, after just a 
single freeze-thaw cycle, density of infection was much more variable between 
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successive reactions. Hence, samples were treated in a consistent manner for 
measurement of bacterial loads. 
3.3.3 Methods used for the quantification of H. pylori 
Histological analysis of H. pylori infection is widely used, although the use of the 
commonly applied Sydney system is semi-quantitative. Comparison of bacterial 
load measured by histology and qPCR did show a significant trend in antral 
samples between mild and severe colonisation. Although not statistically 
significant, the same trend was observed in the corpus. The lack of statistical 
significance may be due to small sample numbers. Previous comparative studies 
between the two quantitative methods showed a similar result. Kobayashi et al. 
also reported a significant correlation between mild and severe colonisation 
density in antral and corpus samples for a larger data set (Kobayashi et al., 2002; 
Lascols et al., 2003). The qPCR assay developed in the current study showed 
excellent reproducibility, implying that histology is a poor method for 
quantification, perhaps because only a small part or the mucosal surface is 
examined. However, reproducibility experiments for histology were not 
performed, which limits our ability to fully interpret the comparison. 
Several studies have used histology to determine the patterns of colonisation 
density (Jonkers et al., 1998; Louw et al., 1993), described as antral-predominant, 
corpus-predominant and pan-colonisation. The accuracy of histology in 
comparison to qPCR in this regard was also investigated. A better correlation 
between histology and PCR was observed. This was most apparent when looking 
at antral predominant colonisation for which 80% concordance was observed. 
This illustrates that previous studies using histology should not be discounted. 
Some studies have employed the use of 4 point grading systems in an attempt to 
improve quantification (Twisk et al., 2001). Actual bacterial counts within a small 
field of the tissue cross section, normalised by the number of gastric epithelial 
cells, may prove more accurate. However, this may be time consuming as a 
number of different fields would have to be analysed for an accurate analysis. 
Accurate examination of slides is widely dependent on the expertise of the 
pathologist, and may be subjective. Studies have shown inter-observer variability 
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when evaluating H. pylori gastritis (Aydin et at, 2003; EI-Zimaity et al., 1996). In 
the present study, all slides were examined by an individual, qualified pathologist 
to minimise variability in grading. Immunohistochemistry with a specific H. 
pylori antibody may also be used, and has been shown both to improve variability 
in results between pathologists in comparison to routine histology, and also 
proved to have higher sensitivity and specificity for detection (Camorlinga-Ponce 
et al., 2003; Jonkers et al., 1997; Orhan et al., 2008). 
Previously, bacterial load has been widely measured using culture (Chen et al., 
2001; Rad et al., 2006), but was not considered in this study as in our laboratory, 
we frequently failed to culture H. pylori when other methods have shown it to be 
positive. Also, previous comparative studies have shown quantitative culture to be 
less sensitive in comparison to PCR, with a log difference in detected bacterial 
loads (Lascols et al., 2003; Roussel et al., 2007). One major limitation associated 
with quantitative culture is the reliance on viable bacteria. However, this does 
highlight a drawback to qPCR, in that this method does not account for dead 
bacteria in the gastric tissue on collection. Use of ethidium bromide monoazide 
(AEM) has been suggested for detection of viable cells alone by PCR, as AEM 
only penetrates dead cells, and covalently binds to DNA preventing amplification 
(Nogva et al., 2003). 
It is important to note that treatment with proton pump inhibitors (PPI) and 
antibiotics may affect bacterial load, and may result in false negative results with 
culture, histology, urea based tests and PCR. PPIs have a weak anti-bacterial 
effect (Figura et al., 1997), and their action interferes with the pH of the stomach 
thus changing the local environment. In turn, the distribution of H. pylori in the 
gastric mucosa may be changed, in particular leading to disappearance of the 
bacterium in the antrum (Megraud et al., 1991). This effect depends on the dose 
and length of treatment. Changes to the bacterial niche may also trigger a change 
from a typical morphology to a coccoidal form of H. pylori, which may also 
impact diagnostic testing, and would hence affect quantification. It has also been 
reported that PPIs may have antiurease properties that may interfere with urease 
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based testing (Tsuchiya et al., 1995; Yakoob et al., 2005), although this has not 
been shown in all studies conducted (Tang et al., 2009). 
Overall, an ideal quantitative system allows for accurate absolute quantification 
with excellent specificity, sensitivity and reproducibility. However, no individual 
system has been reported to fit such criteria. The system developed in the current 
study was highly specific for H. pylori detection. Excellent reproducibility was 
observed, both between replicates within a run, and between subsequent PCR 
reactions. Furthermore, the quantitative assay developed performed better in 
comparison to semi-quantitative histology. 
As mentioned, quantitative tools are essential in a number of applications. In 
particular, qPCR can be used for determining factors that may affect colonisation 
in the gastric mucosa, including bacterial virulence factors and the host response 
to infection. This is the focus of the following chapters. 
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Chapter 4 
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4. THE RELATIONSHIP BETWEEN H. 
PYLORI COLONISATION DENSITY AND 
DISEASE, 
4.1 INTRODUCTION 
4.1.1 H. pylori colonisation density in the ¢astric mucosa 
H. pylori-associated disease occurs in only a small proportion of the infected 
population and a number of factors are known to drive the progression of disease 
(Kusters et al., 2006). 
The development of specific disease profiles has been attributed to the patterns of 
gastritis and acid secretion in the stomach, with DUD associated with antral- 
predominant gastritis and hyperchlorhydria, whilst inflammation of the whole 
stomach and low acidity drives development of GUD (Figure 4.1). 
H. Mori can induce changes to both acidity and inflammation by means of 
virulence factor expression, for instance the acid neutralising urease enzyme, and 
CagA which induces a proinflammatory host response. Gastric acid secretion 
appears to play a key role in colonisation by the bacterium. Logan et al. 
demonstrated that acid suppression resulted in a shift of H. pylori colonisation that 
was accompanied by increased bacterial load in the corpus and reduced acid 
secretion (Logan et al., 1995). With this in mind, it is possible that the 
development of a particular ulcer disease may relate to localisation of the 
bacterium in the gastric mucosa. Previous studies have demonstrated such a 
relationship to exist, reporting an antral predominant pattern of colonisation with 
DUD, and corpus predominant colonisation with GUD, a result that was also 
observed in children (Jonkers et al., 1998; Louw et al., 1993). However, these 
reports differ with respect to the degree of colonisation measured in the antrum 
and the corpus for both DUD and GUD. Louw et al. (1993) reported antral 
colonisation to be more common in patients with DUD compared to GUD, with 
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no difference in corpus colonisation for either disease, suggesting that antral 
colonisation may act as a determinant of disease progression. However, they also 
showed that higher grades of colonisation were observed in the corpus of patients 
with GUD compared to those with DUD. Conversely, Jonkers et al. (1998) 
demonstrated increased bacterial load in the corpus for GUD compared to DUD. 
A later study by Tham et al. (2001) demonstrated increased bacterial colonisation 
in patients with DUD in comparison to those with GUD and gastritis in the antrum 
and corpus. 
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Figure 4.1: Factors that that drive disease outcome in H. pylori infection. 
A combination of environmental, bacterial and host factors contribute to the 
pattern of gastritis that develops in response to H. pylori infection. An antral- 
predominant gastritis has been associated with the development of peptic ulcer 
disease, whereas a pan-gastritis is known to increase the risk of developing gastric 
cancer (Adapted from Kusters et al., 2006). 
H. pylori infection is an important risk factor for the development of gastric 
adenocarcinoma. The progression of H. pylori associated malignant disease 
follows changes in the gastric mucosa that involve stages of gastritis, atrophy and 
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intestinal metaplasia of the gastric mucosa which may develop into gastric 
adenocarcinoma (Correa, 1995; Fox & Wang, 2001). The appearance of atrophy 
and IM are associated with a change in the local environment that disfavours 
bacterial growth and colonisation is often not detectable in patients that have 
developed gastric cancer (Peek & Blaser, 2002). The degree of gastric atrophy and 
the presence of intestinal metaplasia (IM) have indeed been found to negatively 
correlate with bacterial density (Kekki et al., 1991; Kuipers et at, 1995c; Valle et 
al., 1996). Presence of this pathology was also found to relate to peptic ulcer 
disease, with reduced occurrences of both atrophy and IM in the antrum of 
patients diagnosed with DUD compared to GUD (Louw et al., 1993). 
4.1.2 Experimental aims 
9 To determine the density of the bacterium and the pattern of colonisation 
for patients with DUD, GUD and no ulcer disease. 
" 
To assess the relationship between density of infection and premalignant 
pathology. 
9 To assess the relationship between patterns of gastritis and the pattern of 
H. pylori colonisation. 
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4.2 RESULTS 
4.2.1 Determination of H. nvlorf colonisation in the gastric mucosa in 
aatients with differine disease status. 
Patterns of gastritis and acid secretion are associated with particular disease 
profiles, and localisation of the bacterium in the stomach has previously been 
demonstrated to correlate with disease (Jonkers et al., 1998; Kato et al., 2006; 
Louw et al., 1993). However, the question of how such patterns of colonisation 
arise still remains (Kato et al., 2006; Louw et al., 1993). 
To further investigate the degree of H. pylori colonisation in the gastric mucosa, 
density was determined by qPCR (as described in Chapter 3) in gastric tissue. 
Bacterial load is given as 16SrRNA/GAPDH gene copy numbers unless stated 
otherwise. Samples were collected from the antrum and corpus of 41 H. pylori 
infected patients. Of these samples, disease status was available for 36 patients, of 
which 11 presented with duodenal ulcer disease (DUD), 5 with gastric ulcer 
disease (GUD), and 20 with gastritis alone. 
No statistical difference was observed for bacterial load measured in the antrum 
(gastritis: median= 0.36, n=20, IQR=0.17-0.63; DUD: median=0.37, n=11, 
IQR=0.21-1.19; GUD: median=0.5, n=5, IQR=0.25-1.38). However, a 
significantly higher density was observed in the corpus for GUD (median=1.82, 
n=5, IQR=1.06-6.12) compared to DUD (median=0.14, n=ll, IQR=0.07-0.33; 
P=0.02), and gastritis (median=0.38, n=20, IQR=0.12-1.02; p=0.01) (Figure 4.2). 
In addition, much lower bacterial loads were measured in the corpus of patients 
with DUD compared to those with gastritis alone, although not statistically 
significant. The overall level of H. pylori colonisation between all antral 
(median=0.34, n=41, IQR=0.17-0.71) and corpus biopsies (median=0.25, n=41, 
IQR=0.08-1.22) of the study population were not statistically significant. 
Together, these data suggest that the degree of colonisation in the corpus, but not 
the antrum, may have an impact on the clinical outcome of infection. 
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Figure 4.2: The association between bacterial load and disease status. 
Bacterial load was measured by qPCR in gastric tissue taken from A- the antrum 
and 13- the corpus of each patient. Colonisation density was stratified according to 
whether patients presented with gastritis (n=20), DUD (n=l 1), or GUD (n=5). H. 
pylori genomic DNA copies were normalised for human GAPDH gene copy 
number. * indicates outlier values. 
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The effect of higher corpus bacterial loads became more apparent when bacterial 
density was represented as an antrum: corpus ratio. The pattern of colonisation for 
patients with DUD favoured antral predominance (72% of patients, median=2.10, 
n=11, IQR=0.99-3.77), whereas a corpus predominant pattern was observed with 
GUD (100% of patients, median=0.37, n=5, IQR=0.08-0.76). The group of 
patients with gastritis did not appear to favour a particular distribution, however 
the median reflected pan-colonisation of the gastric mucosa (median= 1.00, n=20, 
IQR=0.37-2.44) (Figure 4.3). 
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Figure 4.3: The pattern of H. pylori colonisation densities observed in the 
gastric mucosa of patients with gastro-duodenal disease. 
Bacterial load was measured in gastric biopsies taken from the antrum and corpus 
of 20 patients with gastritis, I1 with DUD and 5 with GUD. H. pylori genomic 
DNA copy numbers were normalised for human GAPDH gene copy number. The 
pattern of colonisation was described as the antrum: corpus ratio of bacterial 
density measured by qPCR. A reference line at I on the y-axis indicates equal 
colonisation in both regions of the stomach. An antral predominant colonisation 
was described as having a ratio of density greater than 1, and a corpus 
predominant colonisation described as having a density lower than 1. 
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4.2.2 The relationship between H. nvlorl colonisation and are-malignant 
patholoev 
To further investigate the relationship between bacterial colonisation and H. 
pylori-associated gastroduodenal disease, the association with premalignant 
pathology was also assessed as no patients in the current study were found to have 
gastric cancer. For this, the degree of atrophy and intestinal metaplasia (IM) was 
measured in antral and corpus tissue sections from individual gastric biopsies 
using the Sydney scoring system. 
Analysis of bacterial loads for each grade of atrophy and IM was not possible as 
there were too few samples in each group. Instead, the relationship with bacterial 
load was assessed in the presence (scores 1,2 and 3) or absence (score 0) of these 
features. As only 4 patients were found to have atrophy in the corpus, only data on 
the antrum was assessed. Trends showed higher H. pylori density in the antrum 
with the presence of atrophy (presence of atrophy: median=0.50, n=11, 
IQR=0.22-0.75; absence of atrophy: median=0.30, n=27, IQR=O. 17-0.67) and 
interestingly with IM too (presence of IM: median=0.45, n=8, IQR=0.13-0.65; 
absence of IM: median=0.34, n=30, IQR=0.17-0.62). However, these were not 
statistically significant. 
4.2.2.1 The use of serum biomarkers for assessing the relationship 
between gastric atrophy and bacterial load 
Levels of serum gastrin-17 and pepsinogen have been previously used as 
biomarkers for the degree of gastric atrophy (di Mario & Cavallaro, 2008; 
Vaananen et al., 2003). G-17 has previously been used to identify atrophic antral 
gastritis. As G- 17 is produced by G cells in the antrum, the loss of glands when 
atrophy develops correlates with a reduction in G-17 levels (Vaananen et al., 
2003). Serum pepsinogen I (sPGI) and pepsinogen II (sPGII) levels have 
previously been used to assess the degree of atrophy in the corpus (di Mario & 
Cavallaro, 2008). Pepsinogen is a precursor of the digestive enzyme pepsin, and is 
secreted in two forms, PGI and PGII. PGI is secreted by chief and mucous neck 
cells in the corpus. PGII is also produced in these cells, as well as cells in the 
cardiac, pyloric and duodenal Brunner gland cells, and therefore the distribution 
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of PGII secretion is widespread through the entire stomach. Serum PGI: PGII 
levels are often used to assess atrophy in the corpus (Samloff, 1971; Samloff & 
Liebman, 1973). Reduced levels of serum PGI: PGII are observed with corpus 
atrophy, which results from a loss of PGI secreting glands. 
To assess the degree of atrophy in the antrum in more depth, the level of serum 
gastrin- 17 (G- 17) was determined. sG- 17 levels were assessed in 60 patients, and 
atrophy was assessed by histology. sG-17 levels were significantly decreased 
when atrophy was present (median=7.67, n=25, IQR=4.90-16.0) compared to 
when atrophy was absent (median=14.7, n=23, IQR=10.5-23.7) (p=0.02) (Figure 
4.4). Bacterial loads measured by qPCR were therefore assessed against the level 
of serum G-17. Data on bacterial load and G-17 levels were available for 16 
samples, however an association was not found between the two in the antrum (r= 
-0.30, p=0.24). 
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Figure 4.4: Association between serum gastrin-17 levels and presence of 
atrophy in the antrum. 
Serum gastrin-17 levels were measured in 60 patients to assess the relationship 
with gastric atrophy in the antrum. Atrophy was diagnosed by histopathology, and 
patients were grouped according to whether atrophy was absent (n=23) or present 
(n=25). * represents outlier values. 
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As only 4 patients in the data set examined were found to have atrophy in the 
corpus, it was not possible to determine if the level of serum pepsinogen was 
associated with atrophy. The level of sPGI, sPGII and PGI: PGII was determined, 
and their relationship with bacterial load was assessed. 
No correlation was observed between the level of sPGI and bacterial density 
(density in the antrum: r=0.07, p=0.74; density in the corpus: rß. 37, p=0.09, 
antral: corpus ratio of colonisation: r=0.05, p=0.81). Similarly, no relationship was 
observed between levels of sPGII and density (antrum: r- 
-0.17, p=0.43; corpus: 
r= 
-0.04, p=0.84; antrum: corpus ratio: r= 
-0.09, p=0.70). 
Serum PGI/PGII levels were determined in 21 patients for which bacterial density 
was also available. No correlation was observed in the antrum (r=0.20, p=0.36) or 
corpus (rß. 16, p=0.45). However, when looking at the pattern of colonisation, a 
positive correlation was observed with PGI/PGII levels (r-0.51, p=0.02) (Figure 
4.5). 
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Figure 4.5: Association between patterns of colonisation and serum 
PGI: PGII levels. 
Serum PGI: PGII levels were measures in 21 H. pylori infected patients. For these 
patients, the pattern of H. pylori colonisation was determined in gastric biopsies 
using qPCR. A linear trendline is shown with an r value of 0.51. Apositive 
correlation between sPGI: PGII and the pattern of colonisation was found 
(P-0.02). 
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4.3 DISCUSSION 
It is well established that the patterns of gastritis and acid secretion in the stomach 
are key determinants for the progression of specific disease profiles. Certain 
factors, both host and bacterial, are known to drive the progression of disease 
(reviewed by Blaser & Atherton, 2004), but whether colonisation density plays a 
role is still unclear. 
4.3.1 Determination of H. nvlori colonisation in the gastric mucosa in 
patients with differing disease status 
Colonisation of the gastric mucosa was found to be significantly greater for 
patients with GUD compared to patients with DUD and gastritis in the corpus, but 
not in the antrum where bacterial loads were very similar for each patient group. 
Furthermore, lower bacterial loads were observed in patients with DUD compared 
to those with gastritis alone. This suggests that disease progression is related to 
the degree of colonisation in the corpus but not the antrum. Also, antral- 
predominant colonisation was associated with DUD, whilst corpus-predominant 
colonisation was found to be associated with GUD. Although a much greater 
spread in the pattern of colonisation density was observed for patients with 
gastritis, the median was 1, which represents a pan-colonisation. Notably, this 
group also represents patients that may be at risk of developing peptic ulcer 
disease but did not present with ulceration at the time of endoscopy, which this 
may explain the wide spread of data within the gastritis group. 
Previously, an association between the pattern of colonisation and disease status 
has been reported, and in agreement with Jonkers et al., (1998) the present study 
demonstrated that corpus colonisation plays a role in determining disease 
outcome. As known, DUD is linked with an antral-predominant gastritis, which is 
associated with an increase in acid secretion in the corpus (El-Omar et al., 1995; 
Graham et al., 1993). This may result in a less hospitable environment and 
reduced corpus colonisation under such conditions. However, H. pylori infection 
and inflammation in the corpus suppresses acid secretion, and may create a niche 
capable of supporting bacterial growth. The relationship between patterns of 
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inflammation and acid secretion may explain the association between corpus 
colonisation and disease status observed in this study. 
Although a relationship was observed between bacterial density and clinical 
outcome of infection, patients with gastric adenocarcinoma were not represented 
in this population. Atrophy and IM were assessed however as they represent 
precancerous changes in the mucosa, and provide an opportunity to investigate 
host-bacterial relationships prior to the development of cancer. As the 
development of such pathology alters the gastric environment and no longer 
supports H. pylori colonisation, a negative correlation would be expected with 
density of infection. Surprisingly, a trend towards a positive association between 
density and the presence of atrophy and IM was observed, although not 
statistically significant. It is possible that the level of atrophy and IM was mild, 
and only when severe, the loss of bacterial cells is seen. Therefore, increased 
bacterial load could be associated with the development of mild precancerous 
changes in the gastric mucosa. 
Also, histological analysis of IM demonstrates bacterial cells are present except in 
the vicinity of goblet cells that are characteristic of IM. Unless IM is widespread, 
the relationship with bacterial load may be masked as bacterial load, when 
measured by qPCR, used a whole individual tissue biopsy. Assessing the 
relationship between bacterial load and IM may therefore be more accurately 
achieved by histology, and the examination of multiple slides from several 
different tissue samples is necessary for accurate determination of the degree of 
IM. This was not possible for samples tested in this study as few patients were 
diagnosed with IM. Of interest may be the use of narrow band imaging, which 
allows for magnification of the gastric mucosa during endoscopy. This technique 
assesses the loss of the normal subepithelial capillary network for diagnosis of 
atrophy, and has been successfully utilised for accurate diagnosis of gastric 
atrophy (Mannath & Ragunath, 2010; Tahara et al., 2009). With this technique, 
bacterial density can be assessed in gastric biopsies taken from areas of known 
atrophy and IM. 
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Given the association between G-17 levels and antral atrophy, bacterial load was 
assessed against serum gastrin levels in order to further investigate the 
relationship with atrophy. However, no association was observed. Serum gastrin 
levels have previously been shown to negatively correlate with bacterial load in 
the antrum and corpus (Karttunen et al., 1991), although this was not the case in 
all studies (Perez-Paramo et al., 1997). Increased sample numbers would be 
needed in order to investigate this relationship further. 
For investigation of corpus atrophy, the levels of serum pepsinogen were 
assessed. Decreased sPGI: PGII levels would be expected with atrophy. A positive 
association was observed between sPGI: PGII and the pattern of bacterial 
colonisation. This may indicate that high corpus colonisation may lead to changes 
in the corpus, possibly cell damage and loss of cell function, that results in 
reduced levels of sPGI, and hence sPGI: PGII levels. In contrast, antral- 
predominant colonisation may induce changes in the antral gastric mucosa that 
leads to a reduction in sPGII levels, and consequently increased sPGI: PGII levels. 
Therefore, this data suggests that bacterial colonisation may impact cell secretions 
in the gastric mucosa, but whether this is a result of cell damage and glandular 
atrophy is unclear from the data presented in this study. 
Overall, patterns of colonisation in the gastric mucosa were found to be associated 
with disease. However, whether bacterial or host factors play a role in influencing 
this relationship is not clear. 
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Chapter 5 
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S. THE RELATIONSHIP BETWEEN 
H. PYLORI COLONISATION DENSITY 
AND VIRULENCE DETERMINANTS OF 
THE INFECTING STRAIN. 
5.1 INTRODUCTION 
5.1.1 H. avlori colonisation density and virulence determinants. 
The relationship between H. pylon and host responses is complex and bacterial 
factors have pleiotropic effects (Chapter 1, section 1.6). 
It is well known that cagA has been associated with the development of peptic 
ulcer disease and gastric cancer via a number of cellular responses to the 
cytotoxin and cag PAI-encoded type IV secretion system (Blaser et al., 1995; 
Nomura et al., 2002). For instance, CagA is known to interact with cellular 
proteins involved in maintaining the integrity of epithelial cell junctions. The 
adherence of H. pylori at cell junctions was associated with the relocalisation of 
ZO-1 and JAM to the site of bacterial attachment resulting in disruption of the cell 
junction. Such interactions were found to not only be dependent on CagA, but 
also related to the EPIYA-repeat region of the gene and not tyrosine 
phosporylation of the motif (Amieva et al., 2003; Higashi et al., 2005). Loosening 
of these tight junctions may result in leakage of essential nutrients that may aid in 
bacterial growth. 
Observations of these CagA interactions highlight the close association between 
H. pylori cagA positive strains with the gastric epithelium. cagA positive strains 
have been reported to colonise at the surface of the cell and in the intercellular 
epithelial spaces more so than in the mucous gel (Camorlinga-Ponce t al., 2004). 
Such intimate associations between the bacterium and the host cell have been 
associated with reduced colonisation densities (Twisk et al., 2001), and these 
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observations might suggest reduced bacterial densities may result from infection 
with bacteria harbouring the cytotoxin. 
The relationship between cagA and bacterial load has been studied with varying 
results. In those studies that observed a correlation, presence of the virulence 
factor was actually associated with increased colonisation, although this fording 
was controversial with respect to the localisation in the stomach. Some studies 
reported such a relationship in the corpus, whilst others found this to be true only 
for the antrum (Gunn et al., 1998; Umit et al., 2009). An association was also 
observed between increased density and increasing numbers of EPIYA repeat 
regions (Basso et al., 2008), and increased bacterial burden with cagA positive 
strains was observed in children (Dzierzanowska-Fangrat et al., 2002; Homan et 
al., 2009). Importantly, a number of studies have failed to show a significant 
association (Demirturk et al., 2001; Kaklikkaya et al., 2006). One study however 
demonstrated reduced density with cagA positive strains in comparison to cagA 
negative strains (van Doorn et al., 2000). 
cagA positive strains also have a demonstrated function in regulating gastric 
acidity. Transcription levels of cagA were shown to increase at low pH, which 
suggests a role for the cytotoxin in limiting acid stress (Karita et al., 1996; Karita 
& Blaser, 1998). Interestingly, cagA was found to aid colonisation of the corpus 
and increase acidity in a gerbil model (Rieder et al., 2005). These observations 
suggest that cagA is important in regulating acid output, permitting increased 
colonisation of the corpus, and consequently altering the pattern of bacterial 
colonisation in the stomach. The resulting inflammatory response and mucosal 
damage that follows in the corpus may provide a means by which this cytotoxin 
induces the development of gastric adenocarcinoma. 
A multitude of functions have been described for VacA which may impact on 
colonisation of H. pylori. The vacuolating activity of this cytotoxin is ascribed to 
its ability to form selective channels within biological membranes. Pore formation 
is related to toxicity of VacA, (Atherton et al., 1995; Letley et al., 2003; Rhead et 
al., 2007). Channel formation is not restricted to internal compartments, and the 
formation of pores at the surface membrane of the epithelial cell may result in the 
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release of essential nutrients into the lumen, including pyruvate that has been 
demonstrated to aid the growth of the bacterium (Testerman et al., 2006; Tombola 
et al., 1999). With this in mind, strains harbouring the more toxic form of VacA 
may be associated with increased bacterial density as a result of cell leakage. Urea 
also becomes available as a result of increased membrane permeability, which 
aids in neutralising the local acid pH environment and survival of the bacterium. 
Importantly, neutralising the pH environment may also assist in colonisation of 
the acid producing corpus, thus having effects on bacterial localisation in the 
stomach as well as density. Increased corpus colonisation may provide a possible 
driving force for the development of GUD. VacA association with disease is well 
established with the more toxic variants, although some questions remain about 
the impact of moderate toxic forms of VacA, as some are associated with the 
development of gastric cancer (Basso et al., 1998; Evans et al., 1998). The recent 
discovery of the polymorphic i-region has been linked to the development of 
gastric cancer with these strains, and its association with increased vacuolating 
activity may also implicate this region in bacterial colonisation density (Rhead et 
al., 2007). 
As seen with cagA, the observed relationship between bacterial load and 
polymorphisms of vacA is mixed amongst studies. A number of studies have 
failed to find a relationship with s- and m-type of vacA with colonisation density 
(Atherton et al., 1996; Elitsur et al., 1999; Ko et al., 2008; Soltermann et al, 
2007; Umit et al., 2009). However, many studies have demonstrated an 
association between increased H. pylori density and sl genotypes of the toxin in 
comparison to the less toxic s2 type (Homan et al., 2009; Nogueira et al., 2001; 
Tham et al., 2001). Mid-region polymorphisms have been related to increased 
bacterial burden, where increased load was seen with more virulent forms of the 
toxin (Han et al., 1999). Conversely, some studies observed increased density 
with s2 and m2 strains (Nogueira et al., 2001; van Doom et al., 2000). Again, the 
question of whether these findings are restricted to either the antrum or the corpus, 
or both, remains unclear. The relationship between i-region polymorphisms and 
colonisation density has not previously been investigated. 
5-148 
The recently discovered dupA has been described as an independent determinant 
in the development of DUD and protection against the development of GUD and 
adenocarcinoma (Lu et al., 2005; Zhang et al., 2008). Little is known about the 
function of this virulence factor, although induction of an inflammatory response 
has been demonstrated. Based on previously described associations between an 
antral-predominant gastritis and colonisation with the development of DUD 
(Kuipers et al., 1995b), it is possible that the observed association between dupA 
and DUD may result from a preferential colonisation of the antrum. 
Overall, it is clear from previous observations that relationships between bacterial 
density and virulence factor genotype of the colonising strain still remain unclear, 
with both positive and negative findings reported in different populations. 
As previously mentioned, disease progression is widely observed with virulent 
strains of the bacterium. Although most studies have reported a positive 
correlation between the presence of both atrophy and IM with cagA (Basso et al., 
2008; Kaklikkaya et al., 2006; Nogueira et al., 2001; Soltermann et al., 2007; 
Umit et al., 2009), the relationship between vacA subtypes is not as clear, with 
some studies reporting an association (Basso et al., 2008; Nogueira et al., 2001; 
Soltermann et al., 2007), whilst others have not (Kaklikkaya et al., 2006; Umit et 
al., 2009). 
5.1.2 Experimental aims 
" To investigate the relationship between virulence factors of the bacterium 
and colonisation, including dupA, cagA, and vacA in vivo. 
" To determine the impact of the major virulence determinants CagA and 
VacA on colonisation of gastric epithelial cells in vitro. 
" To determine the relationship between the presence of virulence factors 
and the clinical outcome of infection. 
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5.2 RESULTS 
5.2.1 Associations between bacterial virulence and colonisation density. 
Increased virulence properties of the colonising bacterial strain are known risk 
factors for in the development of gastric disease during H. pylori infection 
(Atherton, 2006). 
The major virulence factors CagA and VacA are known to elicit numerous 
cellular responses that have varying effects. Previous reports investigating the 
association between these virulence factors and colonisation density conflict 
(Gunn et al., 1998; Han et al., 1999; Nogueira et al., 2001; Umit et al., 2009; van 
Doom et al., 2000). The presence of the dupA gene has been linked to the 
development of DUD (Lu et al., 2005). As antral predominant gastritis and 
colonisation have been reported as factors contributing to the development of 
DUD (Kuipers et al., 1995b), the presence of dupA may be associated with the 
localisation of the bacterium in the gastric mucosa. Therefore, the association 
between bacterial factors and colonisation was investigated. 
To determine the virulence status of the colonising strain, bacterial isolates 
cultured from antral biopsies were genotyped by PCR for the presence of dupA 
and cagA, and for vacA allelic type. Bacterial loads were measured by real-time 
PCR. Genotyping data was available for 24 isolated strains for cagA status, 23 for 
dupA status, and 26 for vacA status. Typing data for some strains was previously 
obtained by other members of the group using DNA extracted from bacterial 
cultures. However, not all genes were typed at the same point in time. As strains 
were often difficult to re-isolate from tissue samples, in cases where bacterial 
cultures were no longer available, it was not possible to obtain DNA for further 
typing. Therefore, data for all genes was not available, resulting in genotype 
numbers differing for each gene. 
For the population examined, most strains were cagA positive (70.8% of strains). 
No association between cagA status and bacterial density was observed in either 
the antrum or the corpus. Furthermore, no apparent difference in the pattern of 
colonisation was observed (Table 5.1). 
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When assessing dupA status, bacterial load was not found to differ significantly 
between dupA+ and dupA- bacterial strains in the antrum or the corpus. However, 
when looking at the distribution of bacteria within the gastric mucosa, patients 
infected with dupA+ strains of H. pylori demonstrated a tendency towards an 
antral predominant colonisation whereas infection with dupA- strains 
preferentially colonised the corpus (Table 5.1). This is represented graphically in 
Figure 5.1. 
To assess the relationship between vacA and bacterial load in the gastric mucosa, 
all 3 polymorphic regions were analysed individually to ascertain if a particular 
region of the gene was associated with differences in colonisation density. vacA 
was successfully genotyped in 26 strains for all three polymorphic regions. The 
vacA sl genotype was more common than vacA s2 in the population examined 
(85% of strains). Overall, no difference was observed in bacterial loads between 
vacA allelic types of the colonising strain. A trend towards increased density with 
ml type strains in the corpus was found, however this did not achieve statistical 
significance. Most variability in bacterial density was found in the corpus for the 
m- and s-region, whilst density measured in the antrum was very similar with all 
allelic types of each vacA region (Table 5.1). 
Strains harbouring the more virulent form of the vacA m-region, ml, are known to 
be significantly more likely to also have the s1 and il genotype (Rhead et al., 
2007). As well as investigating the relationship of the individual regions of vacA 
with bacterial density, the entire polymorphic vacA gene was therefore also 
considered. Strains were classified based on the toxicity of VacA, with sl/il/ml 
type strains considered to be the most toxic, and s2/i2/m2 types the least. Strains 
with all other combinations of these alleles were referred to as mixed. As only 2 
patients in this data set were infected with an s2/i2/m2 type strain, analysis of 
these data was not possible. A higher degree of colonisation was seen with 
s 1/i 1/ml strains in comparison to mixed strains for the antrum (s 1/i 1/rn 1: median= 
0.39, n=ll, IQR=0.21-0.75; mixed: median=0.22, n=12, IQR-0.13-0.37) and 
corpus (s 1/i l/ml : median=0.32, n=11, IQR=0.11-2.63; mixed: median=0.11, 
n=12, IQR=0.04-0.98). However, these differences did not quite reach statistical 
significance (p=0.06). No association was found between the pattern of 
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colonisation and vacA strain type (sl/il/ml: median=1.01, n=11, IQR=0.11-2.10; 
mixed: median= 1.00, n=11, IQR=0.07-6.23) suggesting that vacA virulence may 
have an impact on the density of infection but not the pattern of colonisation. 
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Bacterial load 
Antrum Corpus Antrum: Corpus 
cagA+ median (n) 
IQR 
0.27 (17) 
0.17-0.62 
0.14 (17) 
0.07-1.70 
1.00 (17) 
0.24-2.83 
cagA- median (n) 
IQR 
0.21 (7) 
0.01-0.57 
0.20 (7) 
0.08-0.85 
0.67 (7) 
0.08-2.76 
P value NS NS NS 
dupA+ median (n) 
IQR 
0.34 (13) 
0.21-0.58 
0.11 (13) 
0.07-0.68 
2.10 (13) 
0.31-5.21 
dupA- median (n) 
IQR 
0.26 (10) 
0.17-1.04 
0.20 (10) 
0.13-1.18 
0.07 (10) 
0.07-1.32 
P value NS NS 0.03 
vacA sl median (n) 
IQR 
0.30 (22) 
0.17-0.62 
0.20 (22) 
0.08-1.48 
1.00 (22) 
0.10-3.87 
vacA s2 median (n) 
IQR 
0.39 (4) 
0.21-0.96 
0.13 (4) 
0.07-0.85 
1.46 (4) 
0.82-2.48 
P value NS NS NS 
vacA ml median (n) 
IQR 
0.34 (13) 
0.17-0.75 
0.31 (13) 
0.11-2.63 
1.00 (13) 
0.24-2.10 
vacA m2 median (n) 
IQR 
0.33 (13) 
0.17-0.63 
0.16 (13) 
0.07-1.02 
1.00 (13) 
0.13-4.18 
P value NS NS NS 
vacA il median (n) 
IQR 
0.31 (14) 
0.16-0.69 
0.28 (14) 
0.08-1.67 
0.87 (14) 
0.10-2.52 
vacA i2 median (n) 
IQR 
0.30 (12) 
0.10-0.60 
0.27 (12) 
0.08-1.31 
0.84 (12) 
0.16-2.48 
P value NS NS NS 
Fable 5.1- The rplatinnchin hPfwPPn H nuinri virnlpne determinants and 
bacterial density. 
Bacterial isolates were genotyped for cagA, dupA and vacA status, and median 
bacterial densities in antral and corpus gastric biopsies are given for each 
genotype. IQR= inter quartile range. 
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Figure 5.1: dupA status of the colonising strain on and the pattern of 
colonisation in the human gastric mucosa. 
The ratio of bacterial load for colonisation with dupA+ and dupA- strains is 
shown. A reference line of 1 indicates equal colonisation density in both the 
antrum and corpus. 
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As dupA status was shown to be linked to antral-predominant patterns of 
colonisation, data were subdivided into groups controlled for the dupA status of 
the colonising strain. dupA status was successfully typed for 29 strains that were 
also genotyped for cagA, and 24 strains that were also typed for vacA. 
No significant difference was observed between density of infection and cagA 
status when controlled for dupA. Within the dupA+ group, increased colonisation 
density was observed for in 1 compared to m2-type strains in the corpus (Table 5.2 
and Figure 5.2). The same trends were observed with the i-region, however this 
difference failed to reach statistical significance. Such a trend was not observed in 
the antrum (Table 5.2). Higher colonisation densities were observed with the more 
virulent types of vacA for the m- and i-region that were also dupA-, but this was 
not statistically significant (Table 5.2). As only 1/12 strains were typed as vacA 
s1, analysis of this region was not possible. 
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Figure 5.2: Relationship between the polymorphic vacA in region and 
bacterial density in the corpus for dupA+ strain infections. 
Bacterial colonisation densities were measured in gastric biopsies taken from the 
corpus that were infected with dupA+vacA m1 and m2 strain genotypes. 
represents outlier values. 
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Median bacterial load 
Antrum Corpus 
dupA +vacA: 
ml (n) 0.36 (8) 0.28 (8)* 
IQR 0.22-0.62 0.07-1.82 
m2 (n) 0.34 (5) 0.07 (5) 
IQR 0.09-0.83 0.02-0.23 
il (n) 0.34 (9) 0.25 (9) 
IQR 0.19-0.39 0.03-1.27 
i2 (n) 0.34 (3) 0.08 (3) 
IQR 0.21-0.38 0.08-0.30 
dupA-vacA: 
mI (n) 0.74 (4) 1.00 (4) 
IQR 0.05-4.41 0.12-4.50 
m2 (n) 0.26 (8) 0.50 (8) 
IQR 0.18-0.82 0.13-1.10 
il (n) 0.74 (4) 1.00 (4) 
IQR 0.05-4.41 0.12-4.50 
i2 (n) 0.22 (7) 0.50 (8) 
IQR 0.15-0.57 0.13-1.10 
Table 5.2: Relationship between vacA polymorphisms and bacterial load 
controlled for dupA genotype. 
Bacterial density was assessed for vacA m- and i-region allele strain types when 
corrected for dupA status. Median bacterial loads in each group are shown. 
[QR=interquartile range. * p=0.049. 
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5.2.2 In vitro analysis of the relationship between H. pylori virulence 
and density of infection 
To assess the relationship between virulence determinants of H. priori and 
bacterial burden, bacterial density was determined for the H. pylori 60190 wild 
type strain and its cagA, vacA and cagE isogenic deletion mutants. cagE mutants 
render the Cag PAI non-functional. The non-toxic Tx30a (cagPAI-, vacA 
s2/i2/m2) was also examined. Strains were cultured with AGS cells in 6 replicate 
wells, and bacteria were plated after 24hrs in order to determine average CFU 
counts. Differences in CFU counts between isogenic deletion mutants and wild 
type strains were not statistically significant (Figure 5.3). 
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Figure 5.3: In vitro analysis of cagA as a determinant of bacterial density. 
AGS cells were cultured with H. pylori 60190wt, 60190M'accA, 6019OAcagA, 
6019OAcagE, or Tx30a for 24hrs. Cells were plated onto blood agar plates after at 
each time point, and CFU counts were enumerated. Each bar is representative of' 
average CFU counts from 6 replicates. Error bars represent standard deviation. 
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Although statistically non significant, lower CFU counts were observed at 24 
hours with H. pylori 6019OAcagE. To rule out experimental error, OcagE mutants 
in the H. pylori 84183 and 11637 strain backgrounds were also cultured along 
with wild type strains. However, no difference in CFU counts was observed 
between AcagE mutant and wild type in any of the three strain backgrounds at 
24hrs (Figure 5.4). 
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Figure 5.4: Determining the effect of the AcagE mutation on bacterial 
density. 
AGS cells were cultured with wild type and cagE isogonic mutants of N. pylori 
strains 60190,84183, and 11637. Cells were plated onto blood agar plates after 
24hrs, and CFU counts were enumerated. Bars represent average CFU counts in 6 
replicates. Error bars represent standard deviation. 
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5.2.3 The association between virulence determinants and the clinical 
outcome of infection. 
H. pylori virulence factors are a known risk factor for the progression of disease 
during infection. cagA and vacA have been linked to the development of peptic 
ulcer disease and the eventual progression to gastric adenocarcinoma, and dupA 
has been shown to be associated with DUD (Lu et al., 2005; Zhang et al., 2008). 
To assess the association between disease and virulence determinants of the 
colonising strain in this population, 56 patients were categorised according to 
whether they presented with gastritis (25 patients), DUD (26 patients), or GUD (7 
patients) during routine endoscopy. 
The dupA genotype of the colonising bacterial strain was determined for 56 
samples. DUD was found to be more prevalent amongst dupA+ infections, 
although not statistically significant. The development of GUD was not associated 
with dupA status (Table 5.3). 
cagA was successfully genotyped for 52 samples. The majority of samples were 
found to be cagA positive infections, and amongst cagA+ infections, no 
association was seen between patients with gastritis or patients that developed 
DUD. Interestingly, all 7 cases of GUD were colonised with cagA positive strains 
(Table 5.3). 
Clinical manifestations with H. pylori infection were analysed with respect to 
vacA polymorphisms in the m-region (56 samples) and i-region (52 samples). As 
only 6/55 strains were genotyped with an s2 region, analysis of the s-region was 
not possible. No association was observed for disease development and the m- 
region. However, i2-type strains appeared to be related to a decreased occurrence 
of developing DUD compared to strains carrying il-type vacA, although this was 
not statistically significant. As with cagA, the more virulent alleles of vacA were 
found in strains isolated from patients diagnosed with GUD (Table 5.3). 
To further investigate the role of bacterial virulence factors in the progression of 
disease, premalignant pathology was also considered with respect to the virulence 
of the colonising strain. Patients were categorised according to whether atrophy 
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and intestinal metaplasia (IM) were present or absent in gastric biopsies. As only 
4 patients were found to present with atrophy and IM in the corpus, only antral 
data was assessed. Pathology scores were available for 67 patients for which cagA 
status was also determined, 56 with dupA status, and 65 with vacA status. 
No association was observed between the virulence status of the colonising strain 
and the presence of pre-malignant pathology. 
Gastritis DUD GUD 
dupA: 
+ 
- 
6 
17 
10 
16 
3 
4 
cagA: 
+ 
- 
17 
4 
18 
5 
7 
0 
vacA: 
ml 
m2 
12 
12 
14 
11 
6 
1 
ii 
i2 
13 
11 
15 
6 
6 
1 
Table 5.3: The association of H. pylori virulence determinants with clinical 
outcome of infection. 
H. pylori strain isolates were genotyped for dupA (n=56), cagA (n=52), vacA in- 
region (n=56), and vacA i-region status (n=53). H. pylori infected patients were 
categorised according to whether they presented with gastritis, DUD or (IUD. The 
number of H. pylori infected patients that possess dupA+, cagA+, vacA in I. and 
vacA i1 strains for each disease group arc shown. 
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5.3 DISCUSSION 
The pathogenicity of bacterial strains varies according to virulence determinants 
expressed by H. pylori, which are known risk factors for in the development of 
gastric disease during infection (Atherton, 2006). The question of whether density 
is influenced by the expression of virulence determinants remains unclear. 
5.3.1 Association between bacterial virulence and bacterial load 
5.3.1.1 cagA 
Colonisation density was not found to be associated with cagA status when 
measured by qPCR, as was the case with in vitro analysis of infection with 
cagPA! and cagA mutants. Although an association with cagA and colonisation 
density was not observed, previous studies in animal models have demonstrated 
reduced bacterial loads when infected with H. pylori strains with non-functional 
CagPAI (Eaton et at, 2001a; Marchetti & Rappuoli, 2002; Rieder et al, 2005). 
Interestingly, Eaton et al. (2001) demonstrated these trends only at earlier time 
points, and colonisation densities in comparison to animals infected with wild 
type H. pylori strains were similar at later times point. This suggested that these 
cagPAI mutant strains have delayed growth rates and do not affect final bacterial 
density. However, numerous studies have demonstrated a positive association 
between CagA and bacterial load when estimated by histopathology (Atherton et 
at, 1996; Dzierzanowska-Fangrat et al., 2002; Gunn et al., 1998; Homan et at, 
2009), although other studies have failed to show such an association (Basso et 
al., 2008; Demirturk et al., 2001; Kaklikkaya et at, 2006; Twisk et al., 2001). 
Importantly, the cagA genotype of the colonising strain does not confer 
functionality of the CagPAI, which is often incomplete or non-functional, which 
renders the type IV secretion system incapable of delivering CagA into the host 
cell (Kauser et at, 2004; Matteo et at, 2007). Also of consideration would be the 
impact of EPIYA-C motifs on density. A previous study which found no 
association with bacterial load and cagA positivity did report increased 
colonisation densities with multiple EP1YA-C phosphorylation sites (Basso et al., 
2008). 
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5.3.1.2 dupA 
Currently, there are no studies that have investigated the association between 
dupA and colonisation density. In this study, dupA status was significantly 
associated with the pattern of colonisation in the stomach, with strains carrying 
this virulence factor preferentially colonising the antrum. Little is known of DupA 
function, so the mechanism by which these strains influence bacterial localisation 
is unclear. Interestingly, Lu et al. (2005) observed increased acid tolerance of 
dupA+ strains, suggesting that these strains may be more adapted to survive under 
high acid conditions in the stomach. Therefore, it is possible that the relationship 
observed in the current study between bacterial localisation to the antrum and 
dupA+ strains may be linked to an antral-predominant gastritis, which is 
associated with increased acid load and consequently DUD. 
Although dupA+ strains are known to be associated with DUD in certain 
populations (Lu et al., 2005; Zhang et al., 2008), and an antral predominant 
colonisation is related to development of DUD, this disease profile was not found 
to correlate with the dupA status of the infecting strain. Importantly, almost half of 
dupA- strains were associated with DUD, which suggests that other factors 
contribute to risk of developing DUD, for example other virulence factors. Lu et 
al. (2005) reported a reduced incidence of GUD with dupA+ strains, but this was 
not apparent in the current data set. Importantly, some studies have failed to 
observe the association between dupA and DUD (Argent et al., 2007; Douraghi et 
al., 2008). However, such differences may be population based (Schmidt et al., 
2009), which may reflect the nature of the plasticity region in which the gene is 
located. Recently, dupA was found to be polymorphic, and a high rate of strain 
variation within a single host has also been observed (Hussein et al., 2010; Matteo 
et al., 2010). In the current study, and previous studies investigating dupA status, 
dupA genotying was based on the presence or absence of the gene, and did not 
account for the presence of the more common full length "dupAl' allele or the 
shorter "dupA2" type allele (Hussein et al., 2010). However, a strong association 
in the pattern of colonisation was observed, and it may be possible that all the 
strains studied in this data set were genotypically the same. In addition, whether 
polymorphisms in the dupA gene confers a phenotypic change is unknown, 
although Hussein et al. (2010) did demonstrate increased levels of IL-12 
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production in mononuclear cells infected with H. pylori dupAl type strains, 
suggesting that polymorphisms confer a functional difference. 
Further investigation of the function and role of dupA in colonisation is necessary. 
As localisation of the bacterium is related to this gene rather than colonisation 
density, an in vitro assay with gastric cell lines would not represent an appropriate 
model for investigating the effects of dupA. However, an in vivo analysis using 
animal models may help to elucidate the nature of infection with strains carrying 
this gene, and the consequence of infection with dupAl and dupA2 strains. In 
addition, determining the patterns of colonisation that develop in gastrin knock- 
out (GAS-OK) mice and hypergastrinemic transgenic (INS-GAS) mice may 
reveal the possible relationship between acid levels and dupA status. 
5.3.1.3 vacA 
The three polymorphic regions of the vacA gene were assessed as possible 
determinants of colonisation density of H. pylori. Only infection with the more 
virulent ml-type strain in the corpus appeared to associate with increased 
bacterial loads, but this was not statistically significant. When controlled for 
dupA+ status, increased densities were observed with both m- and i-regions, 
although not statistically significant with the latter. Interestingly, this trend was 
observed in the corpus but not the antrum. However, a trend towards increased 
density with ml and il-type strains was observed in both the antrum and corpus 
among dupA- strains. As dupA+ strains have a tendency towards antral- 
predominant colonisation, differences in colonisation density between ml and 
m2-type strains may be masked in the antrum, therefore explaining why a trend 
was not observed in the antrum for strains that were also dupA+. Therefore, 
virulent forms of vacA may be associated with increased bacterial density, as 
found in previous studies (Han et al., 1999; Homan et al., 2009; Nogueira et al., 
2001; Tham et al., 2001). 
The interaction of the toxin with host cells is known to interfere with tight 
junction integrity through modulating tyrosine phosphorylation of ß-catenin 
(Adamsky et a1., 2003; Meng et al., 2000), which has been implicated in tight 
junction formation (Rajasekaran et al., 1996). Thus, nutrient "leakage" into the 
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gastric lumen may be involved in bacterial growth, and may therefore explain the 
observed relationship in the current study. 
Bacterial density was not associated with VacA in vitro. However, these growth 
conditions may not be representative of the human gastric mucosa, and the model 
utilised may not account for other host factors that may influence growth such as 
acidity. In this respect, a mouse model may be more beneficial. Furthermore, 
investigation of earlier time points are important in order to determine whether 
bacterial overgrowth at later times points may be masking the impact of virulence 
determinants of bacterial density. 
Of consideration is the reported cross-talk between CagA and VacA (Argent et 
al., 2008; Tegtmeyer et al., 2009). Argent et a!. (2008) demonstrated increased 
vacuolation of epithelial cells with AcagA and L cagE mutants, whereas the AvacA 
mutants significantly increased CagA-induced AGS cell elongation, as compared 
with wild type strains. Tegtmeyer et al. (2009) later found a small proportion of 
H. pylori strains that did not induce cell elongation despite possessing a functional 
CagPAI, and demonstrated increased vacuolation of gastric cells. Furthermore, 
this modulation of CagA function was demonstrated to be dependent on VacA. 
These studies have important implications for the in vitro model used in the 
current study, as vacA mutants may have enhanced CagA activity, which may 
mask any impact on bacterial load, and vice versa. However, the extent of 
regulation and whether this is restricted to cell elongation and vacuolating activity 
is unknown. Such cross-talk may therefore make the assessment of individual 
bacterial factors difficult, although the implication for bacterial density remains 
unclear. 
5.3.2 The association between virulence determinants and the clinical 
outcome of infection. 
An association was not observed between virulence determinants and clinical 
outcome of infection. As mentioned, dupA status was not associated with DUD as 
shown previously (Lu et al., 2005; Zhang et al., 2008), although the majority of 
dupA positive strains were isolated from DUD patients. No association was found 
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between disease status and cagA and vacA strain types. Interestingly, all 7 patients 
presenting with GUD were infected with cagA+ strains, and ml and il 
-types 
strains were isolated in 6/7 GUD cases, which supports previous reports of 
increased risk of GUD and gastric cancer with the presence of these virulence 
factors (Blaser et al., 1995; Kikuchi et al., 1999; Parsonnet et al., 1997). 
Pathology was also not related to virulence factor expression. 
Overall, these data suggest a role of dupA in determining patterns of H. pylori 
colonisation in the human stomach, and a possible relationship between bacterial 
load and vacA type. 
The presence of other virulence factors, that have not been considered in this 
study, may also affect colonisation as many have been associated with increased 
risk of developing severe H. pylori related disease. These include babA2, sabA 
and oipA, which play a role in bacterial adherence to epithelial cells and 
encourage bacterial colonisation. oipA and babA2 have in fact previously been 
associated with increased colonisation density in gastric tissue (Yamaoka et al., 
2002a). Furthermore, there is a clear association between these virulence factors 
and increased inflammatory responses as well as increased risk of developing 
disease (Rad et al., 2002; Zambon et al., 2003). Importantly, these factors may be 
linked with gastroduodenal disease because they are associated with the presence 
of other virulence factors. For instance, cagA+ strains are associated with babA2 
expression (Ilver et al, 1998). These close associations make in vivo analysis of 
virulence factor effects in the human host difficult, and illustrates the need for 
controlled animal studies and in vitro models to further investigate the 
relationship between bacterial colonisation and bacterial factors. 
Bacterial factors clearly play a role in modulating colonisation density. However, 
cytotoxins are known to induce host responses which in turn regulate the local 
environment and effectively create micro-niches, as well as inducing 
inflammatory responses that are capable of attacking H. pylori in an attempt to 
clear the infection. With this in mind, it is important to consider the role of the 
host inflammatory response and its effect on colonisation density. 
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Chapter 6 
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6. PRO-INFLAMMATORY HOST 
RESPONSES TO H. PYLORI INFECTION 
IN THE GASTRIC MUCOSA 
6.1 INTRODUCTION 
One of the major characteristics of H. pylori infection that has drawn much 
attention is the capacity of the bacterium to maintain a chronic infection in the 
host (Kusters et al., 2006). H. pylori has developed a number of mechanisms that 
prevent the immune response from clearing the infection. Consequently, a huge 
number of studies have concentrated on understanding the relationship between 
the bacterium and host immunity. 
During the effector-specific immune response to infection, naive CD4+ T cells 
differentiate in response to specific cytokine profiles, and polarised responses can 
either have a ml, Th2, Th17 or Treg phenotype. Th-cell polarisation is dependent 
on environmental factors; an IL-4 rich milieu is capable of stimulating Th2 cell 
differentiation, whereas IL-12 and IFNy favour the differentiation of Thl cells 
(Spellberg & Edwards, 2001). In the presence of TGF-ß, naive CD4+ T cell 
differentiation favours a Treg phenotype (Chatenoud & Bach, 2006). However, 
differentiation of Th17 cells is dependent on TGF-ß, IL-6 and IL-23 (Bettelli et 
al., 2006). 
A large amount of evidence is now available in support of a Th 1 polarised 
response to H. pylori infection in the gastric mucosa in humans (Bamford et a!., 
1998; Karttunen et al., 1995; Mohammadi et al., 1996; Sommer et al., 1998; 
Tomita et al., 2001). For instance, increased expression of the Th 1-defining 
cytokines IFNy and IL-12 were found in gastric biopsy samples of H. pylori- 
infected patients (Pellicano et al., 2007). Furthermore, Th2 responses were not 
found to be up-regulated during H. pylori infection, and IL-4 has been detected at 
low levels, or not at all in some cases, in the gastric mucosa of most H. pylori- 
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infected persons (Karttunen et al., 1995; Lindholm et al., 1998; Sommer et al., 
1998). In addition to this evidence, Yamauchi et al. examined the role of IL-18, 
another Thl 
-related cytokine, which promotes the production of IFNy by T cells 
in the presence of IL-12. IL-18 was found to be markedly increased in H. pylori 
infected epithelial cells and monocytes, which was dependent on the CagPAI and 
OipA (Yamauchi et al., 2008). Other bacterial factors have also been implicated 
in driving the immune response towards a Th l phenotype, including HP-NAP, 
which not only induces an IL-12 rich environment, but also down-regulates the 
Th2 antibody response resulting in Thl polarised immunity (Amedei et al., 2006) 
(Chapter 1, section 1.6.7). 
The levels of numerous pro-inflammatory cytokines, including TNFa, IL-10 and 
IL-8 are up-regulated in the gastric mucosa of H. pylori infected individuals 
compared to uninfected humans, and are key to the immune response against the 
bacterium (Crabtree et al., 1991 a; Crabtree, 1996; Lindholm et al., 1998). 
6.1.1 Interleukin-8 (IL-8) 
IL-8, also known as CXCL8, is a pro-inflammatory chemokine produced by 
macrophages, neutrophils and epithelial cells, and is essential for the recruitment 
of neutrophils to the site of infection. Expression of the IL8 gene is regulated by 
NF-i3, although other hormone response elements and NF-IL6 consensus sites 
have been found in the promoter region of the gene. A number of stimuli can 
regulate IL8 expression, including inflammatory signals such as TNFa and IL-1 P 
(Waugh & Wilson, 2008). In addition to its role as a chemoattractant for 
neutrophils, IL-8 also induces the respiratory burst in neutrophils. Once bound to 
cell surface receptors, IL-8 also activates signalling pathways involved in cell 
proliferation and survival (Waugh & Wilson, 2008). 
IL-8 production is up-regulated during H. Pylori infection (Crabtree et al., 1994; 
Gionchetti et al., 1994; Sharma et al., 1998). A major stimulus for the expression 
of IL8 in gastric epithelial cells is the CagPAI, which activates NOD 1 through the 
injection of peptidoglycan into the cell cytoplasm, consequently stimulating 1L8 
expression through NF-icB activation (Boughan et al., 2006; Viala et al., 2004). In 
addition, CagA also induces IL-8 secretion via a mechanism independent of 
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NOD1 (Brandt et al., 2005) (discussed further in Chapter 1, section 1.6.3.1). In 
support of this, various studies have observed reduced IL-8 secretion with CagA 
or CagPAI mutant strains (Brandt et al., 2005; Eaton et al., 2001a). In addition, 
other H. pylori-specific factors have also been associated with up-regulated IL-8 
responses in the gastric mucosa, including OipA, BabA (Yamaoka et al., 2002a) 
and DupA (Lu et al., 2005). 
High IL-8 levels may also be associated with an increased risk of developing H. 
pylori-related disease. This is highlighted in studies looking at the effect of the IL- 
8 
-251 polymorphism, which results in high IL-8 production and was found to be 
associated with increased risk of developing gastric cancer and ulcer disease 
(Kang et al., 2009; Taguchi et al., 2005). However, this may be population 
specific as an association was not observed in all populations examined (Canedo 
et al., 2008). These studies demonstrate the importance of IL-8 during H. pylori 
infection. 
6.1.2 Interferon-Y (IFNvI 
IFNy is a cytokine produced by Thl cells, CD8+ T cells and natural killer cells, 
and is essential in the activation of macrophages and suppression of Th2 
responses. IFNy is therefore essential to the activation of the adaptive immune 
response (Murphy & Reiner, 2002). Other effects of IFNy include the recruitment 
of effector cells to the site of inflammation through stimulating the production of 
chemokines by macrophages, and stimulation of the macrophage oxidative burst 
via enhanced expression of the enzymes NOS and NADPH oxidase (Baccala et 
at, 2005; Borden et at, 2007). 
IFNy production is up-regulated in the gastric mucosa during H. pylori infection 
(Karttunen et al., 1995; Lindholm et al., 1998), and is essential for clearance of 
the bacterium during immunisation models in mice (Sayi et at, 2009). 
Furthermore, this cytokine may also play a role in the progression of gastric 
cancer (Hossein et al., 2010). In support of this, IFNy knockout mice infected 
with H. pylori were demonstrated to be protected against the development of 
gastric atrophy (Houghton et al., 2002; Smythies et aL, 2000). 
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Although polymorphisms in the IFNy gene have been shown to induce increased 
cytokine production, an association with H. pylori disease has not been shown 
(Rad et al., 2004; Zambon et al., 2005). However, recent data suggests that a 
polymorphism in the IFNGR2 gene (Ex7-128), an important receptor of the IFN-y 
pathway, may be linked to the development of gastric cancer. In this study, it was 
also found that this polymorphism in combination with the TNFa 
-308 
polymorphism (discussed in section 6.1.4) elevated the risk of gastric cancer (Hou 
et al., 2007). Therefore, IFNy plays a key role in the immune response to H. 
Mori. 
6.1.3 Interleukin 10 (IL-18) 
EL-10 is a pro-inflammatory cytokine produced by many cell types including 
monocytes, macrophages, neutrophils, and dendritic cells (Curfs et al., 1997). It is 
produced in response to numerous stimuli and nearly all microbial infections have 
the capability to induce expression of the cytokine (El-Omar, 2001). IL-1 ß exerts 
its biological effects on almost all cell types, and broadly speaking, it functions to 
induce pro-inflammatory responses, mainly by inducing the expression of other 
pro-inflammatory cytokines by either initiating transcription, or stabilising their 
mRNA. These cytokines include T NFa, IL-2, IL-6 and IL-8 (Dinarello, 1996). In 
addition, it is important in the activation of various cells including T and B cells, 
and natural killer cells. 
IL-10 plays an important role in the pathogenesis of H. pylori infection, and is up- 
regulated during infection with the bacterium (Jung et at, 1997; Noach et at, 
1994a). The cytokine is a potent inhibitor of acid secretion in the infected 
stomach, and does so via a number of different pathways (Beales & Calam, 1998). 
The importance of IL-1ß was demonstrated in a Mongolian gerbil model in which 
the addition of an IL-10 receptor (IL-IR) antagonist lead to increased gastrin 
levels and acid output, therefore demonstrating the role of IL-lß in the 
physiological changes that arise in the stomach (Takashima et al., 2001). Along 
with inducing hypochlorhydria, IL-lß also modulates the function of several 
gastric epithelial cells. It stimulates the release of gastrin from G cells, and 
decreases histamine release and apoptosis in ECL cells (Mahr et al., 2000; Prinz 
6-171 
et al., 1997). Low acid production is strongly associated with gastric cancer 
(Correa, 1995; El-Omar et al., 2000), and the importance of IL-10 in the 
development of disease is apparent through studies that have demonstrated gene 
polymorphisms to be strongly associated with gastric cancer (El-Omar et al., 
2000; EI-Omar et at, 2003) (discussed in more detail in Chapter 1, section 1.2.2). 
Furthermore, IL-i has also been linked to the development of PUD (Hsu et al., 
2004; Watanabe et al., 2001), and is therefore fundamental to the pathogenesis of 
H. pylori infection. 
6.1.4 Tumour necrosis factor a (TNFa) 
TNFa is a pro-inflammatory cytokine that is secreted by a number of cells 
including macrophages, natural killer cells and T-cells. This cytokine has 
pleiotropic functions, and is important in promoting inflammatory responses to 
infection, as well as activating macrophages and neutrophils (Le & Vilcek, 1987). 
In addition, TNFa induces the expression of adhesion molecules such as VCAM- 
1, indicating the importance of the cytokine as a chemoattractant for other cells 
(Curfs et al., 1997). TNFa secretion is induced by a number of stimuli including 
LPS (Crabtree et al., 1991 a). Like IL-1p, TNFa stimulation of cells induces NF- 
uB signalling pathways, and is therefore important in cell proliferation and 
survival (Curfs et al., 1997). 
TNFa production is upregulated during H. pylori infection (Crabtree et at, 1991 a; 
Noach et at, 1994a), and induces the transcription of other pro-inflammatory 
cytokines and chemokines (Gents, 1997a). An important function of this cytokine 
is the inhibitory effect on gastric acid secretion (Reales & Calam, 1998). It was 
found to inhibit somatostatin release from D cells, which negatively regulates the 
release of gastrin from G cells (Beales et al., 1997). Increased TNFa production 
has been associated with H. pylori specific virulence factors, including TNFa- 
inducing protein (TIPa) (Suganuma et al., 2005) and JHP940 (Rizwan et al., 
2008). A correlation has also been observed between disease severity and TNFa 
secretion (Lehmann et al., 2002). As discussed earlier (Chapter 1, section 1.2.2), 
TNFa polymorphisms are associated with an increased risk of developing gastric 
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cancer (El-Omar et al., 2003), demonstrating the importance of TNFa to H. 
pylori-associated inflammatory responses. 
6.1.5 Interleukin 17 (IL-17 
In recent years, the Th 1 /Th2 paradigm has expanded to include a new subset of T 
helper effector cells termed Th 17 which produce IL-17A and IL-17F. IL-17A is 
also produced by natural killer cells, neutrophils, eosinophils, and other cells of 
the innate immune system which are believed to play a role in immune 
surveillance (Cua & Tato, 2010). Therefore, IL- 17 is produced by cells of both the 
innate and adaptive immune systems, suggesting a role for the cytokine in 
bridging the two immune responses. IL-17 is a pro-inflammatory cytokine that 
acts on a broad range of cells (Kolls & Linden, 2004), and functions to induce the 
expression of numerous cytokines including TNFa, IL-6, IL-lß, and IL-8 
(Jovanovic et al., 1998; Laan et al., 1999). 
Up-regulation of IL-17A has been demonstrated in the gastric mucosa of H. pylori 
infected compared to uninfected people (Caruso et al., 2008; Luzza et al., 2000). 
Notably, IL17 expression was found to be higher in ulcer tissue compared to non- 
ulcerated tissue in the antrum of infected patients (Mizuno et al., 2005). IL-17 
levels have also been found to correlate with neutrophil infiltration in the H. 
pylori infected gastric mucosa (Mizuno et al., 2005), and have been associated 
with increased secretion of IL-8 (Luzza et al., 2000), suggesting that IL-17 may 
be crucial to the recruitment of immune cells to the gastric mucosa and the 
gastritis that develops in response to H. pylori. 
6.1.6 Interleukin 22 QL-22) 
A novel T helper subset has recently been described which characteristically 
secretes IL-22, and is thus called Th22 (Dunen et al., 2009; Trifari et al., 2009). 
IL-22 was later found to be expressed at low levels in natural killer cells, and in 
activated T cells including Thl and Th17 cells, with the highest frequency of IL- 
22 producing cells having the Th22 or Thl phenotype (Duhen et al., 2009). The 
functions of IL-22 appear to differ to other cytokines, as it is produced by immune 
cells but regulates the functions of certain tissue cells. Overall, IL-22 functions to 
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increase the innate immunity of tissue cells, protects tissue from damage and 
enhances regeneration of tissue (Duhen et al., 2009). The IL-22 receptor complex 
is composed of the IL-22R1 and IL-10R2 subunits. As IL10-R1 is ubiquitously 
expressed, the expression of the IL-22R1 chain determines the cellular targets of 
IL-22 (Wolk et al., 2004). There is no evidence to date that IL-22 expression is 
modulated by H. pylori infection. However, IL-22R1 chain expression has been 
demonstrated in the stomach (Wolk et al., 2004). 
6.1.7 Evidence for Th1 effects on bacterial load 
Various studies in mouse models have demonstrated the detrimental effects of 
pro-inflammatory responses to H. pylori colonisation density. A number of studies 
have showed that IFNy-deficient mice develop a mild gastritis post-infection in 
comparison to wild type strains, and increased bacterial loads were concurrently 
observed (Eaton et al., 2001 b; Sawai et al., 1999; Sayi et al., 2009). Eaton et al. 
(2001) reported the development of more severe gastritis and metaplasia in SCID 
mice that were given CD4+ splenocytes in comparison to CD4+ depleted 
recipients. Bacterial loads however were found to be more reduced in mice that 
exhibited greater degrees of gastritis then in those with mild gastritis. 
Furthermore, IFNy-deficient mice infected with H. pylori were colonised with 5- 
fold greater bacterial loads than wild type mice, and gastritis was reduced. IL- 10- 
deficient mice on the other hand exhibited the opposite, with 2-fold reduced 
bacterial loads compared to wild type strains, and a much more severe gastritis. 
Notably, Sayi et al. (2009) reported increased colonisation densities 1 month post- 
infection in IFNy knockout mice, which suggests that the adaptive immune 
response may play a role in bacterial clearance. In addition to the effect of IFNy 
on bacterial load, other pro-inflammatory mediators have also been found to have 
an inverse relationship with bacterial load, for instance the IL-12-/' (Garhart et al., 
2003) and nitric oxide"'" mice (Blanchard et al., 2003) were more severely 
colonised in comparison to wild type strains. Delayed clearance of N. pylori was 
also observed in neutrophil depleted IL-10 deficient mice, highlighting the 
importance of these cells in the protection against infection. Importantly, as IL-8 
is essential in the recruitment of neutrophils to the gastric mucosa, these data 
suggest a possible relationship between IL-8 production and bacterial colonisation 
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density (Ismail et al., 2003). The Thl response to Helicobacter infection was 
elegantly demonstrated by Fox et al. In this study, H. fells infected mice were 
found to express higher levels of pro-inflammatory cytokines IFNy, TNFa and IL- 
1ß in comparison to mice with a concurrent helminth infection, which 
characteristically induces a Th2 response. Furthermore, the expression of 
suppressive cytokines IL-10, IL-4 and TGF-ß was found to be higher in these 
mice compared to those infected with H. fells alone (Fox et al., 2000). 
Importantly, although a number of different cytokine responses may contribute to 
the immune response that is responsible for clearing or reducing bacterial load, 
these studies do suggest that increased pro-inflammatory responses are associated 
with reduced bacterial load, and limiting this inflammatory response is associated 
with higher colonisation compared to wild type strains. Therefore, in animal 
models, an inverse association is observed between inflammation and H. pylori 
colonisation. Although a reciprocal relationship between inflammatory responses 
and bacterial burden may also be expected in humans, such an association remains 
to be shown. 
6.1.8 ExDerimental aims 
" To evaluate the relationship between IL8 expression and bacterial burden 
in the gastric mucosa of infected individuals. 
" To investigate the role of pro-inflammatory cytokines stimulation of 
gastric epithelial cells on H. pylori colonisation density in vitro. 
" To determine the effect of cytokine stimulation on IL-8 secretion in 
epithelial cells in vitro. 
" To assess the relationship between IL8 expression and H. pylori strain 
genotype in vivo. 
" To investigate the association between IL8 expression and pathology and 
disease in vivo. 
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6.2 RESULTS 
The inflammatory response to infection plays a key role to the pathogenicity 
associated with H. pylori infection. Whilst inflammation is advantageous with 
respect to protection against the bacterium, the noxious effects of inflammatory 
mediators necessary for bacterial clearance also result in mucosal damage, leading 
to loss of tissue and disease (Robinson et al., 2007). An aggressive inflammatory 
response would be expected to reduce colonisation density, whereas a higher 
bacterial load may be seen with reduced inflammation. As mentioned, previous 
studies in mice suggest that this is the case (Blanchard et al., 2003; Eaton et al., 
2001b), however little evidence for this association in the human gastric mucosa 
is available. 
6.2.1 The relationship between IL8 expression and bacterial load in the 
H. Mod infected eastric mucosa 
IL-8 is an important pro-inflammatory cytokine induced by H. pylori infection 
(Sharma et al., 1998). High expression of the cytokine that results from IL8 gene 
polymorphisms has been associated with an increased risk of developing H. pylori 
disease (Kang et al., 2009; Taguchi et al., 2005). IL-8 is therefore an important 
cytokine in the immune response mounted in response to H. pylori infection. 
Previous studies in mice have reported an inverse relationship between bacterial 
burden and the severity of gastritis in mice (Blanchard et al., 2003; Eaton et al., 
2001b; Sawai et al., 1999). However, it is unclear whether IL8 plays a role in the 
degree of H. pylori colonisation in the gastric mucosa. In order to investigate this, 
IL8 expression levels were measured using RNA extracted from 33 gastric tissue 
samples obtained from the antrum and corpus of infected patients, for which 
bacterial load was also determined from DNA extracted from the same gastric 
tissue sample. 
A plot of IL8 expression against bacterial load shows a large group of samples 
that cluster within a region of low IL8 expression (appearing below125) and low 
bacterial load (appearing below 1). It would appear that the highest IL8 expression 
levels were observed with lower bacterial loads, and the highest bacterial loads 
were observed in samples with low IL8 expression levels (Figure 6.1). 
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Figure 6.1: The relationship between bacterial load and IL8 responses in the 
gastric mucosa. 
Bacterial load and IL8 expression levels were determined in 33 H. pylori infected 
antral gastric tissue biopsies ("), and 33 H. pylori corpus gastric biopsies (+ ). Each 
data point represents the average IL8 expression level and bacterial load measured 
in 3 replicate reactions. To highlight the cluster of samples with low IL8 
expression that also presented with low bacterial density, a reference line for the 
y-axis was placed at 1, and at 125 for the x-axis. 
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Based on this data, a simple linear negative relationship was not observed 
between colonisation density and IL8 expression. To confirm that IL8 expression 
is upregulated in the H. pylori infected gastric mucosa, IL8 expression levels were 
measured in 34 H. pylori infected and II uninfected biopsies taken from the 
antrum and corpus. As expected, IL8 expression levels were elevated in the gastric 
mucosa of infected patients compared to uninfected patients in the antrum and 
corpus (Figure 6.2). IL8 expression between H. pylori infected antral and corpus 
biopsies did not differ (antrum: median=48.7, n=48, IQR=4.49-61.8; corpus: 
median=29.1; n=34, IQR= 15.7-74.8). 
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Figure 6.2: IL8 responses in the gastric mucosa of H. pylori infected and 
uninfected patients. 
IL8 expression levels were determined for 34 H. pylori infected and II uninfected 
antral and corpus gastric biopsies. Data were normalised relative to GAPDH 
expression, and a sample from an uninfected donor was used as an internal 
comparator to provide a fold-difference. * represents outlier data points. 
6-178 
6.2.2 The relationship between ILS eaaression and Inflammation In 
gastric tissue 
As mentioned, IL-8 plays a crucial role in the recruitment of neutrophils to the site 
of infection, and is hence essential for the induction of the inflammatory response 
in H. pylori infection. The degree of neutrophil infiltration into the lamina propria 
(described as "activity" by histopathologists) would be expected to reflect the 
level of IL8 expression. However, this was not the case in a number of studies 
(Bayraktaroglu et al., 2004; Camorlinga-Ponce et al., 2003). In order to 
investigate whether this relationship exists in the gastric mucosa, the grade of 
activity determined by histology was assessed in comparison to IL8 expression. 
Severe grades of activity (Sydney score of 3) were not observed in the data set 
studied. A small increase in IL8 expression was observed between mild and 
moderate degrees of activity in the antrum (for grade 1: median=24.7, n=9, 
IQR=12.6-55.3; for grade 2: median=36.7, n=17, IQR=4.59-83.9) and corpus (for 
grade 1: median=17.6, n=9, IQR=12.0-115.5; for grade 2: median=30.5, n=13, 
IQR=20.8-91.2), but was not statistically significant. Higher IL8 expression levels 
were observed in the presence of activity (scores of I and 2 combined) compared 
to samples that showed no activity in the antrum (absence of activity: 
median=4.47, n=7, IQR=2.61-23.3; presence of activity: median=31.2, n=26, 
IQR=5.42-80.0; p=0.02), but was not the case in the corpus (absence of activity: 
median=40.4, n=11, IQR=12.5-67.8; presence of activity: median=29.1, n=22, 
IQR=18.0-88.9). 
The relationship between IL8 expression and mononuclear cell infiltration 
(described as "inflammation" by histopathologists) was also investigated, and was 
positively associated with histological grading of inflammation in both antral (for 
grade 1: median=3.22, n=8, IQR=2.31-27.0; grade 2: median= 34.2, n=21, 
IQR=6.06-79.2; grade 3: median=67.8, n=5, IQR=13.6-140.4) and corpus (for 
grade 1: median=19.8, n=17, IQR=13.1-52.0; grade 2: median= 30.4, n=14, 
IQR=18.2-83.9; grade 3: median=119.6, n=3, IQR=62.2-158.1) biopsy samples 
(Figure 6.3A and B). Therefore, IL8 expression is a good indicator of the degree 
of mononuclear cell infiltration in the gastric mucosa. 
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Figure 6.3: Relationship between IL8 expression and inflammation 
Levels of IL8 mRNA were determined in 34 gastric biopsies taken from A- the 
antrum and B- the corpus. Expression levels were categorised by the level of 
mononuclear cell infiltration (inflammation) as determined by histology. 
*indicates outlier values. 
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6.2.3 The effect of pro-inflammatory cvtokines on bacterial load in vitro 
The data presented here have demonstrated that IL8 mRNA levels are markedly 
increased in H. pylori infected gastric tissue samples in comparison to uninfected 
samples, but the relationship with bacterial load is complex. However, IL8 mRNA 
levels were positively associated with the level of inflammation as determined by 
histology. Other cytokines are known to modulate IL8 expression such as IL-10 
and TNFa (Crabtree et at, 1994), and IL-17 (Luzza et al., 2000). Therefore, the 
relationship between these cytokines and bacterial load was assessed. 
Previously, our group have demonstrated the effects of II. 
-10 cytokine stimulation 
of H. pylori infected AGS cells on bacterial CFU counts in co-culture (Robinson 
et al., 2008). This method was therefore utilised in order to investigate the impact 
of a panel of inflammatory cytokines on bacterial burden on gastric epithelial 
cells. IL1,8 and TNFa expression is known to be induced in response to H. pylori, 
and as these cytokines are associated with disease progression (Camilleri et at, 
2007; Crabtree et at, 1991a; Crabtree et at, 1994), both were chosen for 
investigation. Recent evidence has highlighted the potential role for IL- 17 in H. 
pylori-associated inflammation, suggesting that IL-17 responses may be 
associated with H. pylori-specific disease profiles (Caruso et al., 2008; Mizuno et 
al., 2005). Th17 skewed responses in mice were found to be associated with 
reduced bacterial densities, and IL-17 was therefore investigated (Kao et al., 
2010). 
AGS gastric epithelial cells were infected with H. pylori strains 60190 (CagPAI 
positive) or Tx30a (CagPAI negative), in the presence or absence of cytokine 
stimulation. Each condition was performed in 6 replicates, on two separate 
occasions to minimise experimental error. Cells were incubated for 24 hours, after 
which the number of bacterial CFUs were determined. To assess CFU counts, a 
serial dilution of the culture suspension was spotted onto blood agar plates. CFU 
counts were enumerated after incubating the plates for 3-4 days (a detailed 
description is given in section 2.6). Stimulation with IL- I A, TNFct and IL- 17 did 
not reduce bacterial CFU counts in comparison to the unstimulated control (Table 
6.1). 
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Average CFU count/ml after 24hrs (SD) 
IL-lß TNFa IL-17 
AGS cells cultured with H. pylori 60190 
+ H. pylori 
9.98x10 
(1.89 x 107) 
1.02x10' 
(2.26 x 107) 
3.73x10 
(1.09 x l07) 
+ H. pylori 
+ cytokine 
1.03 x 108 
(5.64 x 107) 
1.01 x 10'1 
(2.65 x 107) 
4.46 x 107 
(8.49 x 10") 
P NS NS NS 
AGS cells cultured with H. pylori Tx30a 
+ H. pylori 
1.66x 10 
(4.52 x 107) 
1.86x 108 
(2.69 x 107) 
1.17x 10 
(2.24 x 107) 
+ H. pylori 
+ cytokine 
1.71 x 108 
(3.68 x 107) 
2.34 x 108 
(5.54 x 107) 
1.29 x 10' 
(1.51 x 107) 
P NS NS NS 
Table 6.1: The effect of cytokine stimulation on bacterial load when cultured 
with human gastric epithelial cells. 
AGS cells were stimulated with 50ng/ml of cytokine and infected with either H. 
pylori strains 60190 or Tx30a (MOI=100). After 24hrs, the average number of 
colony forming units (CFU/ml) in 6 replicates was determined. Differences in 
CFU counts between cells cultured in the absence or presence of cytokine were 
not statistically significant. No H. pylori growth was observed in uninfected AGS 
controls. SD = standard deviation, NS = not significant. 
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IL-8 responses to H. pylori infection and cytokine stimulation were investigated in 
order to confirm that stimulation with these cytokines induces increased IL-8 
production as previously reported (Crabtree et al., 1994; Luzza et al., 2000). AGS 
cells were cultured as before with H. pylori strain 60190 in the presence or 
absence of cytokine stimulation. An increase in IL-8 secretion was observed in 
uninfected AGS cells in the presence of IL-lß (54-fold increase compared to AGS 
control) and TNFa (23-fold increase). IL-8 responses were also induced with 
unstimulated H. pylori infected cells (34-fold increase). However, the greatest 
response was observed with infected cells that were stimulated by IL-10 and 
TNFct. Interestingly, although IL-17 stimulation of AGS cells did not induce IL-8 
secretion, IL-17 stimulation of H. pylori infected AGS cells further induced IL-8 
responses in comparison to untreated H. pylori infected cells (Figure 6.4). 
Overall, H. pylori infected AGS cells were in fact responsive to cytokine 
treatment, but these responses were not associated with a reduction in bacterial 
numbers. 
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Figure 6.4: IL-8 secretion levels in response to cytokine stimulation of gastric 
epithelial cells infected with H. pylori. 
AGS cells were cultured with Helicobacterpylori strain 60190 (MOI=100) in the 
presence or absence of cytokine (50ng/ml). IL-8 responses to IL-1ß, TNFa and 
IL-17 stimulation were measured by ELISA after 24 hours in 6 replicates. 
Unstimulated and stimulated AGS uninfected controls were included for each 
experiment. * represents a significantly higher IL-8 secretion after cytokine 
stimulation in comparison to unstimulated controls (p<0.005). 
AGS cells alone 
* AGS cells + H. pylori 60190 
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The role of IL- 17 in the defence against Gram negative bacteria was demonstrated 
with Klebsiella pneumonia infection, where stimulation of bronchial cell lines 
with IL-17 induced the expression of IL-6, and the addition of IL-22 further 
increased expression levels of IL-6 (Aujla et at., 2008). Furthermore, bacterial 
burden in IL-17'1' mice was found to be elevated in comparison to wild type 
strains, and the addition of anti-IL-22 was associated with higher CFU counts 
compared to controls, suggesting that functions of IL-17 are enhanced by IL-22. 
Given the recent evidence of IL-22 receptor expression in the stomach (Wolk et 
al., 2004), the effects of IL-22 in combination with IL-17 on H. pylori density 
were investigated. Aujla et al. (2008) demonstrated increased cytokine expression 
after the addition of IL-22 at 2-fold higher concentrations than IL-17. The same 
conditions were therefore applied in the current study. Cells were stimulated with 
IL-22 at concentrations ranging from 20ng/ml-80ng/ml, and IL-17 ranging from 
20-lOng/ml. However, a significant reduction in bacterial CFU counts was not 
observed. This was also the case when cells were stimulated with IL-22 alone 
(Table 6.2A and B). 
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A 
Average CFU count/ml 
after 24brs 
Minus cytokine 1.97 x 10 
Plus IL-22 (50ng/ml) 2.29 x 10 
13 
Pius IL-22: IL-17 at concentrations: 
Average CFU count/ ml 
after 24hrs 
80ng: 40ng 9.20 x 10 
40ng: 20ng 8.85 x 10 
20ng: 10ng 9.65 x 10 
Minus cytokines 7.00 x 10 
Table 6.2: IL-22 mediated effects on bacterial load when cultured with 
human gastric epithelial cells. 
AGS cells were infected with H. pylori strains 60190 (MOI=100), and stimulated 
with A- IL-22 alone (SOng/ml). B- cultures stimulated with a combination of IL- 
22 and IL-17 at IL-22: IL-17 concentrations of 80ng: 40ng, 40ng: 20ng, and 
20ng: l Ong per ml were also examined. After 24hrs, the average number of colony 
forming units (CFU/ml) was determined in 6 replicates. Differences in CFU 
counts between cells cultured in the absence or presence of cytokine were not 
statistically significant. 
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As IL-22 has previously been demonstrated to work synergistically with IL- 17 for 
the induction of IL-6 in bronchial epithelial cells (Aujla et al., 2008), the effects 
of this cytokine combination were investigated in order to determine if such a 
relationship exists for the secretion of IL-8 in H. pylori infected gastric cells. 
AGS cells infected with H. pylori strain 60190 were stimulated with IL-22 and IL- 
17 as previously described (Table 6.2). Stimulation of H. pylori infected cells with 
IL-22 at various concentrations did not significantly induce IL-8 production. As 
before, IL-17 stimulation was associated with increased levels of IL-8 secretion, 
although this was not a dose dependent effect. Furthermore, IL-8 responses to IL- 
17 treatment were not affected by the addition of IL-22 (Figure 6.5). 
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Figure 6.5: IL-8 response to IL-22 and IL-17 cytokine stimulation of H. pylori 
infected gastric cells. 
AGS cells were cultured with Helicobacter pylori strain 60190 (MOI=100). Cells 
were stimulated with IL-22 (at concentrations of 80ng/ml, 40ng/ml, and 20ng/ml), 
IL-17 (40ng/ml, 20ng/ml, and lOng/ml), or a combination of IL-22 and IL-17 
(80: 40ng/ml, 40: 20ng/ml, and 20: 10ng/ml). IL-8 responses were measured by 
ELISA after 24 hours. A H. pylori infected no cytokine control was included. The 
level of IL-8 was also measured in H. pylori negative AGS cells. A level of 
I3.3ng/ml was measured (data not shown in the above graoh). Error bars represent 
the standard deviation between 4 replicates. * represents a significantly higher IL- 
8 secretion after cytokine stimulation in comparison to unstimulated controls 
(p<0.03). 
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6.2.4 The relationship between ILS expression levels and bacterial 
virulence factors 
Recent evidence suggests that VacA may have the capacity to induce NF-uB 
activation in T cells, and therefore presents a possible route for induction of IL8 
expression (Takeshima et al., 2009). In addition, DupA was found to induce IL-8 
secretion in gastric cell lines (Lu et al., 2005) and the gastric mucosa (Hussein el 
al., 2010). Also, it is well known that CagA and the CagPAI are capable of 
inducing IL8 expression in gastric epithelial cells (Brandt et al., 2005). These data 
suggest that H. pylori virulence factors may induce pro-inflammatory host 
responses, in particular IL8 expression, which in turn may impact bacterial load. 
To investigate the relationship between bacterial virulence factors and host 
inflammatory responses, H. pylori strains isolated from gastric biopsies were 
genotyped for cagA (n=20), vacA s-, m-, and i-region (n=23), and the presence of 
dupA (n=22), and IL8 expression was compared (summarised in Table 6.3). In 
antral biopsies, cagA positive strains were associated with numerically almost 5- 
fold greater IL8 levels compared to those determined in cagA negative infected 
biopsies, although this difference was not statistically significant. The opposite 
trend was observed in the corpus, but again was not statistically significant. 
Expression levels did not differ between dupA positive and negative isolated in 
the antrum or corpus. As CagA and CagPAI induces IL8 expression (Brandt et al., 
2005), samples were corrected for cagA positivity. Consequently, IL8 expression 
was found to be numerically higher for dupA+cagA+ strains in comparison to 
dupA-cagA+ strains in both the antrum and corpus but this was not statistically 
significant. 
In the corpus, high IL8 expression was observed in biopsies infected with the most 
virulent isoforms of vacA, but this was not statistically significant. Antral samples 
demonstrated opposite trends with exception to the s-region. Correcting for cagA 
positivity did not alter the trends. As too few strains were genotyped as vacA S2- 
type, correcting for cagA status was not possible. 
Overall, the levels of IL8 expression between different H. pylori strain genotypes 
were not significantly different. 
6-189 
Antrum Corpus 
Median (n) IQR Median (n) IQR 
cagA 
+ 22.4 (16) 4.47-61.7 52.0 (16) 15. I 
- 
4.54(4) 1.23-49.1 83.7(4) 5.81-152.3, 
dupA 
+ 28.3 (11) 4.2O-99.4 30.3 (11) 1 1-1-74.2 
- 
42.3 (11) 10.8-62.0 30.5 (11) 17.6-8 3.2 
+ (cagA+) 34.2 (8) 4.77-79.2 50.5 (8) I4.0-98'. 0 
- 
(cagA+) 23.3 (4) 6.41-62.0 42.2 (4) 18.7-75. S 
vacA 
sl 32.6 (19) 4.72-63.2 40.4 (19) 19.0-74.2 
s2 11.9(4) 0.51-241.2 12.0(4) 3.25-118.9 
ml 14.7 (12) 3.02-56.2 66.5 (12) 18.2-126.7 
m2 31.1 (11) 4.77-195.9 19.6 (11) 13.2-37.9 
ii 22.4 (12) 4.54-61.7 66.5 (12) N. 7-1., 7.4 
i2 31.1 (11) 4.77-63.1 30.3 (11) 0.27-44. o 
mI (cagA+) 14.9 (9) 3.11-70.5 70.7 (9) 2. x. 2-1 3'. u 
m2 (cagA+) 27.3 (7) 4.61-59.1 30.3 (7) 13.3-53.9 
i1 (cagA+) 22.4 (9) 6.06-79.2 70.7 (9) 23.2-132.0 
i2 (cagA+) 31.1 (5) 1.77-67.8 50.2 (5) 
Table 6.3: IL8 responses in relation to H. pylori strain virulence. 
H. pylori strains colonising gastric biopsies were genotyped for eagA, clupA, and 
vacA s-, m- and i-region. IL8 expression levels in the antrum and corpus were 
determined for each strain genotype. As CagA is a potent inducer of 1L8 
expression, data for dupA and vacA were also corrected for cagA to rule out a 
bias. Sample sizes (n) are indicated in brackets. 
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6.2.5 ILS responses in relation to uatholoev and disease. 
Severe inflammatory responses are associated with damage to the gastric mucosa, 
which may induce the development of disease, and IL8 expression has previously 
been associated with increased risk of developing disease. (Kang et al., 2009; 
Taguchi et al., 2005) This was not found for the data set investigated in the 
present study, for which there was no significant difference in IL8 expression 
between patients diagnosed with gastritis, although a trend towards increased IL8 
expression in the antrum was observed in patients with gastritis (antrum: 
median=23.3, n=17, IQR=12.0-122.3; corpus: median=29.1, n=18, IQR=15.7- 
59.5) and those diagnosed with DUD (antrum: median=48.1, n=12, IQR=26.3- 
48.1; corpus: median=20.8, n=12, IQR=14.4-80.1). As only 3 patients in this data 
set were diagnosed with GUD, they were not considered for analysis. 
The relationship between IL8 expression and premalignant pathology, i. e. atrophy 
and IM, was also considered. As mentioned earlier, too few samples were 
available with either atrophy or IM to assess each grade of pathology. Therefore, 
samples were categorised according to whether pathology was present or absent. 
A statistical difference was not observed for atrophy in the antrum (absent: 
median=43.7, n=23, IQR=19.1-80.8; present: median=22.4, n=11, IQR=2.4- 
159.7) or IM in the antrum (absent: median=39.2, n=27, IQR=14.9-80.8; present: 
median=34.2, n=7, IQR=14.6-298.9). Too few patients were found to have 
atrophic gastritis or signs of IM in the corpus, and were therefore not assessed 
further. 
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6.3 DISCUSSION 
Variations in the host immune response and the resulting inflammation are key to 
the mucosal damage that is associated with H. pylori-associated disease 
progression (Robinson et al., 2007). 
H. pylori infection characteristically induces a Thl immune response, with a 
significant upregulation of inflammatory mediators (section 6.1.1 to 6.1.6). Mouse 
studies have demonstrated the importance of these inflammatory mediators to the 
development of gastritis, and the resulting impact on bacterial density (Blanchard 
et al., 2003; Eaton et al., 2001b; Garhart et al., 2003) (discussed in section 6.1.7). 
This chapter investigated the role of the inflammatory response in regulating 
bacterial density in co-cultures with gastric epithelial cells, and the relationship in 
the gastric mucosa. 
6.3.1 IM expression in the H. nvlorß infected gastric mucosa and the 
relationship with bacterial density 
Numerous cytokines are involved in the host inflammatory response to H. pylori 
(Lindholm et al., 1998). As IL-8 is an important proinflammatory cytokine 
expressed in the response to H. pylori infection, expression levels of this cytokine 
in the gastric mucosa were estimated in order to determine if an inverse 
relationship existed between bacterial load and inflammation. This hypothesis was 
based on the observation of previous studies that reported an inverse relationship 
exists between gastritis and bacterial load in mice studies (Blanchard et al., 2003; 
Eaton et al., 2001b; Sawai et al., 1999). 
The majority of biopsies in the data set were found to have low bacterial 
colonisation and low 1L8 expression. High IL8 expression levels were found for a 
number of samples and interestingly, these samples were concurrently colonised 
with low bacterial densities. In contrast, tissue colonised with high levels of H. 
pylori demonstrated low IL8 expression. These data suggest hat in the majority of 
cases, a balance exists between colonisation and IL8 expression resulting in 
relatively low IL8 expression and low colonisation densities. However, when this 
balance is disrupted, a negative association appears to exist and demonstrates the 
inverse relationship between inflammation and bacterial burden. Of note, and in 
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support of this hypothesis, is the absence of samples that exhibited high H. pylori 
colonisation and high IL8 expression. 
Few studies have characterised IL8 expression levels with respect to bacterial 
density, as most reports which have attempted to determine the relationship 
between inflammation and bacterial density have instead used IFNy as a marker 
for inflammation (Bamford et at, 1998; Karttunen et al., 1995; Sommer et al., 
1998). Yamaoka et al. (1999) did however demonstrate a positive relationship 
between bacterial load and IL-8 production. Although the less sensitive methods 
of quantitative culture and ELISA were used in comparison to the current study, 
their data set was much larger. This positive correlation was also demonstrated 
between bacterial density and the degree of mononuclear cell and 
polymorphonuclear cell infiltration. Moreover, they investigated the relationship 
in cagA positive strains only, and divided the groups according to disease profiles 
(Yamaoka et al., 1999). This data does highlight the need to correct for such 
parameters, which was not possible in the current study as sample sizes were too 
small. In contrast, a study of H. pylori infection in children, observed few cases 
where IL-8 staining co-localised with bacterial density measured by 
immunofluorescence, and in many cases no H. pylori colonisation was evident in 
areas stained for IL-8 (Camorlinga-Ponce t al., 2003). Therefore supporting the 
hypothesis that an inverse relationship may exist between inflammation and 
bacterial density. 
Although quantitative real time PCR is an accurate tool for determination of 
cytokine expression and bacterial colonisation, the use of immunostaining may be 
beneficial in assessing this relationship in more detail as demonstrated by 
Camorlinga-Ponce et at (2003), and would allow us to confirm if indeed low 
levels of IL-8 are observed within these areas of high H. pylori colonisation (or 
vice versa). Of further interest would be the relationship between the number of 
inflammatory cells in the gastric mucosa and bacterial load. Histology is useful in 
determination of the extent of the inflammatory infiltrate in the gastric mucosa. 
However, mononuclear cells observed by histology encompass all T helper 
subsets, including suppressive T helper cells, and is therefore not truly 
representative of the inflammatory infiltrate. Bearing this in mind, the use of 
FACs for determination of the number of Th1 or Th17 cells in gastric tissue may 
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be more appropriate for investigation of the relationship between H. pylori density 
and the number of inflammatory cells. Previously, IFNy has been extensively used 
as a marker for Thl cells (Bamford et al., 1998; Sommer et at, 1998). A clear 
limitation of this approach is the need for different sets of gastric biopsies for 
FACs analysis and for bacterial quantification. This was not the case for the 
method applied in the current study as RNA and DNA was extracted from the 
same biopsy for quantification of IL8 and bacterial load. 
IL-8 is an important cytokine expressed in response to H. pylori, however it is not 
representative of pro-inflammatory responses as a whole, and other cytokines 
must also be investigated to determine if inflammation is related to bacterial 
density. As mentioned, IFNy has been shown to be inversely associated with 
bacterial density in mouse models (Bamford et al., 1998; Karttunen et al., 1995; 
Sommer et al., 1998). Furthermore, IFNy has been associated with atrophy, 
inflammation and hyperplasia, demonstrating the importance of the cytokine to H. 
pylori-associated disease (Sayi et al., 2009), and supporting the need to 
investigate the role of IFNy in determining bacterial density in humans. 
Although a simple negative correlation was not observed between IL8 expression 
levels and bacterial load, IL8 levels were upregulated in the gastric mucosa of H. 
pylori infected compared to uninfected samples. Importantly, IL8 expression was 
found to be associated with the level of mononuclear cell infiltration in the gastric 
mucosa, thus demonstrating that IL-8 is a key cytokine expressed during an 
inflammatory response to H. pylori infection. 
IL-8 is a chemoattractant factor for neutrophils, and as would be expected, a 
positive association has been previously observed between IL8 and neutrophil 
infiltration in the gastric mucosa (Mizuno et al., 2005; Suzuki et al., 2004b). In 
the current study, severe neutrophil infiltration (an activity score of 3) was not 
observed in the data set examined. A trend towards higher 1L8 expression was 
observed in both the antrum and corpus between mild and moderate, although not 
statistically significant, which may be a consequence of sample size. Increased 
IL8 expression was observed where activity scores were greater than 0 compared 
to samples with activity scores of 0. 
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6.3.2 The effect of cvtokine stimulation on bacterial load 
In vitro culture assays were used to determine if pro-inflammatory cytokines, 
which are known to induce IL-8 production, have an effect on bacterial density. 
Cytokine stimulation of gastric AGS cells in the presence of H. pylori strain 
60190 or Tx30a had no impact on bacterial CFU counts. This was surprising, 
particularly as both IL-i P and TNFa have been shown to induce the expression of 
human ß-defensin 2 in AGS cells, which has potent bactericidal activity against H. 
pylori (O'Neil et al., 2000). One experimental factor that may have suppressed the 
response to cytokine stimulation is the use of serum rich media. In this study, cells 
were maintained and cultured in FBS-supplemented F-12 ham medium. Both have 
been shown to support higher growth rates of H. pylori (Douraghi et al., 2010; 
Sainsus et al., 2008), therefore the culture conditions may have enhanced the rate 
of H. pylori growth and masked the epithelial cell response to cytokine 
stimulation. The choice of incubation time may also be of consideration. Although 
Douraghi et al. found bacterial viability to be maximal at 24 hours in comparison 
to later time point, the effect of growth supplements at earlier time points were not 
investigated (Douraghi et al., 2010). In addition, hßD2 expression was previously 
shown to be highest at 4 hours post infection in comparison to 24 hours (O'Neil et 
al., 2000). These factors merit the investigation of cytokine stimulation of gastric 
epithelial cells and their effect on bacterial density at earlier time points. 
IL-8 secretion levels in AGS cells in response to cytokine stimulation were also 
investigated. Increased IL-8 secretion was observed when uninfected AGS cells 
were stimulated with IL-lß (H. pylori-, IL-lß+ AGS cells), and also with 
unstimulated H. pylori infected AGS cells. The highest level of IL-8 was observed 
with H. pylori infected AGS cells that were stimulated with IL-lß. Interestingly, 
the levels detected for IL-1ß+ uninfected cells plus that measured in unstimulated 
H. pylori infected cells would be similar to that of AGS cells that were infected 
with H. pylori and treated with IL-lß, suggesting an additive effect. The same was 
observed for TNFa stimulation. 
Of interest was the level of IL-8 detected in response to IL-17 stimulation. In this 
study, IL- 17 did not induce IL-8 secretion in AGS cells alone. However, when H. 
pylori infected AGS cells were stimulated with IL-17, an increase in IL-8 
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secretion was observed. This could be due to direct effects of bacterial infections 
or as a result of the induction of other cytokines. It is also possible that H. pylori 
infection stimulates the expression of IL-17 receptor. Of note is a study by Liang 
et al. who reported increased hBD2 expression after IL-17 stimulation of human 
keratinocytes (Liang et al., 2006). If this also applies to gastric epithelial cells, 
then it suggests that with increased epithelial cell responsiveness to IL-17 during 
infection, this cytokine may be essential as an inflammatory mediator in response 
to H. pylori infection. In contrast, previous studies have demonstrated increased 
IL-8 secretion in IL-17 stimulated, uninfected AGS cells. However, different 
culture conditions were used to the current study, which may induce secretion of 
IL-8. Also, studies have shown a further increase in IL-8 secretion after infection 
with H pylori in comparison to uninfected cells, supporting that found in the 
current study (Mizuno et al., 2005; Zhou et al., 2007). 
As mentioned, IL- 17 and IL-22 cooperatively enhance defence against Klebsiella 
pneumonia (Aujla et al., 2008). This cooperative relationship was also 
investigated in H. pylori infection, but was not found to influence bacterial CFU 
counts in AGS cultures. Furthermore, stimulation of AGS cells with IL-22 alone, 
or in combination with IL-17, did not induce IL-8 secretion in the presence or 
absence of H. pylori. However, whether AGS cells express the IL-22 receptor 
must be established before it can be concluded that IL-22 responses are not 
targeted towards increasing IL-8 secretion. Little is known of the signalling 
pathways that are associated with IL-22 receptor activation, although most studies 
to date have demonstrated the activation of JAK/STAT pathways, particularly the 
activation of STAT3 (Wolk et al., 2010). As IL8 expression is regulated by NFxB, 
IL-22 is unlikely to activate IL-8 production. The fact that receptor expression has 
previously been found in the stomach, and IL-22 reportedly functions to 
upregulate AMP secretion (Wolk et al., 2010) suggests a potential for IL-22 based 
cell responses during H. pylori infection (Wolk et a!., 2004). 
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6.3.3 Characterisation of the relationship between IL8 expression levels 
with bacterial virulence factors and disease. 
H. pylori virulence factors are commonly associated with gastroduodenal disease 
induced by infection with the bacterium. Many of these are thought to enhance 
disease risk through the induction of pro-inflammatory cytokine release from 
epithelial cells (Robinson et al., 2007). The relationship between H. pylori 
virulence factors and the degree of IL8 expression was determined in order to 
investigate this relationship in the population examined for the current study. 
Overall, IL8 expression levels were not associated with strain genotype. Although 
CagPAI activity is associated with increased IL8 expression (Brandt et al, 2005; 
Eaton et al., 2001a), an association was not observed between cagA status and IL8 
mRNA levels. However, as only 4 isolated strains were genotyped as cagA 
negative, statistical analysis was difficult. Furthermore, cagA genotyping does not 
account for CagPAI functionality, which may introduce error into the analysis. 
Little is known about the function of DupA, however recent studies have 
demonstrated the association between this virulence factor and IL8 expression 
(Hussein et al., 2010; Lu et al., 2005). Recent work in our group found an 
association between dupA and IL8 expression in gastric tissue samples donated by 
H. pylori infected patients (Hussein et al., 2010). This result was not observed, 
however, when a larger data set was examined, as demonstrated in the present 
study. Furthermore, our group demonstrated that like vacA, gene variability is 
seen within the dupA gene, giving rise to the extended dupAI type and the shorter 
dupA2. Strain genotyping of H. pylori isolates in the current study did not 
investigate the effect of dupA gene polymorphism, which may have a significant 
impact on cytokine expression. 
As mentioned, increased risk of developing H. pylori-associated disease is 
principally a result of an aggressive pro-inflammatory response. In the present 
study, increased IL8 expression was observed in the antrum with DUD in 
comparison to gastritis, although not statistically significant, and an association 
was not observed with pathology. 
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Overall, specific inflammatory responses did not correlate with bacterial load in 
vitro, and the IL8 expression levels may be inversely related to bacterial load 
when the equilibrium established between the bacterium and host is disrupted. 
However, other markers of inflammation must be investigated in order to 
determine if pro-inflammatory responses are related to bacterial density. Evidence 
now suggests that the T cell response to infection is mixed, with a regulatory T 
cell response also induced during H. pylori infection (Goll et al., 2007). Whether 
such suppressive cells are capable of influencing bacterial colonisation must also 
be investigated. 
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Chapter 7 
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7. ANTI-INFLAMMATORY HOST 
RESPONSES TO H. PYLORI 
INFECTION IN THE GASTRIC MUCOSA 
7.1 INTRODUCTION 
The immune response has evolved to protect the host from a wide range of 
potentially pathogenic microorganisms. In parallel, mechanisms to control 
excessive responses and prevent reactivity to self antigens are required to limit 
host damage. Regulatory T-cells are essential for such control. 
As mentioned previously (Chapter 1, section 1.7.2.4), regulatory T cells are key to 
the modulation of inflammation, and one mechanism by which they exert such 
regulation is through the secretion of suppressive cytokines such as IL-10 and 
TGF-ß, both of which have been shown to be important in the host response to H. 
pylori infection (Chen et al., 2001; Kao et al., 2010; Li & Li, 2006; Maloy et al., 
2003). 
7.1.1 Interleukin 10 (IL-10) 
IL-10 is an anti-inflammatory cytokine that plays a crucial role in preventing 
inflammatory and autoimmune pathologies (Moore et al., 2001). This cytokine 
was initially thought to be a product of Th2 cells that inhibit Th 1 inflammatory 
responses. Since the realisation that the repertoire of T helper cell types is more 
expansive than the Thl/Th2 paradigm, IL-10 production has been associated with 
regulatory T cells as well as Thl, Th17, CD8+ T cells and B cells (Maynard & 
Weaver, 2008; Moore et at., 2001; Trinchieri, 2007). In addition, the production 
of IL-10 has been reported in cells of the innate immune response such as DCs, 
macrophages, mast cells, eosinophils and neutrophils (Moore et al., 2001). 
The IL- 10 receptor is composed of the IL-IORa chain, which is unique to IL- 10 
signalling and is expressed on hematopoietic cells, and the IL-I OR( chain which 
is ubiquitously expressed and is also involved in IL-22 signalling (Moore et al., 
7-200 
2001). Stimulation of the receptor activates Jakl signalling pathways (O'Shea & 
Murray, 2008), and it is believed that Stat3 is required for the inhibitory functions 
of IL-10. In addition, other signalling pathways play a role in the anti- 
inflammatory function of IL-10 (Calado et al., 2006). A particularly pertinent 
mechanism for H. pylori infection is the ability of IL-10 to prevent NF-xB 
activation, and thus suppress pro-inflammatory gene expression including IL-8 
(Robinson et al., 2008). 
IL-10 appears to indirectly affect T cell and NK cell function by inhibiting MHC 
class II and B7-1B7-2 expression on monocytes and macrophages, and limiting 
the production of pro-inflammatory cytokines such as IL-10, TNFa, IL-8 and 
RANTES (Moore et al., 2001). Furthermore, IL-10 signalling in DCs has been 
shown to inhibit chemokine production and prevent the trafficking of these cells 
to lymph nodes, resulting in a disruption of Thl differentiation and recruitment 
(Demangel et al., 2002). Direct effects of IL- 10 on CD4+ T cells have also been 
reported through inhibition of T cell proliferation and the production of pro- 
inflammatory cytokines (Joss et al., 2000; Moore et al., 2001; Taylor et al., 2007). 
The importance of IL-10 in the regulation of inflammatory responses was first 
suggested by Kuhn et al. who demonstrated IL-10 to be essential in the 
modulation of gut inflammation (Kuhn et al., 1993). During infection with H. 
pylori, increased ILIO expression has been observed in the gastric mucosa (Goll et 
al, 2007; Robinson et al., 2008). In H. pylori infected IL-10'1' mice, severe 
inflammation coupled with reductions in colonisation density has been 
demonstrated. This suggests an essential role for this cytokine in modulating 
inflammatory responses, which favours persistence of H. pylori infection (Chen et 
al., 2001). Interestingly, Berg et al. also found a greatly exacerbated inflammation 
and pre-malignant pathology in the gastric mucosa of H. fells infected IL-10''' 
mice, suggesting a role for this cytokine in limiting disease progression (Berg et 
al., 1998). In addition, our group have shown low levels of IL- 10 secreting T-cells 
in the gastric mucosa of H. pylori infected patients with peptic ulcer disease 
(Robinson et al., 2008). Therefore, IL-10 appears to be important for the 
modulation of inflammatory responses elicited in response to H. pylori. 
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As mentioned previously, polymorphisms in the ILIO gene have been reported 
(Chapter 1, section 1.2.2), which alter the amount of IL- 10 secreted, and therefore 
have an impact on the inflammatory response to infection and risk of developing 
disease. 
7.1.2 Transforming growth factor B (TGF-B) 
Transforming growth factor ß (TGF-ß) belongs to a family of cytokines with 
pleiotropic functions, having potent regulatory and inflammatory activity. Its 
effects on numerous immune functions are dependent on the cellular and 
environmental context within which it is expressed (Li et al., 2006b). Unlike most 
other cytokines, TGF-ß is produced by many immune and non-immune cells, and 
virtually all cell types are responsive to the cytokine (Li et al., 2006b). 
There are three forms of TGF-ß in mammals (TGF-ßl, TGF-02, and TGF-ß3), of 
which TGF-ß 1 is the major form expressed in the immune system. The active 
form of the cytokine binds to the TGF-ß receptors (TGF-ßRI and TGF- 3RII), 
which are widely expressed on hematopoietic and nonhematopoietic ells (Li et 
al., 2006b). Binding of TGFJ triggers the kinase activity of the receptor 
cytoplasmic domain, which ultimately leads to nuclear translocation of Smad 
molecules, and the transcription of target genes (Derynck & Zhang, 2003; Shi & 
Massague, 2003). 
TGF-ß is important for the regulation of immune responses and the induction of 
peripheral tolerance. One mechanism by which TGF-ß maintains peripheral 
tolerance is through the maintenance and survival of naturally occurring Treg 
cells (Li et al., 2006a). In the periphery, TGF-ß is necessary for the survival of 
naive T cells (Li et al., 2006b), and in the presence of IL-2 and retinoic acid (RA), 
it promotes the differentiation of induced Treg cells (iTreg) (Coombes et al., 
2007; Davidson et al., 2007) (Figure 7.1). TGF-ß also plays an important role in 
suppressing the responses of innate immune cells (Laouar et al., 2005; Laouar et 
al., 2008; Town et al., 2008). 
Furthermore, TGF-ß is also known to be involved in the induction of pro- 
inflammatory responses. In the presence of IL-6, TGF-ß stimulates the 
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differentiation of T helper 17 (Th17) cells, which can promote further 
inflammation in the presence of IL-23 (Bettelli et al., 2006) (Figure 7.1). 
Increased levels of TGF-ß have been demonstrated in the gastric mucosa of H. 
pylori individuals in comparison to uninfected patients (Li & Li, 2006; Robinson 
et al., 2008). Similar to IL-10, expression of the cytokine tended to be negatively 
associated with the development of peptic ulcer disease, although this trend for 
TGF-ß did not reach statistical significance (Robinson et al., 2008). The 
importance of TGF-ß during H. pylori infection was also demonstrated in mouse 
studies reporting that neutralisation of the cytokine was associated with an 
increased severity of gastritis (Kao et al., 2010). Interestingly, the expression of 
TGF-ß by H. pylori infected gastric cell lines appears to be controversial. Some 
studies have observed increased expression in numerous gastric cell lines, 
including AGS cells (Wu et al., 2007). However, another study failed to show an 
effect on cytokine levels on infection with the bacterium in AGS cells, as well as 
other gastric cell lines (Nakachi et al., 2000). 
Single nucleotide polymorphisms in the TGFBI gene have been observed at 
positions 
-509, -869 and 
-915, and an insertion in the 5'-untranslated region (5'- 
UTR) (at position +72) has also been identified. These mutations appear to be 
associated with a reduced risk of developing duodenal ulcers (Polonikov et al., 
2007), and an association with gastric cancer has not been reported (Garcia- 
Gonzalez et al., 2007; Seno et al., 2007). However, a recent study reported a 
relationship between the 
-509 polymorphism and an increased risk of developing 
premalignant lesions (Achyut et al., 2009). 
Overall, these studies demonstrate the importance of TGF-ß during infection with 
H. pylori and the progression of disease. 
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Figure 7.1: Role of TGF-ß in the regulation of T cell differentiation. 
TGF-ß controls T cell tolerance through direct inhibition of T helper 1 (Th 1), Th2, 
and cytotoxic T lymphocyte (CTL) differentiation. TGF-ß is involved in the 
maintenance of regulatory T (Treg) cells, and also promotes the differentiation of 
induced Treg (iTreg) cells, which also requires the presence of IL-2 and retinoid 
acid (RA). However, when IL-6 is present, TGF-ß drives the differentiation of 
Th17 cells and maintains these cells in a regulatory state (rThl7). IL-23 
stimulation of rTh17 cells in the absence of TGF-ß induces their differentiation 
into effector Th17 cells (eTh17) (Taken from Li & Flavell, 2008). 
7.1.3 FOXP3 
As mentioned, FOXP3 is a transcription factor that is expressed in subsets of T 
cells, and has key functions in the suppression of immune responses (Chapter 1, 
section 1.7.2.4). In mice, foxp3 expressing cells also express CD25, and foxp3 
mutant or deficient mice develop severe autoimmune disease, demonstrating that 
Foxp3 is a key regulator of Treg cell development and function in mice (reviewed 
by Buckner & Ziegler, 2008). However, the Treg population of cells in humans is 
heterogeneous, and the role of FOXP3 in human Tregs is less straightforward. 
Although FOXP3 is required for human Treg cell development and function, 
stable and high expression of the transcription factor is required to maintain 
regulatory function (reviewed in Sakaguchi et al., 2010). Furthermore, FOXP3 
expression is not sufficient for regulatory function, as a proportion of FOXP3 
expressing cells do not possess suppressive activity (Allan et a/., 2007; Morgan et 
al., 2005; Wang et al., 2007). In addition, a significant proportion of T cells with 
suppressive activity do not express FOXP3, for example Trl cells (O'Garra & 
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Vieira, 2007). The expression of FOXP3 has been shown to be induced by 
cytokines such as IFNy (Wang et at., 2006) and IL-2 (Zorn et al., 2006). Also, 
oestrogen has been associated with the expansion of Tregs in mice, suggesting 
that Treg responses may differ between men and women (Tai et al., 2008). 
Studies that have investigated FOXP3 expression levels in humans infected with 
H. pylori have demonstrated an upregulation of mRNA levels, suggesting the 
importance of FOXP3 expressing cells during infection (Kandulski et al., 2008; 
Robinson et al., 2008). 
7.1.4 Regulatory T cell responses in H. ovlori infection 
The importance of Tregs for the modulation of the inflammatory response and 
persistence of Helicobacter infections has been demonstrated widely in mouse 
models. In a study by Rad et al., depletion of CD25+ T cells in C57BL/6 mice 
infected with H. pylori resulted in the development of severe gastritis with 
increased infiltration of mucosal T cells and macrophages and a reduction in 
bacterial load (Rad et al., 2006). In support of this data, Maloy et al. (2003) 
demonstrated the suppression of immune responses when RAG-1- mice infected 
with H. hepaticas were reconstituted with CD4+CD25+ T cells, a suppression 
dependent on IL-10 and TGF-ß. Furthermore, a study by Lee et a!. (2007) using 
H. pylori infected RAG"'" mice showed decreased bacterial loads after transfer of 
effector T cells. Following the introduction of Tregs however, increased CFU 
counts were recovered and a reduction in the expression of inflammatory 
cytokines IFN-y and TNF-a was observed. These studies demonstrate the role of 
regulatory T-cells in the persistence of infection and the attenuation of deleterious 
host responses associated with H. pylori infection in mouse models. 
Studies in humans have reported increased expression of the Treg markers 
FOXP3, CTLA-4, IL-10 and TGF-ß in gastric tissue of H. pylori infected patients 
in comparison to uninfected controls (Lindholm et al., 1998; Lundgren et al., 
2005b; Robinson et al., 2008). The association between Treg responses and 
colonisation density in humans is particularly poorly studied. 
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7.1.5 H. Mori virulence factors and lmmunomodulatorv responses 
Whether H. pylori virulence determinants are associated with the modulation of 
suppressive immune responses is unknown. Antigens present in the lamina 
propria as a result of virulence factor-induced mucosal damage and leakage 
(described in Chapter 1, section 1.6) are capable of activating Treg cells. As the 
degree of virulence of the colonising strain determines the extent of mucosal 
damage, it is feasible to hypothesise that strain virulence may be associated with 
Treg responses (reviewed and discussed in Raghavan & Holmgren, 2005). In 
support of this hypothesis is the recent suggestion that the Treg response to H. 
pylori infection may be implicated in the protection against atopic disease such as 
asthma, with large epidemiological studies reporting a negative association 
between the disease and the incidence of H. pylori infection (Blaser et al., 2008; 
Chen & Blaser, 2007), an association that was found to be strongest with cagA 
positive strain infections (Chen & Blaser, 2008). 
Recently, the neutrophil activating protein of H pylori (HP-NAP) was shown to 
strongly inhibit bronchial inflammation and to reduce Th2 cytokine production 
when administered to ovalbumin sensitised mice, suggesting this virulence factor 
may be an important candidate in the prevention of asthma during H. pylori 
infection and may therefore play a role in induction of suppressive responses 
(Codolo et al., 2008). 
Therefore, a relationship may exist between H. pylori virulence determinants and 
Tregs responses, and hence H. pylori-associated disease. 
7.1.6 Trees and cancer 
As well as modulating gastric inflammation during H. pylori infection (Chen et 
al., 2001; Kuhn et al., 1993), Tregs may encourage cancer development through 
inducing tolerance to tumours (Yamaguchi & Sakaguchi, 2006). Activated 
tumour-specific immune cells have been found in cancer patients; however, the 
immune response fails to prevent tumour growth, suggesting a mechanism of 
escape or suppression is induced. 
Tumour antigens are derived from the host, and many are also self-antigens, 
therefore promoting tumour tolerance through the activation of Tregs, which 
protect against immunity to self (Pardoll, 2003). In support of this hypothesis, 
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murine tumour models have shown that transfer of CD4+CD25+ Tregs can inhibit 
tumour-specific CD8+ cell-mediated immunity (Antony et al, 2005), whereas 
depletion of CD25+ Tregs significantly enhanced tumour rejection (Onizuka et aL, 
1999; Shimizu et al., 1999). Furthermore, an increased frequency of 
CD4+CD25+FOXP3+ Tregs have been found in patients with various types of 
cancers (Zou, 2006), and increased CD4+CD25hi cells were found in patients with 
gastric cancer (Kawaida et al., 2005; Kono et al., 2006; Sasada et al., 2003). Treg 
responses are therefore associated with poor prognosis. In addition, the tumour 
environment has been shown to promote Treg responses through secretion of 
tumour-specific antigens capable of activating Tregs (Nishikawa et al, 2005). 
Furthermore, the tumour cell environment induces the secretion of TGF-ß from 
immature myeloid DCs, which in turn promotes Treg proliferation (Ghiringhelli et 
al, 2005). 
We have previously found that low-level mucosal expression of Treg-associated 
genes were associated with the presence of PUD, but whether a similar putative 
protective association existed with the development of gastric adenocarcinoma is 
not known. However, as Treg responses are elevated during cancer (Kuhn et al., 
1993; Lundin et al., 2007), it is difficult to assess whether Treg responses are 
beneficial in preventing carcinogenesis. It may be more appropriate to investigate 
this relationship at stages of pre-cancerous pathology. 
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7.1.7 Experimental aims 
" To investigate the association between anti-inflammatory responses and 
bacterial load. 
" To investigate the relationship between bacterial virulence determinants 
and the anti-inflammatory response. 
" To determine the relationship between inflammation and anti- 
inflammatory responses. 
" 
To assess the degree of anti-inflammatory responses in H. pylori 
associated isease and pathology. 
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7.2 RESULTS 
Numerous studies have demonstrated that a regulatory T cell response is induced 
during H. pylori infection in the human gastric mucosa. These responses have 
been characterised by quantifying expression levels of IL-10, FOXP3 and TGF-ß, 
and increased numbers of Tregs (Lindholm et al., 1998; Lundgren et al., 2005b; 
Robinson et al., 2008). 
7.2.1 The relationship between Tree-vene expression and H. nvlori 
density in human eastric mucosal tissue 
As mentioned, Treg responses have previously been linked to the density of H. 
pylori infection in mouse models, where the depletion of Tregs or neutralisation 
of suppressive cytokines has been associated with reduced bacterial loads (Kao et 
al., 2010; Rad et al., 2006). Conversely, adoptive transfer of Tregs was found to 
increase bacterial burden (Lee et al., 2007a). In order to determine if such a 
relationship exists in the human stomach, the density of infection and the level of 
the Treg response and cytokine gene expression was investigated in human gastric 
mucosal biopsies. 
IL10 expression levels and bacterial colonisation densities were determined in 33 
antral gastric biopsies. An association was not observed (r=0.21, p=0.24). No 
association was observed between expression levels of FOXP3 and TGFBI and 
bacterial load measured in 21 antral gastric biopsies (Figure 7.2). 
Overall, although we have previously demonstrated that treatment of H. pylori 
infected cells with recombinant IL-10 in vitro induced increased bacterial 
numbers (Robinson et al., 2008), suppressive responses in vivo were not 
associated with bacterial density. 
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Figure 7.2: The relationship between bacterial load and Treg-associated gene 
expression levels in the gastric mucosa. 
Bacterial load and ILIO mRNA expression levels were determined in 33 H. pylori 
infected antral gastric tissue biopsies. FOXP3 and TGFBI expression levels were 
determined in 21 antral biopsies for which bacterial load was also quantified. 
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To confirm that suppressive immune responses are upregulated in the H. pylori 
infected gastric mucosa, the expression level of ILIO, FOXP3 and TGFBI were 
determined for 50 antral gastric biopsies. Cytokine expression was also assessed 
in 14 uninfected antral biopsies. Increased levels of ILIO, FOXP3 and TGFBI 
were found in H. pylori infected compared to uninfected individuals (Figure 7.3). 
Therefore, although expression levels were not associated with bacterial load, 
increased expression was found in comparison to uninfected individuals, as 
previously demonstrated (Lindholm et a!., 1998; Lundgren et al., 2005b; 
Robinson et a!., 2008). 
IL10, FOXP3, and TGFBI expression levels were determined for 50 H. pylori 
infected and 14 uninfected antral gastric biopsies. Data were normalised relative 
to GAPDH expression, and a sample from an uninfected donor was used as an 
internal comparator to provide a fold-difference. * p<0.03. 
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Figure 7.3: Treg associated gene expression in the gastric mucosa of H. pylori 
infected and uninfected patients. 
7.2.2 The effects of anti-inflammatory cytokines on bacterial density 
in vitro 
As we have previously demonstrated increased bacterial CFU counts in response 
to IL-10 in vitro (Robinson et al., 2008), the effects of TGF-ß on bacterial 
colonisation were assessed here, and the effects of IL- 10 were repeated. AGS cells 
were infected with H. pylori strains 60190 and Tx30a at an MOI of 100, and 
incubated for 24 hours before viable counts in 6 replicates were determined. The 
presence of 50ng/ml IL-10 resulted in an increase in CFU counts as previously 
found (2-fold increase with 60190,1.4-fold with Tx30a), however, this only 
achieved statistical significance with Tx30a. The treatment of H. pylori 60190 
infected AGS cells with TGF-ß resulted in only a small increase in CFU counts 
(1.2-fold increase), but this was not the case when infected with Tx30a (Table 
7.1). 
Average CFU count/ml after 24hrs (SD) 
1L-10 TGFß 
AGS cells cultured with H. pylori 60190 
+ H. pylori 
3.55x10 
(1.72 x 107) 
6.44x10' 
(9.01 x 10'') 
+ H. pylori 
+ cytokine 
5.74 x 107 
(2.51 x 107) 
7.63 x 10" 
(5.72 x 10'') 
P 0.06 0.02 
AGS cells cultured with H. pylori Tx30a 
+ H. pylori 
1.34 x 108 
(3.55 x 107) 
1.08 x 10, 
(1.01 x 107) 
+H. pylori 
+ cytokine 
1.89x 10" 
(4.99 x 107) 
1.06x 10' 
(1.25 x 107) 
P 0.03 NS 
Table 7.1: The effect of anti-inflammatory cytokine stimulation on bacterial 
load when cultured with human gastric epithelial cells. 
AGS cells were treated with 50ng/ml of cytokine and infected with either If. 
pylori strains 60190 or Tx30a (MOI=100). After 24hrs, the average number of 
colony forming units (CFU/ml) in 6 replicates was determined. Standard deviation 
(SD) is shown. NS = not significant. 
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7.2.3 The association between Tree gene expression levels and 
virulence determinants of H. nvlori 
Although a Treg response is induced during H. pylori infection, whether bacterial 
factors are associated with driving such a response is still unknown. Previously, 
increased levels of ILIO mRNA were found in the corpus of patients infected with 
cagA+ strains compared to cagA- infections. This trend was also observed in the 
antrum, but was not statistically significant (Hida et al., 1999). However, 
numerous other studies have failed to show an association between bacterial 
virulence and Treg responses (Goll et al., 2007; Obonyo et al., 2006; Wu et al., 
2007). As strain genotype information was available for the data set examined 
here, the relationship between Treg-associated gene expression levels and 
virulence of the colonising strain was assessed. 
IL10, FOXF3 and TGFB1 mRNA expression levels were determined in 39 gastric 
biopsy samples for which cagA status was also available, in 30 samples with 
known dupA status, and 35 with known vacA genotype. As only 4 samples in the 
data set were genotyped as s2-type strains, the s-region was not considered for 
further analysis. Expression levels of Treg associated genes stratified according to 
strain virulence are presented in Table 7.2. 
A trend towards increased levels of ILIO was observed for cagA+ strains, 
although not statistically significant. This trend was not observed with FOXP3 
and TGFBI expression levels. 
A trend towards increased FOXP3 expression was observed with dupA+ strains, 
although not statistically significant. This was not observed with ILIO and TGFBI 
expression. As cagA has previously been shown to be associated with increased 
IL10 mRNA levels, dupA status was controlled for the cagA status of the 
colonising strain. When looking at dupA+cagA+ strains, increased FOXP3 
expression was found in comparison to dupA-cagA+ (p=0.04). A similar trend 
was also seen with IL10 expression, but did not achieve statistical significance. 
Such a trend was not observed for TGFBI expression levels. As only 9/39 strains 
were found to be cagA-, it was not possible to assess Treg-associated gene 
expression when correcting for cagA-status. 
Treg-associated gene expression levels did not differ with vacA m-region allelic 
type, even when controlled for cagA + status. Increased expression of TGFBI was 
observed with i2-type strains compared to il-type strains (p=0.02). This trend was 
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still present when controlled for cagA+ status, but was not statistically significant. 
No difference in ILIO and FOXP3 expression was found between vacA i-region 
alleic types. 
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Treg gene expression level 
IL 10 FOXP3 TGFBI 
Median (n) IQR Median (n) IQR Median (n) IQR 
cagA + 6.06 (31) 2.77-22.5 4.70 (31) 1.36-8.12 2.79 (30) 1.12-8.47 
cagA 
- 1.93 (9) 0.00-17.5 4.40 (11) 1.05-9.37 2.79 (9) 2.14-8.34 
P NS NS NS 
dupA + 7.63 (13) 3.11-27.0 6.83 (10) 4.00-9.05 2.64 (12) 1.72-9.75 
dupA 
- 6.06 (20) 1.40-28.9 3.84 (22) 0.51-10.0 2.79 (22) 0.84-7.40 
P NS NS NS 
dupA + 
(cag q +) 8.21 (10) 5.25-24.7 7.26(9) 5.58-9.97 2.60 (9) 1.75-16.3 
dupA- 
(cagA+) 3.71 (15) 0.28-22.9 2.57 (15) 0.23-9.39 2.71 (15) 0.16-4.05 
P NS 0.04 NS 
vacA m1 5.15 (24) 2.08-22.8 4.80 (25) 1.30-8.75 2.55 (23) 1.13-8.43 
vacA m2 7.21 (20) 0.93-11.9 4.69 (18) 1.90-10.5 4.57 (18) 1.82-7.06 
P NS NS NS 
vacA m1 
(cagA+) 8.79 (19) 2.77-24.1 4.85 (21) 2.18-8.75 2.45 (20) 1.08-11.8 
vacA m2 
(cagA+) 6.06 (20) 0.00-10.5 3.52 (10) 0.41-8.91 4.26 (10) 1.82-7.61 
P NS NS NS 
vacA i1 5.57 (21) 1.06-22.7 4.80 (25) 1.30-8.75 2.31 (19) 1.07-4.05 
vacA i2 7.42(16) 3.35-22.6 4.53 (18) 2.56-7.41 6.31 (16) 2.57-9.27 
P NS NS 0.0 2 
vacA i1 
(cagA+) 7.63 (19) 2.53-22.9 4.85 (17) 0.96-10.6 2.60 (17) 1.10-4.33 
vacA i2 
(cagA+) 5.18 (8) 3.35-11.5 4.65 (7) 2.38-6.40 5.59 (8) 1.96-10.6 
P NS NS NS 
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Table 7.2: The association between Treg gene expression levels and H. pylori 
strain virulence. 
H. pylori strains colonising gastric biopsies were genotyped for cagA, dupA, and 
vacA m- and i-region. IL10, FOXP3 and TGFB1 expression levels in antral gastric 
tissue were determined and stratified according to strain genotype. Data for dupA 
and vacA were also corrected for cagA+ status. Sample sizes (n) and interquartile 
ranges (IQR) are given. NS=not significant. 
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7.2.4 The relationship between suppressive host responses and the 
degree of inflammation of the Qastric mucosa 
As Treg responses play a role in dampening inflammation, a negative correlation 
between the degree of inflammation and the number of Tregs in the gastric 
mucosa would be expected. This has previously been demonstrated in a mouse 
study, where infection of RAG2''' mice with H. hepaticus induced inflammation, 
but mice reconstituted with purified CD4+CD25+ cells developed reduced 
inflammation (Maloy et al., 2003). To investigate the relationship between Treg 
responses and the level of inflammation in the human gastric mucosa, the 
expression levels of IL10, FOXP3 and TGFBI were assessed in 50 antral gastric 
biopsies of H. pylori infected patients, and were stratified according to the level of 
inflammation as determined by histology. 
The levels of ILIO expression was significantly decreased in samples with 
inflammation scores greater than I (for grade 1: median=24.1, n=15, IQR=3.23- 
151.1; for grade 2: median=5.10, n=30, IQR=0.00-15.2; for grade 3: 
median=22.5, n=7, IQR=5.18-43.0). This was also the case with the level of 
FOXP3 expression (for grade 1: median=6.7, n=13, IQR=3.04-19.5; for grade 2: 
median=4.09, n=30, IQR=1.2-6.83; for grade 3: median=2.38, n=7, IQR=1.78- 
7.89) (Figure 7.4). Levels of TGFß1 mRNA were not significantly different (for 
grade 1: median=2.88, n=16, IQR=0.10-32.0; for grade 2: median=2.71, n=30, 
IQR=1.18-7.28; for grade 3: median=9.93, n=4, IQR=6.13-18.8). 
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Figure 7.4: The relationship between Treg associated gene expression and 
inflammation in antral gastric tissue. 
Expression levels of A- IL10 and 13- FOXP3 were measured in 50 antral gastric 
biopsies of H. pylori infected patients, and stratified according to the degree of 
inflammation determined by histopathological scoring (grade I=mild, grade 
2=moderate, grade 3=severe). 
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The degree of inflammation was also assessed in comparison to the frequency of 
Treg cells in the gastric mucosa. The number of CD4'CD25h"IL-l0' cells was 
assessed in pooled cells isolated from 6 antral gastric biopsies, and FACs analysis 
was completed by a colleague (Darren Letley). The numbers of CD4+CD25h'IL- 
l0s were also found to negatively correlate with the severity of inflammation. 
With moderate (score 2) and severe (score 3) inflammation, fewer Treg cells were 
found in comparison to mild inflammation (p=0.006 and p=0.02 respectively) 
(Figure 7.5). This is in agreement with the negative association observed with 
Treg-associated gene expression levels (Figure 7.4). 
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Figure 7.5: The relationship between inflammation and the frequency of 
Treg cells in the antrum. 
The percentage of ILIO+ events amongst CD4+CD25hi events were measured in 
antral gastric biopsies of 30 H. pylori infected patients, and stratified according to 
the degree of inflammation determined by histopathology. I =mild inflammation 
(n=6); 2=moderate inflammation (n=18); 3=severe inflammation (n=6). 
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121 
7.2.5 The relationship between suouresslve Immune resuonses and 
pre-mall¢nant oathoio¢v In the gastric mucosa 
We have previously demonstrated that increased Treg gene expression is 
associated with reduced occurrence of peptic ulcer disease (Robinson et at, 
2008). The investigation of Treg responses to cancer is complicated by the 
induction of cancer specific Tregs (Chattopadhyay et at, 2005; Kosmaczewska et 
al., 2008). In order to fully understand the relationship between H. pylori related 
Tregs and cancer progression, their association with precancerous changes in the 
gastric mucosa such as atrophy and metaplasia must be investigated. To assess 
this relationship, expression levels of ILIO, FOXP3 and TGFBI were measured in 
50 antral gastric biopsies and were stratified according to the presence or absence 
of atrophy and IM. Of the 50 patients included, 21 patients had gastric atrophy 
and 12 had intestinal metaplasia in the stomach. Significantly lower expression 
levels of all 3 genes were observed in the presence of atrophy (Figure 7.6A). 
Where IM was present (scores 1-3), significantly lower levels of FOXP3 and IL10 
mRNA were observed (Figure 7.6B). TGFBI mRNA levels were lower when IM 
was present but the difference did not reach statistical significance. 
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Figure 7.6: Investigating the relationship between Treg gene expression levels 
and premalignant pathology. 
Expression levels of FOXP3, ILIO and TGFBI were measured in 50 antral gastric 
biopsies of H. pylori infected patients, and stratified according to the presence or 
absence of A- atrophy or B- IM. * significantly reduced expression (p<0.05). 
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This relationship was investigated further by assessing the frequency of 
CD4+CD25hiIL-10+ cells in 30 patient samples. When examining the frequencies 
of Treg cells present in tissues with and without IM, higher levels of IL-10+ 
CD4+CD25h' cells were present (p=0.02) (Figure 7.7). There were no differences 
in the numbers of ILI 0+CD4+CD25h' cells with respect to presence and absence of 
atrophy. 
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Figure 7.7: The frequency of IL-10+CD4+CD25hi cells in the absence or 
presence of IM in antral gastric biopsies. 
The percentage of IL10+ events amongst CD4+CD25hi events were measured in 
antral gastric biopsies of 30 H. pylori infected patients. 22 had no sign of IM on 
histological analysis, and 8 had IM. 
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7.3 DISCUSSION 
As well as a Thl polarised immune response (Bamford et a!., 1998; Karttunen et 
al., 1995; Mohammadi et al., 1996), it is now known that a potent regulatory T 
cell response is also induced during infection with H. pylori. The suppression of 
inflammatory responses may play a role in the persistence of infection. Treg 
responses have been negatively associated with the level of inflammation and 
gastritis in mice (Kao et al., 2010; Maloy et al., 2003). As inflammatory responses 
are known to play a role in H. pylori-associated disease (Kang et at, 2009; 
Taguchi et al., 2005), Treg responses may also be important in protecting the host 
from the deleterious effects of inflammation. 
7.3.1 The relationship between suppressive host immune responses 
and H. nylon colonisation density 
In agreement with previous studies (Goll et al., 2007; Kandulski et al., 2008; Li & 
Li, 2006; Lindholm et al., 1998; Robinson et al., 2008), increased expression 
levels of ILI0, FOXP3 and TGFBI were found in H. pylori infected patients when 
compared to uninfected controls. 
Numerous studies in mice have shown a positive association between the density 
of H. pylori infection and suppressive immune responses (Chen et al., 2001; Kao 
et al., 2010). Although mouse studies have provided insight into the role of IL-10 
in determining colonisation of the bacterium, these studies have not reliably 
shown whether this association also occurs in humans. Most studies in mice have 
used IL10"' mice, in which IL-10 production is completely abrogated (Berg et al., 
1998; Chen et al, 2001). It is not possible to gain any information on the 
physiological threshold level of this suppressive cytokine required for reducing 
bacterial load. 
In the current study, no association was observed between Treg-associated gene 
expression levels and bacterial load in vivo. This is in agreement with a previous 
study of 126 H. pylori infected patients in Korea, which reported no significant 
difference in the proportion of Tregs between different grades of H. pylori density 
(Jang, 2010). In addition, a study of Treg responses in children and adults reported 
significantly increased numbers of FOXP3+ cells in children, but no difference in 
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colonisation was observed (Harris et at, 2008). However, a positive association 
has been observed in a German population, although a smaller sample set of 17 
antral biopsies were assessed. Furthermore, it appeared that samples with a 
density grade of 0 were included in the statistical analysis conducted, which may 
have skewed the data (Kandulski et al., 2008). In support of Treg association with 
bacterial density, Kao et al. (2010) demonstrated reduced H. pylori CFU counts 
recovered from mice treated with anti-CD25 monoclonal antibody, and adoptive 
transfer of Tregs resulted in higher bacterial recovery (Lee et at, 2007a). 
It is important to note that mRNA expression levels may not always reflect the 
suppressive state in the gastric mucosa. As mentioned, cells expressing ILIO and 
FOXP3 may not necessarily have suppressive functions (Allan et at, 2007; 
Couper et al., 2008), highlighting the importance of assessing protein levels. In 
this context, the use of FACs to assess these responses may be more informative. 
However, this method may not benefit the investigation of TGF-ß as it is believed 
that this cytokine is stored in cells ready for release when needed and detected 
mRNA levels may not reflect secretion of the cytokine. 
In contrast to that observed in vivo, treatment of H. pylori infected AGS cells with 
recombinant IL- 10 resulted in an increased number of CFUs. It is likely that IL-10 
regulates inflammatory responses in the gastric epithelium resulting in persistent 
colonisation. In support of this hypothesis, our group have previously shown a 
dose dependent reduction of IL-8 secretion when H. pylori infected AGS cells 
were stimulated with IL- 10 (Robinson et al., 2008). 
AGS cells treated with TGF-ß were associated with higher CFU counts when 
infected with H. pylori 60190. As this was not observed when cells were infected 
with the non-toxic Tx30a strain, this response may be dependent on strain 
virulence, and suggests that TGF-ß may interfere with signalling pathways that 
are activated in response to such bacterial factors. However, the major virulence 
factors, including CagA and VacA, were not previously found to be associated 
with TGF-ß levels in vitro (Wu et al., 2007), Interestingly, Wu et a!. (2007) also 
demonstrated a relationship between the multiplicity of infection and TGF-ß 
production in AGS cells, with increasing levels detected as MOI increased. 
Whether this is a direct effect is unknown. However, a recent study showed 
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decreased etection of TGF-ß secretion in H. pylori infected SNU- 16 gastric cells 
(Jo et al., 2010). The observed TGF-ß response may therefore be cell specific, and 
highlights the need to repeat in vitro studies completed in the current study with 
various cell lines in order to confirm the relationship observed. It is also important 
to note that only a small increase in CFU counts were observed when cultures 
were stimulated with TGFD, and requires repeating to rule out experimental error. 
A further limitation in the current study is the use of AGS cells when investigating 
the effects of TGF-ß as the function of TGF-ß secreted by tumour cells may be 
different to normal cells (Siegel & Massague, 2003). Therefore, use of primary 
gastric epithelial cells may be more appropriate for such investigations. 
It is interesting that suppressive cytokines were associated with bacterial 
colonisation in vitro, but not in the human gastric mucosa. The high 
concentrations of recombinant cytokine may have induced a response in AGS 
cells that influences H. pylori density, and such levels may not represent 
physiological thresholds in the gastric mucosa. Also, the in vitro study did not 
account for the influence of immune cells which are present in the lamina propria. 
It has been demonstrated that cytokines alter suppressive functions of Tregs and 
make T effector cells resistant to Treg function, which has been demonstrated 
with the pro-inflammatory cytokines IL-15 (Ben Ahmed et al., 2009) and IL-21 
(Peluso et al., 2007), which have both been found to be upregulated in the gastric 
mucosa of H. pylori infected patients (Caruso et al., 2007; Luzza et a!., 1999). 
However, the mechanism by which these cytokines exert their action is unknown. 
Therefore, in the gastric mucosa, even if high levels of suppressive cytokine are 
present, which are associated with reduced gastric inflammation, they do not 
appear to be directly associated with bacterial colonisation. 
7.3.2 The association between Trea gene expression levels and 
virulence determinants of H. ovlori 
Treg-associated gene expression levels were stratified according to the virulence 
status of the colonising strain in order to determine if bacterial factors may be 
involved in driving the induction of Treg responses. ILIO expression levels tended 
to be greater with cagA positive strains, although not statistically significant. This 
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was not the case for FOXP3 and TGFB1 levels, suggesting a possible role of 
CagA in regulating the IL-10 response. Further investigation of this relationship is 
required as few samples in the data set were genotyped as cagA negative, which 
may affect the statistical test. Also, CagA functionality must also be determined 
for each strain. 
Interestingly, higher expression levels of ILIO and FOXP3 were found with dupA 
positive strains, and when corrected for the cagA status of the bacterial strain, a 
significantly higher level of FOXP3 expression was observed. This is in support 
of previous data reported in our group, which suggest that dupA does not affect 
gastric epithelial cells, but exerts its effects on the underlying immune cells 
(Hussein et al., 2010). The data presented in the current study suggests that Tregs 
may be an additional target for this virulence factor. Again, dupA positivity by 
PCR may not reflect the presence of the functional protein. TGFB1 levels were 
not found to be linked with cagA or dupA status. 
Overall, vacA alleic type did not correlate with IL-10 and FOXP3 expression 
levels. Interestingly, a recent study did demonstrate a role of VacA and y-glutamyl 
transpeptidase (GGT) in the upregulation of microRNA (miR-155) (Fassi Fehri et 
al., 2010), which is known to be upregulated during H. pylori infection (Xiao et 
at, 2009). miR-155 was shown to be needed for the induction of FOXP3 on 
human T cells, and suggests a possible relationship between VacA and FOXP3 
expression levels. However, induction of FOXP3 may not confer suppressive 
function. 
Interestingly, increased TGFBJ responses were observed with i2-type strains. The 
function of the i-region is yet to be determined, but it has been shown that iI 
strains are associated with the development of gastric ulceration and cancer 
(Hussein et al., 2008; Rhead et at, 2007). It would be of interest to investigate 
whether strains carrying the vacA il-type strain drive reduced expression of 
TGFBI which may induce a disease-prone state in the gastric mucosa. 
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7.3.3 The relationship between sunnressive host responses and the 
decree of inflammation of the gastric mucosa 
Tregs are known to modulate immune responses through numerous mechanisms 
including the secretion of anti-inflammatory cytokines, and direct binding through 
CTLA-4 which inhibits DC maturation. Previous studies in mice show an inverse 
relationship between the degree of gastritis that develops when Treg responses are 
abrogated (Chen et al., 2001; Maloy et al., 2003). Here, we show that expression 
levels of the Treg marker ILIO and FOXP3, but not TGFBJ, are negatively 
associated with inflammation in humans. 
In contrast, Kandulski et al. (2008) reported a positive association between 
inflammation and the ft-actin-normalised FOXP3 mRNA levels. However, this 
was observed in a smaller number of samples. Also, some H. pylori infected 
gastric biopsies had an inflammatory score of zero and the maximum score was 
two. In the current study, gastritis was present in all infected samples and a 
maximum score of three was observed in this data set. Quantification of mRNA 
and histopathology analyses was carried out on different biopsy specimens here. It 
is possible that this may introduce error in association data, which may explain 
why the negative relationship observed in this study between inflammation and 
suppressive immune responses was in contrast to that reported by Kandulski et al. 
(2008). However, associations observed with RT-PCR data presented in this study 
were confirmed with flow cytometry analysis of gastric mucosal lymphocytes, 
providing strong evidence of a negative association. However, Jang et al. (2010) 
also reported a positive association between inflammation and the total number of 
FOXP3+ cells using immunohistochemistry. Higher inflammation scores are 
indicative of increased numbers of immune and inflammatory cells, and these 
contain variable proportions of Tregs. In the current study, the proportion of 
CD25h' Tregs was measured amongst the infiltrating lymphocytes, not all of 
which were FOXP3+. 
The data presented here suggest that suppressive responses are associated with 
reduced inflammation, but this suppression may not be sufficient to impact 
bacterial density. Whether this association is dependent on the action of 
suppressive cytokines or a mechanism involving direct cell contact, or both, is 
unknown. 
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7.3.4 The relationship between suppressive immune responses and 
pre-malignant oathologv in the eastric mucosa 
We have previously shown that Treg responses are reduced in patients with peptic 
ulcer disease, suggesting that modulation of inflammation may play a role in 
protecting the host from mucosal damage and disease (Robinson et a!., 2008). 
Whether Tregs are also associated with protection from gastric cancer is 
unknown. Importantly, no patients in the current study had gastric cancer, and as 
Treg expression is different in cancer, it was important to look at stages of disease 
progression before the development of adenocarcinoma. Here, it has been shown 
that decreased levels of Treg specific gene expression were associated with the 
progression of disease to atrophy. Furthermore, lower expression levels of ILIO 
and FOXP3 were associated with the presence of IM, although TGFBI was not. In 
support of the association between ILIO expression and the presence of IM, the 
number of IL10+CD4+CD25hi cells was also associated with the presence of IM, 
suggesting that IL 10 producing Tregs are important in protection against the 
development of H. pylori-associated disease. The number of IL10+CD4+CD25hi 
cells did not correlate with atrophy, however the grading of IM via presence of 
goblet cells is more straightforward. FOXP3 expression levels were also 
associated with premalignant pathology. To further investigate this relationship, 
the number of FOXP3+ Tregs in the gastric mucosa of patients with such 
pathology must also be investigated. 
Interestingly, decreased TGFB1 expression was associated with atrophy but not 
IM. Based on this, it may be possible that TGF-ß plays a smaller role in the 
modulation of inflammation and hence mucosal damage that leads to disease, but 
this is cannot be concluded from the data presented here. 
Previously, IL-10 has been shown to also play a protective role in the 
development of IBD and cancer in Rag2"1" mice (Erdman et al., 2003a). 
Interestingly, another study demonstrated Treg intervention in mice infected with 
H. hepaticus with early stages of cancer development reduced disease symptoms. 
However, with late stage cancer, Treg intervention was not enough to reduce 
disease development. Importantly, this study also found that IL- 10 was required to 
interrupt the progression to IBD and cancer (Erdman et al., 2003b). Also, a recent 
study by Arnold et al. found little if any atrophy and IM in H. pylori infected 
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neonate mice compared to infected adults at 1,2 and 4 months post infection. 
When neonate mice were depleted of Tregs, severe pathology was observed, 
supporting the role of Tregs in protecting against the development of disease 
(Arnold et al., 2010). 
Overall, suppressive immune responses have been shown to be associated with 
decreased inflammation and may play a role in protecting the host against damage 
leading to the development of pre-cancerous changes in the gastric mucosa. 
Whether such responses are capable of modulating bacterial density is still not 
clear, and suppressive functions may not extend to modulating the antimicrobial 
cell responses required to directly combat infection. 
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8. ANTIMICROBIAL PEPTIDES AND 
HELICOBACTER PYLORI INFECTION 
8.1 INTRODUCTION 
Antimicrobial peptides (AMPs) are essential components of the innate immune 
response to infection. Numerous AMPs have been described to have bactericidal 
activity against H. pylori, including members of the defensin family and the 
cathelicidin LL-37 (George et al., 2003; Hase et al., 2003; Otte et al., 2009). 
However, mechanisms involved in the regulation of gene expression remains 
unclear in many cases. AMPs have also been reported to act as 
immunomodulators of the host response, and may have other roles in the immune 
response to H. pylori infection. 
8.1.1 AMPs and H. nvlori infection 
8.1.1.1 a-defensins 
Little is known of the antimicrobial activity of a-defensins against H. pylori, 
although a few studies have observed increased release of both neutrophilic and 
enteric a-defensins during infection (Isomoto et al., 2004; Kocsis et al., 2009b; 
Shen et al., 2005). Release of these AMPs from NK cells induced by other 
bacterial factors such as OmpA and flagellin has been demonstrated (Chalifour et 
al., 2004). Expression of a-defensin, specifically hDS, has been observed in 
gastric tissue in the presence of IM only, a likely consequence of intestinal paneth 
cell differentiation associated with this condition (Shen et al., 2005). Strong 
bactericidal activity of recombinant h-D5 and h-D6 against H. pylori observed in 
vitro (Tanabe et al., 2008) would suggest that enteric a-defensin expression may 
be important in defence against the bacterium during more progressive stages of 
H. pylori associated isease. 
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8.1.1.2 defensins 
ß-defensins are abundantly expressed during H. pylori infection, and have been 
shown to have antimicrobial activity against the bacterium (George et al., 2003; 
Kawauchi et al, 2006; Otte et al., 2009). 
Much work surrounding ß-defensin activity against H. pylori has concentrated on 
hlD2, for which gene expression is inducible. Regulation pathways involved in 
defensin expression seem to be best understood with hßD2, which is modulated in 
an NF-uB-dependent manner (Boughan et aL, 2006). This was found true in 
numerous cell types both in vivo (Taha et al., 2005) and in vitro, including 
keratinocytes, intestinal cells, and AGS, MKN45 and MKN7 cell lines (Bajaj- 
Elliott et al., 2002; O'Neil et al., 2000; Wada et al., 1999; Wada et al., 2001). 
Interestingly, numerous other signalling pathways have also been implicated in 
h3D2 modulation based on studies in different cell lines including JNK and 
MAPK (Boughan et al., 2006). Transcription factor STAT3 has been associated 
with regulation of gene transcription (Wehkamp et al., 2004). Other potential 
promoter binding domains have been recognised including AP-1 and NF-IL6, 
indicating other pathways that may be involved in regulation of hßD2 expression 
(Wehkamp et al., 2004). 
Of importance is htD3, which was not only found to be induced during H. pylori 
infection, but was also observed to have greater bactericidal activity against the 
bacterium compared to h3DI and hßD2 (George et al., 2003). Regulation of hßD3 
is controlled by an NF-KB and cagPAI-independent pathway, although IL-lß 
stimulation was observed to increase expression (Boughan et al., 2006). The ERK 
pathway has been implicated in regulation of this defensin, suggesting a possible 
role for EGFR, a major receptor upstream to the ERK pathway, in gene 
modulation (Boughan et al., 2006). Involvement of TLR4 has also been 
suggested, based on downregulation of hfD3 when the receptor is blocked 
(Kawauchi et al., 2006) and the observed increase in TLR4 expression during H. 
pylori infection (Su et al., 2003). 
The more recently identified h1D4 is also known to be upregulated during H. 
pylori infection by a cagPAl-dependent mechanism. However, unlike with h1D2, 
this was not NF-, B-dependent (Otte et al., 2009), consistent with the lack of NF- 
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xB binding sites observed in the promoter sequence of the gene (Garcia et al., 
2001). Furthermore, stimulation with IL-1p, TNF-a, and IFNy failed to induce 
htD4 expression (Otte et al., 2009). Pathways involved in the modulation of the 
inducible hßD4 gene remain unclear, although sequence analysis has determined 
several AP-1 binding sites (Kawahara et al., 2001). 
Unlike 0-defensins-2, 
-3, and -4, h, 8Dl expression is known to be constitutive in 
many cell types. However, expression of the gene was observed to increase with 
H. pylori infection in vivo (Kocsis et al., 2009a) and in vitro, and expression was 
augmented with IL-10 stimulus. However, this was observed in MKN7 cells but 
not in AGS and MKN45 cell lines (Bajaj-Elliott et al., 2002), and this apparent 
regulation of h/iD1 gene expression was not found in other studies (Liu et al., 
1997; O'Neil et al., 2000). Interestingly, decreased expression of h3Dl has been 
reported in H. pylori infected patients (Taha et al., 2005). These studies, although 
contradictory, suggest that regulatory pathways may exist for the h/iD/ gene. 
Consistent with these findings are the observed binding motifs for NF-1L6 and 
IFNy in the promoter sequence of the gene (Liu et al., 1997). Sequence analysis of 
the DEFBI gene indicated CCAAT/enhancer binding protein-ß (C/EBPP) (Zhu et 
al., 2003) adjacent to an NF-icB binding site (Prado-Montes de Oca et al., 2009), 
which implies the potential for regulation of transcription. 
The downregulation of hßDl has been observed in other bacterial infections 
including enteric pathogens Vibrio cholerae, Escherichia coli (ETEC) and 
shigella dysenteriae (Chakraborty et al., 2008; Islam et al., 2001). Importantly, 
the downregulation observed was ascribed to bacterial toxins, which were found 
to induce cAMP accumulation by several intracellular signalling pathways 
including protein kinase A (PKA) and ERK/MAPK (Chakraborty et al., 2008). 
Clearly, the role of hßDl during H. pylori infection is unclear, and based on 
previous reports, modulation of hßDI expression by both host and bacterial 
factors may be possible. 
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8.1.1.3 Cathelicidins 
The other class of AMPs produced in humans are the cathelicidins encoded by the 
camp gene, of which only one example has been found in humans named LL-37. 
To date, only two studies have investigated the role of LL-37 during H. pylori 
infection, which found that mRNA expression of this AMP is increased during 
infection by a mechanism that may be dependent of the cagPAI, and also showed 
antimicrobial activity of LL-37 against the bacterium (Hase et al., 2003; 
Leszczynska et al, 2009). Like hßDJ, LL37 expression appears to be tissue 
specific as inflammatory mediators were shown to induce LL37 expression in 
keratinocytes (Frohm et al., 1997), but not gastric and colonic cell lines (Hase et 
al., 2002; Hase et al, 2003). Response to bacterial infection also seems to vary, 
with some studies reporting downregulation of LL37 expression (Chakraborty et 
al., 2008), whist others have reported upregulation (Hase et al., 2002; Hase et al., 
2003). 
A number of external stimuli have been reported to modulate LL37 expression, 
including the bacterial metabolite butyrate, which enhances histone acylation at 
the promoter site thus enabling API binding and augmented gene expression. 
Lithocholic acid (LCA) has also been implicated in modulation of LL37; this 
binds nuclear receptors that cause recruitment of PU1, a transcription factor 
important in camp gene transcription. (Kida et al., 2006; Raqib et al., 2006; 
Schauber et al., 2004; Zasloff, 2006). The promoter sequence of LL37 was found 
to include binding sites for NF-icB, as well as NF-IL6 and IFNy response lements 
(Brown & Hancock, 2006), and both IL-la and IL-6 stimuli were found to 
regulate expression in keratinocytes (Erdag & Morgan, 2002). LL37 expression 
was also found to be induced in gastrointestinal cells by histone-deacetylase 
inhibitors (Schauber et al., 2004), and modulated by short fatty acids in 
colonocytes (Schauber et al., 2003). Conversely, LL37 expression can be reduced 
by bacterial proteases or through interference with hCAP-18 expression, although 
the mechanisms involved remain unclear (Belas et al, 2004; Bergman et al., 
2005; Islam et al., 2001). Importantly, a number of truncated forms of the AMP 
have been isolated from the skin which exhibit antimicrobial activity, but have 
reduced immunomodulatory functions (Murakami et al., 2004). 
Due to the tissue specific nature of LL37 modulation and the many potential 
stimuli that may modulate gene expression, it is difficult to hypothesise how the 
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gene is regulated during H. pylori infection, and clearly further investigation is 
needed. 
8.1.2 Immunomodulatorv functions of AMPs. 
More recent findings have established a much broader range of biological 
activities for these AMPs other than their direct killing effects, including their 
roles as modulators of the immune response. Many AMPs have been associated 
with chemotactic activity, working together to direct immune effector cells to the 
site of infection. a-defensins are important in recruiting neutrophils, phagocytic 
cells and monocytes, as are hDD3 and hßD4. Importantly, hßDl, hfD2 and hfD3 
are associated with recruiting immature dendritic cells and memory T cells 
through CC-chemokine receptor-6 (CCR6), hence representing a bridge between 
the innate and adaptive immune response (Yang et al., 2002). Cathelicidins were 
found to be involved in the recruitment of neutrophils, in addition to circulating 
and tissue-derived monocytes (De et al., 2000). AMPs therefore act to induce pro- 
inflammatory immune responses, in some cases inducing immune mediators that 
further induce the expression of these AMPs, effectively creating a positive 
feedback loop. Importantly, considerably higher concentrations of AMPs are 
needed for chemoattraction of leukocytes, limiting their activity to the local 
environment (Zasloff, 2007). 
AMPs may also act to enhance the immune response. For instance, LL-37 was 
found to induce the differentiation of monocyte-derived endritic cells, and mouse 
ßD2 was observed to stimulate dendritic cell maturation and upregulation of MHC 
II (Biragyn et al., 2002). 
Furthermore, studies have shown a role for AMPs in immune suppression as well 
as pro-inflammatory responses that effectively promote bacterial clearance. LL-37 
was observed to bind and neutralise LPS, protecting mice from LPS-induced 
inflammation (Rosenfeld et al., 2006). LL-37 also exhibits suppressive functions 
towards LPS-induced translocation of NF-xB into the nucleus of human 
monocytes and epithelial cells, and reduced expression levels of pro-inflammatory 
cytokines TNFa and IL-6 (Mookherjee et al., 2006). Defensins have also been 
associated with immune-suppressive properties, with murine ßD2 mediating 
dendritic cell death through activation of TLR4, therefore suggesting a role for 
this AMP in inducing the immune response to infection through their chemotactic 
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ability, as well as terminating the immune response through elimination of 
activated APCs (Biragyn et al., 2008). 
Thus, AMPs are important modulators of the immune response, protecting the 
host from potentially harmful microbes directly through their antimicrobial 
activity, and indirectly through recruiting immune effector cells and protecting the 
host from the harmful effects of an active inflammatory response. 
The chemotactic properties of ß-defensins towards dendritic cells may also 
implicate a potential function for AMPs in tumour suppression. Dendritic cells are 
the most powerful APCs and have the capability to prime naive T-cells that 
induce anti-tumour responses (Thomas-Kaskel et al., 2007). However, tumours 
have developed mechanisms to impair dendritic cell function or numbers. 
Downregulation of h3D1 is observed in a number of cancers, including pancreatic 
cancer, as well as oral squamous cell carcinomas (Bose et al., 2009; Wenghoefer 
et al., 2008), and reduced hfDl levels has been related to binding of the Pax2 
oncoprotein, for which expression is upregulated during the development of 
prostate cancer (Bose et al., 2009). 
8.1.3 Experimental aims 
" To investigate the expression of hßD) and LL37 in H. pylori infection both 
in vivo and in vitro. 
" To determine the relationship between hßDI and LL37 expression levels 
and colonisation density in vivo and in vitro. 
" To assess the role of bacterial virulence factors in regulation of hßDl and 
LL37. 
" To determine possible host factors that may be involved in the regulation 
of hßDJ and LL37 expression. 
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8.2 RESULTS 
8.2.1 The relationship between MDl and X. nvlori infection 
h, 8DI is thought to be constitutively expressed in many cell types, with a number 
of reports demonstrating this to be true for H. pylori infection as well (Liu et al., 
1997; ONeil et al., 1999). However, a number of studies have described 
regulation of h/D] expression, although such data is not always consistent (Bajaj- 
Elliott et al., 2002; Kocsis et al., 2009a; Taha et al., 2005). These studies, along 
with the presence of consensus binding regions for regulatory modulators in the 
promoter region of the hßDl gene, would suggest a potential for regulation of 
expression during H. pylori infection. 
In order to investigate the possible regulation of h/D], expression levels were 
quantified using real-time RT-PCR in uninfected and H. pylori infected antral 
gastric biopsies. A 3-fold decrease in hßDl expression was observed for infected 
tissue compared to uninfected controls (p=0.003 by Mann-Whitney U-test) 
(Figure 8.1). 
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Figure 8.1: hßDJ expression during H. pylori infection. 
hßDI expression levels were measured in uninfected (n=15) and H. pylori 
infected (n=26) antral gastric tissues samples, and normalised against GAPDH 
expression levels. * represents outlier values. 
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To further examine the expression levels of h/3Dl in response to H. pylori 
infection, expression was studied in an in vitro model using AGS cells infected for 
24 hours with either the pathogenic 60190 strain or the non-pathogenic Tx30a 
strain of H. pylori. Compared to an uninfected control, expression levels were 
found to be 9-fold lower in cells infected with either 60190 (p=0.0003) or Tx30a 
wt (p=0.005). There was no significant difference between expression levels 
between 60190 and Tx30a infection (Figure 8.2). Thus, H. pylori infection causes 
downregulation of h/3D1 expression. 
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Figure 8.2: In vitro analysis of h#DI expression with H. pylori infection. 
AGS cells were incubated with 24 hour cultures of H. pylori strains 60190 and 
Tx30a at an MOI of 100. AGS cells alone were used as an uninfected control. 
Cells were harvested after 24 hours and hQDI expression was measured using 
quantitative RT-PCR. Mean hßDl expression of 6 replicates is shown with bars 
representing standard deviation. 
p=0.0003 
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Uninfected 
control 
In vitro analysis of h, 8D] expression in gastric epithelial cell lines was previously 
found to vary in a time dependent manner with H. pylori infection (Bajaj-Elliott et 
al., 2002; Kocsis et al., 2009a). To assess the variability in expression over time, 
h, 8D] levels were measured in cultured cells at an earlier time point of 8 hours. 
Mean h, 8DI levels in infected cultures were the same as the uninfected controls, 
suggesting mechanisms involved in down-regulating hßD1 expression are 
activated late during infection (Figure 8.3). 
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Figure 8.3: In vitro analysis of hßDI expression after 8 hours H. pylori 
infection. 
AGS cells were incubated with H. pylori strains 60190 or Tx30a at an MOI of 
100. AGS cells alone were used as an uninfected control. Cells were harvested 
after 8 hours incubation and h/3DI mRNA transcript levels were measured by real- 
time RT-PCR. Expression levels were normalised against GAPDH expression 
levels. Mean h/D1 expression of 6 replicates is shown with bars representing 
standard deviation. 
8-240 
Tx30a 
Antimicrobial activity of hßD I has been previously observed against H. pylori 
(George et al., 2003). However a relationship between H. pylori density and h/DJ 
expression in vivo has not yet been shown. Bacterial load and hßD/ levels were 
determined in gastric antral tissue samples from H. pylori infected patients. 
Colonisation density measured by qPCR did not correlate with hßDJ expression 
in the antrum (n=25, r= 
-0.42, p=0.42 by Pearson correlation test). However, 
using histological grading of density, a 2-fold higher hßDI expression level was 
observed for mild H. pylori colonisation compared to severe H. pylori 
colonisation density (Figure 8.4). No significant difference was observed with 
grade 2 colonisation density, but there were only 4 samples in this category 
(median=0.46, n=4, IQR=0.13-1.84). 
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Figure 8.4: The relationship between hßDI expression and bacterial density. 
H/D] expression levels were evaluated for grades of H. pylori density that were 
determined by histopathology in antral gastric biopsies. Median expression levels 
for mild (score of 1, n=11) and severe colonisation (score of 3, n-l 1) are shown. 
The relative level of h/DI expression meaursed in uninfected patients was 0.82. 
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8 2.1.1 The effect of known H. pylori virulence determinants on hpD1 
expression 
Regulation of the hßDI gene remains unclear as the few studies that have 
investigated expression of this AMP with respect to H. pylori infection have 
provided conflicting results. However, the observed downregulation of hßDI 
reported here has also been noted in other bacterial infections, and bacterial 
derived factors have been implicated as modulators of gene expression 
(Chakraborty et al., 2008). To address the possible involvement of H. pylori 
virulence determinants in hßDI regulation, hßDI expression data for antral gastric 
biopsies was stratified according to the virulence of the colonising strain with 
respect to the three major virulence determinants cagA, vacA and dupA. As only I 
isolated strain carried the vacA s2 genotype, hßDl expression levels for the s- 
region were not assessed. An increase in antral h, 8DJ expression was observed in 
patients infected with strains possessing the least virulent forms of vacA, or that 
were cagA negative. However, these differences did not achieve statistical 
significance, which may be due to small sample sizes. The dupA status of the 
infecting strain did not relate to hODl mRNA levels (Table 8.1). 
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h/! D1 expression 
Median (n) IQR 
H. pylori negative 0.82 (15) 0.49-3.59 
cagA 
+ 0.2g(10) 0.13-0.41 
- 
0.53 (4) 0.12-0.67 
p NS 
dupA 
+ 0.33 (9) 0.18-0.61 
- 
0.28 (5) 0.15-0.46 
p NS 
vacA 
ml 0.16(6) 0.13-0.58 
m2 0.38 (8) 0.27-0.56 
p NS 
il 0.14(6) 0.13-0.46 
i2 0.28 (8) 0.23-0.60 
p NS 
Table 8.1: The association between h/1D1 expression and virulence 
determinants of the colonising strain. 
Median hßDI expression levels were measured in antral tissue samples and 
stratified according to the virulence factor status of the colonising strain. Inter 
quartile ranges are given (IQR). Expression levels were not statistically different 
(NS). The expression levels determined in H. pylori negative patients are given 
for comparison. 
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To investigate this relationship further, hßDl expression was assessed with an in 
vitro model using AGS cells cultured with a series of H. pylori strains of different 
virulence status. These included the non-virulent Tx30a strain (cagPAI/cagA-, 
vacA s2/i2/m2), and the virulent strains 11637 and 60190. To assess the impact of 
individual virulence factors on h, 8DJ expression levels, cagA, cagE and vacA null 
mutants of the 60190 strain were used. For all strains tested, an 8-fold decrease in 
hßDI expression was observed compared to the uninfected control. No significant 
difference in expression levels between 60190wt and cagA or vacA mutant strains 
was observed. A significantly higher levels of h, BDI expression was observed for 
the 601900cagPAI strain compared to the wild type (p=0.03), although this 
difference was less than 2-fold. A second virulent strain, 11627, and the non- 
virulent Tx30a both reduced hßDI expression to the same degree as 60190, 
suggesting that the factors responsible for downregulating hfDI expression are 
present in virulent and non-virulent strains (Figure 8.5). 
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Figure 8.5: In vitro analysis of the relationship between h, 8DI expression and 
H. pylori virulence determinants. 
AGS cells were incubated with H. pylori strains 60190wt, 6019OAcagA, 
6019OAcagE, 60190vacA, Tx30a and 11637wt at an MOI of 100. AGS cells alone 
were used as an uninfected control. h/D] expression was measured in cells after 
24 hours. Mean h, 8D] expression levels of 6 replicates are shown with bars 
representing standard deviation. * represents a significant difference in expression 
compared to the uninfected control (p<0.005). 
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8.2.1.2 The effect of inflammatory mediators on hßD1 expression 
Several previous studies have demonstrated the regulation of ß-defensin 
expression by inflammatory mediators. The mechanisms involved in hßD2 
expression are well understood and hßD2 can be induced with an IL-lß stimulus, 
as well as other activators of NF-icB (Boughan et al., 2006; Wada et al., 1999). 
The mechanisms involved in regulation of hID3 however, appear to be different 
from those that known for h3D2. 
To date, few studies have investigated possible cytokine modulators of h/IDI 
expression. However, response elements for NF-IL6 and IFNy (Liu et al., 1997), 
as well as NF-xB and AP-1 (Prado-Montes de Oca, 2010) promoter binding sites 
have been observed in the promoter sequence of the gene, which may imply 
potential regulation of transcription for h/D). Previous reports have demonstrated 
upregulation of hßDI expression with IL-Iß stimulation (Bajaj-Elliott et al., 2002; 
Liu et al., 1997). In addition, transcriptional regulation of h/D! may be mediated 
through signalling pathways involving ERK and MAPK (Chakraborty et al., 
2008). As TNFa is an important activator of ERK/MAPK signalling pathways, it 
may also play a role in the regulation of h/D]. Although there is no evidence for 
an IL-17-dependent modulation of h/IDl, IL- 17 has been shown to regulate hßD2 
expression via a JAK and NF-iB-dependent pathway. With the known existence 
of NF-xB response elements within the h/D! gene, IL-17 may also play a role in 
the regulation of h/D) (Kao et al., 2004). 
In order to investigate the potential role of cytokine regulation of hßDl, 
expression levels were assessed in AGS cells when stimulated with IL-lß, TNFa 
or IL-17. The effects of IL-10 and TGF-ß were also investigated to determine if 
anti-inflammatory responses, which are upregulated in the gastric mucosa during 
H. Pylori infection (Robinson et al., 2008), have an impact on hßDI expression. 
AGS cells infected with H. pylori 60190 were also included as a control to 
demonstrate modulation of hßDI expression, and cytokine stimulation of infected 
cells was also assessed to determine if immune modulators could further modulate 
gene expression. 
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As observed before, h, BDI expression levels were markedly reduced when AGS 
cells were infected with H. pylori in all experiments conducted (p<0.02). 
Stimulation with IL-lß, IL-17, IL-10 and TGF-ß showed no effect on h/3DI levels 
(Table 8.2). However, TNFa stimulation of AGS cells did result in a reduction in 
the expression level of hßDl. Expression levels did not differ for H. pylori 
infected cells in the presence or absence of TNFa (Figure 8.6). 
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Mean h/1U1 expression level (tit)) 
AGS cells AGS cells + 
H. pylori 60190 
Pro-inflammatory cytokines 
No cytokine 0.83 (0.14) 0.50 (0. I0) 
Plus IL-10 0.95 (0.28) 0.38 (0.35 ) 
p NS NS 
No cytokine 1.17 (0.33) 0.21 (0.11) 
Plus IL-17 1.12 (0.19) 0.20 (0.20) 
p NS NS 
No cytokine 1.06 (0.12) 0.12 (0.05) 
Plus TNF-a 0.73 (0.25) 0.19 (0.15) 
p 0.04 NS 
Anti-inflammatory cytokines 
No cytokine 0.81 (0.02) 0.36 (0.17) 
Plus TGF-ß 0.98 (0.19) 0.39 (0.13) 
p NS NS 
No cytokine 0.87 (0.10) 0.21 (0.11) 
Plus IL-10 1.01 (0.21) 0.29 (0.19) 
p 0.04 NS 
Table 8.2: h/1D1 expression levels in response to cytokine stimulation in AGS 
cells. 
AGS cells were incubated for 24 hours in the presence or absence of cytokinc 
stimulation. AGS cultures infected with H. pylori 60190wt at an MOl of 100 
were included as a positive control for the suppression of h1YD1 expression. The 
mean hßDI expression level and standard deviation (SD) are given fier 4 
replicates. Levels of hßDl were significantly lower in 11. pylori inflected cultures 
compared to the uninfected culture (p<0.02). NS=not significant. 
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Figure 8.6: The effect of TNFa on h/1Dl expression. 
AGS cells were infected with either H. pylori strain 60190wt wt at an MOI of 
100, which were incubated in the presence or absence of TNFa for 24 hours. The 
mean hßDl expression in 4 replicates is shown, with bars representing standard 
deviation. * represents a significant difference in expression compared to the 
uninfected control (p<0.001). 
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&Z1.3 In vivo relationship between host immune responses and hßD1 
expression 
To further assess the relationship between hßD1 expression and cytokine 
responses, expression levels of IL8, IL10 and TGF, B were determined in gastric 
biopsies and compared with hßDI levels. Comparative data was available for 15 
antral gastric tissue samples. However, a correlation was not found (for IL8: r= 
- 
0.11, p=0.63; ILIO: rß. 03, p=0.90; for TGF/: r= 
-0.1 IS, p=0.58, tested by Pearson 
correlation). 
In addition, inflammation was also assessed in gastric tissue samples using 
histopathology scoring. Expression levels were determined in 25 samples for 
which histopathology data was also available. A trend towards a negative 
association between the level of inflammation and hßDl expression was observed, 
although not statistically significant (For grade 1: median=0.7, n=3, IQR=0.64- 
2.04; for grade 2: median=0.28, n=17, IQR=0.15-0.51; Grade 3: median=0.24, 
n=5, IQR=0.18-0.26). This trend was also observed for neutrophilic infiltration 
(For grade 0: median=0.7, n=3, IQR=0.24-2.04; for grade 1: median=0.41, n=5, 
IQR=0.25-0.61; for grade 2: median=0.24, n=17, IQR=0.14-0.41. No samples 
were found to have grade 3 neutrophilic infiltration). 
8.2.1.4 The relationship between hßDl expression and pathology 
htD 1 has also been proposed to have a tumour suppressor function based on the 
absence or downregulation of transcription in numerous tumours, as well as 
having the capability to induce apoptosis in cancerous cells (Bullard et al., 2008; 
Sun et al., 2006; Wenghoefer et al., 2008). Given the association of H. pylori 
infection with gastric cancer, a possible role for h3D1 may exist in cancer 
protection within the gastric mucosa. 
To address the possible relationship between defensin expression and the 
development of gastric cancer, hßDI expression levels were compared in the 
presence or absence of atrophy and IM in 25 antral gastric biopsy samples. The 
presence of such pathology was not associated with hfDI expression (Atrophy 
present: median=0.34, n=9, IQR=0.19-0.61; absence of atrophy: median=0.28, 
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n=17, IQR=0.20-0.59; IM present: median= 0.24, n=5, IQR=0.20-0.59; absence of 
IM: median=0.31, n=20, IQR=0.23-0.63). 
8.2.2 Relationship between LL37 expression and H. Mori infection 
The expression of LL37 is inducible in a number of cell types. However, it is 
unclear as to which mechanisms are involved in the regulation of the gene. 
Studies have demonstrated increased expression of LL37 during H. pylori 
infection (Hase et al., 2003; Leszczynska et al., 2009). To confirm this finding, 
LL37 expression levels were measured in antral gastric tissue biopsies from both 
uninfected and H. pylori infected patients. Expression levels were found to be 5- 
fold greater in infected tissue (uninfected: median=0.62, n=15, IQR=0.23-0.87; H. 
pylori positive: median=3.02, n=17, IQR=1.35-8.86) (p=0.0003) (Figure 8.7). 
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Figure 8.7: LL37 expression and H. pylori infection. 
LL37 expression levels were measured in uninfected (n=15) and H. pylori infected 
(n=17) antral gastric tissues samples. * represents outlier value. 
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This was confirmed with an in vitro AGS culture model, which demonstrated 
upregulation of LL37 gene expression upon infection with a pathogenic strain of 
H. pylori (p=0.0003), but not with the non-pathogenic Tx30a strain (Figure 8.8). 
Therefore, suggesting that expression may be modulated by H. pylori virulence 
determinants. 
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Figure 8.8: In vitro analysis of LL37 expression during H. pylori infection. 
AGS cells were incubated with 24 hour cultures of II. pylon strains 60190 and 
Tx30a at an MOI of 100. AGS cells alone were used as an uninfected control. 
Cells were harvested after 24 hours and LL37 expression was measured. Mean 
LL37 expression levels in 6 replicates are shown, and bars represent standard 
deviation. 
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LL-37 has broad-spectrum antimicrobial activity, and has previously been 
demonstrated to have bactericidal activity against H. pylori (Hase et al., 2003; 
Leszczynska et al., 2009). To confirm this association in vivo, bacterial density 
was assessed with LL37 expression levels in antral gastric tissue. Density of 
infection measured by qPCR did not correlate with LL37 expression (r= 
-0.24, 
p=0.25). 
8.2.2.1 The association between LL37 expression and virulence 
determinants of H. pylori 
LL37 expression levels in AGS cells were very low and only detectable by qPCR 
when a high concentration of cDNA template was used. However, cultures often 
yielded low RNA concentrations, which made increasing cDNA template 
concentrations for all experiments difficult. Furthermore, as uninfected AGS cells 
were used as an uninfected comparator in the quantification of transcripts, it was 
not possible to assess the effects of bacterial and host factors with H. pylori 
infection. Therefore, further in vitro analysis of LL37 expression was not 
conducted. 
The association of LL37 levels with bacterial factors was addressed in gastric 
tissue samples. Expression levels were stratified according to the cagA and dupA 
status and vacA alleic type. LL37 levels were determined for 15 antral biopsy 
samples for which strain genotype data was also available. As only 1 sample was 
found to carry the s2 alleic form of vacA, the s-region was not assessed. LL37 
expression was not associated with cagA or vacA alleic strain type. Increased 
levels ofLL37 were observed for samples infected with dupA- strains compared to 
dupA+, however this was not statistically significant (Table 8.3). 
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LL37 expression 
Median (n) IQR 
H. pylori negative 0.82 (15) 0.49-3.59 
cagA 
+ 3.02 (10) 1.13-4.32 
- 
4.86 (4) 0.30-9.59 
p NS 
dupA 
+ 1.92(9) 0.95-6.11 
- 
4.32 (5) 2.03-8.88 
p NS 
vacA 
ml 3.02 (5) 0.76-8.1 1 
m2 4.22 (9) 1.11-8.57 
p NS 
il 3.02 (5) 1.01-8.38 
i2 4.15(9) 1.14-7.31 
p NS 
Table 8.3: The association between bacterial virulence factors and LL37 
expression in vivo. 
Median LL37 expression levels were measured in antral tissue samples and 
stratified according to the virulence factor status of the colonising strain. Inter 
quartile ranges are given (IQR). Expression levels were not statistically different 
(NS). 
8-254 
8.2.2.2 The relationship between LL37 expression and pathology 
There is growing evidence suggesting a role for LL-37 in tumour suppression, 
with decreased detection of the peptide in gastric adenocarcinoma (Hase et a!., 
2003). Furthermore, LL-37 has recently been shown to activate signalling 
pathways involved in cell-cycle arrest, inhibiting cell proliferation (Wu et a!., 
2010). To assess the relationship between this AMP and gastric cancer, LL37 
expression levels were measured in the presence of premalignant pathology in 25 
gastric antral biopsies. LL37 expression was not significantly related to the 
presence of IM (Presence: median=8.11, n=5, IQR=2.26-9.82; absence of IM: 
median=3.97, n=20, IQR=1.29-9.07). Reduced expression was observed in the 
presence of atrophy (median=1.92, n=9, IQR=0.63-6.27) compared to non- 
atrophic tissue samples (median=6.42, n=16, IQR=2.62-10.54) ( p=0.037) (Figure 
8.9). 
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Figure 8.9: The association between LL37 expression and atrophy. 
LL37 expression was measured in 25 antral gastric biopsies for samples and 
stratified according to the presence (n=9) or absence (n=16) of glandular atrophy. 
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8.3 DISCUSSION 
Antimicrobial peptides play a vital role during microbial infections, acting as a 
key line of defence against invading microbes and also as essential components in 
modulating the immune response to infections. The role of such peptides is made 
clear by the range of disease associated with dysfunctional AMPs. For instance, 
inflammatory diseases such as Psoriasis and Rosacea, which develop from 
increased expression of hßD2 and LL37 (Lande et al., 2007; Yamasaki et at, 
2007), and the development of Crohn's disease due to increased susceptibility to 
intestinal infections as a result of decreased expression of intestinal a-defensins 
(Wehkamp et al., 2007). 
8.3.1 The association between hBD1 exnression and H. vvlori infection 
The ß-defensin group of AMPs have antimicrobial activity against H. pylori 
(George et al., 2003). Of the 4 ß-defensins described, hßDl expression is believed 
to be constitutive, highlighting its importance in host defence. However, 
regulation of the gene during H. pylori infection is controversial, with some 
studies observing an up-regulation of the defensin during H. pylori infection 
(Bajaj-Elliott et al., 2002; Kocsis et al., 2009a), whilst downregulation has also 
been observed (Taha et al., 2005). Importantly, constitutive expression of h/ID! 
during H. pylori has been reported (Liu et al., 1997; ONeil et al., 1999). In the 
current study, decreased hßDI expression levels were observed in vivo and in 
vitro, confirming the report by Taha et al. (2005). Interestingly, the two studies 
reporting an upregulation in h/D) expression used the same primer sequences for 
amplification of the gene (Bajaj-Elliott et al., 2002; Kocsis et al., 2009a), which 
were different to those used in the current study. The differences between reports 
investigating hßDI expression in response to H. pylori could be explained by the 
existence of polymorphisms in the DEFBI gene, giving rise to multiple isoforms 
of hJD1. A number of single nucleotide polymorphisms (SNPs) have been 
described for DEFBI (Prado-Montes de Oca, 2010), and Valore et a!. have 
previously reported the presence of 6 isoforms in the urogenital tract, all with 
varying antimicrobial activity under different conditions (Valore et a!., 1998). The 
presence of hßD1 isoforms was later confirmed in caco-2 cell lines (ONeil et at, 
1999). Bajaj-Elliott et al. (2002) observed upregulated expression of h/4D1 in this 
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cell line, contrary to the reduced expression levels reported in the current study 
when using different primer sets, suggesting the presence of isoforms. However, 
only 1 isoform has previously been reported in AGS cells (ONeil et at., 2000), 
Furthermore, increased expression levels using the same primer set as Bajaj- 
Elliott et al. were also reported in gastric tissue taken from H. pylori infected 
patients (Kocsis et al., 2009a), which may suggest the presence of gene 
polymorphisms and potentially hfD1 isoforms in the human gastric mucosa. It 
would be interesting to assess h, 8D1 expression in the samples used in the current 
study with the primer set described by Bajaj-Elliott et al. (2002), as this may give 
insight into the presence of polymorphic hfDl transcripts. 
Differences in culture conditions must also be considered as a possible source for 
the observed differences in hßDI regulation observed between studies. One 
difference in the culture conditions between studies would be the length of time 
for which cells were cultured with the bacterium. In the current study, no 
difference in hßDI expression was observed after an 8 hour incubation, which 
suggests that mechanisms involved in downregulation of gene expression do not 
occur immediately after infection. Although maximal expression of hßDI has 
been observed at 24hours (Kocsis et at, 2009a), earlier time points have been 
suggested in other gastric cell lines (Bajaj-Elliott et al., 2002), and a time course 
analysis of hßDI expression of infected cells to demonstrate the time at which 
expression levels begin to alter has not yet been examined. The current 
experiment has demonstrated that regulation of hßDI expression does occur 
between 8 and 24 hours post-infection. It is possible that downregulation may be a 
result of cell death, particularly given reduced levels were observed after 24 
hours. However, increased IL8 secretion was detected in these culture 
experiments as described in Chapter 5 (section 6.2.3), which suggest that hßDi 
downregulation was not a result of global suppression of gene transcription or cell 
death, and reduced levels during H. pylori infection were also found in vivo. 
The importance of hßDI regulation was demonstrated here with the negative 
association observed between H. pylori colonisation density and h/D) expression 
in gastric tissue, consistent with antimicrobial activity of the peptide against the 
bacterium. Downregulation of gene expression may therefore be a bacterial driven 
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mechanism of survival. However, in vivo observations do not prove a causal 
relationship between H. pylori and hIDl. The bactericidal activity of h3DI must 
therefore be tested with recombinant peptide in vitro to demonstrate this 
relationship exists. Although previous studies have observed activity of the 
peptide against H. pylori (George et al., 2003), it is important to consider the 
possible presence of isoforms as discussed earlier, and the use of a recombinant 
peptide must reflect the mRNA variant that is detected with the primer set used 
here. Of interest would be to determine the cellular response with respect to hfiD1 
expression to various concentrations of bacteria. The increased expression levels 
of the peptide observed previously was found to be induced in a bacterial dose 
dependent manner (Bajaj-Elliott et al., 2002). If bacterial numbers are in fact 
driving the response observed, then the association between bacterial loads and 
h/Dl expression in gastric tissue may not reflect the antimicrobial activity of the 
peptide. 
It is also important to consider the presence of other AMPs in the gastric mucosa 
that may contribute to killing the bacteria. As previously observed, h3D3 was 
found to have the greatest activity against H. pylori compared to hßD2 and hßD 1, 
and expression of this defensin is associated with H. pylori infection (George et 
al., 2003). Immunohistochemistry may prove useful in determining a relationship 
between H. pylori density and h/D1 expression. 
8.3.1.1 The effect of known H. pylori virulence determinants on hßDl 
expression 
Clearly, hßD1 expression is regulated during H. pylori infection. Bacterial factors 
that may influence gene expression were not associated with hßD) levels in vivo. 
However, larger sample numbers are required. Further in vitro analysis of 
bacterial factors demonstrated that the major virulence factors CagA and VacA 
were not involved. Interestingly, decreased h/3Dl levels was not limited to a 
specific H. pylori strain, as strains Tx30a and 11637 also showed the same 
response with regards to h/D! expression. This implies a common bacterial factor 
such as LPS or an outer membrane protein may be driving the observed response. 
The 6019OAcagE mutant strain was associated with less reduction of hßDI 
concentrations compared to the 60190wt strain, albeit a small difference. This 
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may represent an NF-KB-dependent regulation of hfDl given the known 
association between the CagPAI and this signalling molecule (Brandt et al., 
2005). Furthermore, NF-xB response elements have been described in the hßDl 
promoter sequence (Prado-Montes de Oca et al., 2009). If cagPAI induced 
signalling is involved in regulating h/3D1 expression, a similar level of expression 
to the cagPAI mutant strain should have been observed with the Tx30a strain 
which does not possess the CagPAI. However, other differences between these 
strains may play a role in regulating hßDl. Therefore, the possible effect of such a 
mutation in a different H. pylori strain background would be necessary to rule out 
strain specific associations. 
Interestingly, Bajaj-Elliott et al. demonstrated an increase in hßDI expression 
when infecting AGS cells with the 11637 strain. This strain was also examined in 
the current study, and reduced levels comparable to that observed with the 60190 
strain was observed, therefore suggesting that the observed difference in hßDl 
expression between the current study and that of Bajaj-Elliott et al. (2002) was not 
due to differences in virulence of the infecting strain. 
It is difficult to ascertain from this data whether decreased hßDI expression is a 
result of bacterial factors modulating signalling pathways, or if hßDI transcription 
is regulated by inflammatory mediators that are induced by the bacterium. 
Previous reports have demonstrated the importance of bacterial virulence factors 
in downregulation of h, 8D1. For instance, cholera toxin was found to inhibit gene 
transcription through ERK/MAPK/p38 related signalling pathways (Chakraborty 
et al., 2008). Further investigation of possible virulence determinants of H. pylori 
that are involved in regulation of hßDl is needed. 
8.3.1.2 The effect of inflammatory mediators on hßD1 expression 
The role of immune effectors must also be considered. IL8, ILIO and TGFß 
expression levels did not correlate with hßDI expression levels in vivo. 
Stimulation of AGS cells with IL-10, TGF-ß, IL-17and IL-10 had no effect on 
h13DI expression. However, stimulation with TNFa induced a reduction in hßDJ 
levels. Stimulation of H. pylori infected cells with TNFa did not result in a further 
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reduction in h, 8Dl expression. TNFa signals through numerous pathways, 
including NF-uB (Curfs et al., 1997). This, along with the observed difference in 
hJDl expression between the 60190AcagE mutant strain and the wild type strain, 
suggests an NF-xB-dependent suppression of hßDl expression. Interestingly, NF- 
xB activation is known to induce expression of genes such as IL8 and hßD2 
(Boughan et al., 2006; Brandt et al., 2005). The NF-icB family of transcription 
factors consists of 5 members. NF-KB exists as a homo- or heterodimer of these 
subunits. Of these, p50 and p52 lack the transcription activation domain necessary 
for transcription, and promoter binding of these homodimers can block 
transcription of the target gene (Hayden & Ghosh, 2008). Furthermore, hßDI is 
known to have a p50 binding domain (Prado-Montes de Oca et al., 2009). 
Therefore, activation of such suppressive NF-KB transcription factors may result 
in the reduction of hßDl expression. 
Interestingly, the TIM protein of H. pylori has been shown to induce TNF-ct gene 
expression and NF-icB activation (Suganuma et al., 2005). Furthermore, of the 
clinical isolates tested in the study by Suganuma et al., the TIPa protein was 
found to be produced at a similar level in all strains, indicating that it is 
constitutively expressed. It would be of interest to further investigate this protein 
as a potential regulator of hßDl expression. 
The in vitro studies reported here have provided an insight into the association 
between h/3D1 expression and H. pylori infection in epithelial cell lines. However, 
another consideration is the effect of H. pylori infection on hfDI expression in 
inflammatory cells. As h3D1 is known to be secreted from these cells (Prado- 
Montes de Oca, 2010), it is important to determine if the response observed in 
gastric tissue was solely an epithelial response. 
IL-22 is known to function as an inducer of antimicrobial peptide production. In a 
recent study, increased levels of htD2 and hßD3 were reported in keratinocytes 
stimulated with IL-22. However, this was not found with hl3D1 (Wolk et al., 
2004). It is not known whether the IL-22 specific receptor is expressed in AGS 
cells, and was therefore not investigated in the current study for the effects of the 
cytokine on hßDI expression. Importantly, IL-22 and IL-17 were found to work 
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co-operatively to induce expression of h3D2 (Liang et at., 2006), although their 
effects on hßDl expression are unknown. 
As mentioned, the in vitro model used in this study was limited to a single time 
point of 24 hours. Of consideration is the study by Bajaj-Elliott (2002) who 
demonstrated the impact of IL-lß stimulation on hßDI and hßD2 expression 
levels. It was found that the time of maximum expression for both of these 
defensins in IL-1ß stimulated MKN7 cells was delayed in comparison to H. pylori 
infected cells that were not stimulated with cytokine. This highlights the 
importance of investigating numerous time points when studying the expression 
levels of hßDI in response to cytokine and H. pylori stimulation in vitro. 
From these results, we can only speculate possible regulatory pathways that are 
involved in regulation of h/3Dl expression. Importantly, H. pylori infection did 
not completely abrogate h/3Dl expression, which suggests other response 
elements are involved in h/BD) expression. Previously, a Defbl "" mouse model has 
been used to assess the physiological in vivo functions of the defensin in response 
to Staphylococcus aureus infection (Morrison et al., 2002). A similar approach 
may be useful for determining the role of ß-defensin I during infection with H. 
Pylori 
. 
8.31.3 The relationship between h)D1 expression and pathology 
The tumour suppressive properties of hßDl have not yet been studied in H. pylori 
related gastric cancer. Decreased hßDI levels are observed in numerous cancers 
(Bose et al., 2009; Wenghoefer et al., 2008). Although the mechanisms involved 
in hßDI regulation in cancerous cells have not been elucidated, a cancer specific 
response has been implicated as higher expression levels have been observed in 
normal tissue surrounding cancerous tissue (Donald et al., 2003). Transcriptional 
regulators have been found to modulate gene expression, including c-Myc, a key 
factor in cell proliferation and apoptosis (Sherman & Froy, 2008), and PAX2, an 
oncogene found to down-regulate hßDl expression (Bose et al., 2009). 
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As no patients in the current study were diagnosed with gastric cancer, it was not 
possible to assess this relationship. However, premalignant pathology was 
assessed, but an association was not observed. 
It would be interesting to observe the relationship between H. pylori-associated 
gastric cancer and h/DJ expression in gastric tissue, and to determine if 
downregulation of the gene is another factor that contributes to the progression of 
disease to a cancerous tate. Elucidating the possible H. pylori specific component 
that relates to the decreased expression would be significant in understanding the 
risk associated with developing cancer. Furthermore, previous studies have 
observed rapid cell death in prostate cancer cell lines in the presence of h flD I 
(Bullard et al., 2008), demonstrating the therapeutic advantage of the AMP. 
The reported downregulation of hßDI in a number of cancers raises a limitation 
within the in vitro model used in the current study. AGS cells are a cancerous cell 
line, and it is possible that down-regulation of hßD) expression occurs with AGS 
cells. However, downregulation of hfDI was still observed when infected with H. 
pylori demonstrating a specific response when infected with the bacterium. 
Furthermore, decreased levels of h/D) were also observed in vivo, therefore 
suggesting a non-cancer related regulation of the gene here. However, to rule out 
the possibility of an additional effect of cancerous cells, the in vitro effects of H. 
pylori infection on hßDl expression should be assessed in primary gastric cells 
(Wee et al., 2010). 
Overall, a mechanism is activated during H. pylori infection that downregulates 
the expression of h/IDl. This may be a response triggered by the bacterium in 
order to minimise the deleterious effect this peptide may have on the bacterium. 
As well as the antimicrobial activity of the peptide, the activity of hßD1 in 
recruiting DCs to the site of infection may be important (Yang et al., 2002). In 
this respect, downregulation of gene expression may protect the bacterium from a 
specific antibody response by interfering with the number of APCs. 
8.3.2 The association between LL37 expression and H. Mori infection 
LL37 is another important AMP that has activity against H. pylori. As previously 
demonstrated (Hase et al., 2003; Leszczynska et al., 2009), expression levels of 
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this AMP were increased in gastric tissue taken from patients infected with H. 
pylori compared to uninfected tissue in the current study. This was also confirmed 
in vitro. However, in this study AGS cells were not a suitable model for 
monitoring expression of LL37 due to low expression of the transcript. This may 
suggest that other cell types, possibly underlying immune cells which are known 
to express the AMP (Durr et al., 2006), may be involved in the LL-37 response to 
H. pylori infection. Further investigation of LL37 expression during H. pylori 
infection in other epithelial cell lines is necessary in order to determine if the lack 
of detection observed in the current study is specific to AGS cells, or if LL-37 is 
not released by epithelial cells. Interestingly, AGS cells have previously been 
demonstrated to express LL37 (Hase et al., 2003), and differences in expression 
levels may reflect varying culture conditions, or the amplification of different 
LL37 mRNA products. As with hIDl, isoforms of LL-37 have been found in 
human skin which exhibit variable antimicrobial activity, but show reduced 
immunological response (Murakami et al., 2004). Importantly, these isoforms 
were produced as a result of proteolytic processing of mature LL-37, and this 
highlights the fact that expression of a gene does not reflect the active protein. 
Therefore, although these small peptides prove difficult to assess in vitro, it is 
essential to look at the association of functional LL-37 protein with H. pylori 
infection as well as mRNA transcript. An important difference between the 
processing of h, 8D) and LL37 is that the latter is stored as a proprotein and is only 
activated by signal induced protease cleavage (Braff et al., 2005; Dudal et al., 
2006). Again, the measure of LL37 transcript may not reflect the amount of 
functional protein during infection. However, a clear association between LL37 
and H. pylori was observed, suggesting the bacterium may regulate LL37 gene 
expression. 
The importance of LL-37 with respect to H. pylori infection was demonstrated by 
in vitro analysis of antimicrobial activity against the bacterium, with studies 
showing a strong killing activity. The most convincing data comes from Bubki et 
al. (2010) who demonstrated membrane disruption and blebbing of H. pylori 
using AFM after treatment with LL-37. However, an association between H. 
pylori density and LL37 expression was not observed in the current study. This 
may reflect physiological peptide levels that are incapable of killing enough 
bacterial cells to impact overall bacterial densities. Hase et al. (2003) found that 
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LL-37 concentrations of 41M were needed to cause a log reduction in CFU counts 
after 6 hours, and l6pmol/L were required to eradicate an inoculum of H. pylori. 
Furthermore, culture conditions appear to affect the minimum bactericidal 
concentration (MBC) of LL-37. Leszczynska et al. (2009) demonstrated MBCs of 
over 100µg/ml when cultured in Brucella Broth Bulion, whereas MBCs of 
l0µg/ml on average were required when H. pylori was cultured in HEPES. These 
studies indicate the need for appropriate culture conditions that represent hat of 
the gastric mucosa in order to assess the concentrations of LL-37 required to 
impact colonisation density. 
8.3.2.1 The association between LL37 expression and H. pylori virulence 
determinants 
In vivo assessment of the relationship between bacterial virulence factors and 
LL37 expression showed no association, although a trend towards decreased 
expression levels with dupA+ infections was observed. Interestingly, in vitro 
culture of the virulent 60190 strain did significantly induce expression of LL37, 
but this was not seen with the non-virulent Tx30a strain. This would suggest a 
role for cagA or cagPAI in the modulation of LL37. However, other differences 
exist between these strains in addition to the cagA status. In support of the strain 
specific regulation of the gene is a previous study that demonstrated a cagPAI 
dependent regulation of LL37, which implicates NF-KB as a modulator of its 
expression (Hase et al., 2003). In addition, NF-uB promoter sites have been 
identified in the LL37 gene (Brown & Hancock, 2006). However, addition of NF- 
KB activators were not found to induce increased expression of LL37, therefore it 
may not be involved, or may not be the sole transcriptional regulator of the gene 
(Hase et al., 2003). Of note would be the observed ERK/MAPK/p38 dependent 
downregulation of LL37 by cholera toxin. This suggests similar signalling 
pathways that are involved in hßDI modulation (Chakraborty et al., 2008). 
Identification of an appropriate cell line in which LL37 expression is detectable 
would be of benefit in order to determine and assess the impact of H. pylori 
mutant strains on expression levels of this AMP. 
In further support of a bacterial-specific regulation of LL37 was the finding that 
infection with H. pylori, but not stimulation with pro-inflammatory cytokines, 
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resulted in increased LL37 expression (Hase et at, 2003). In addition, the lack of 
LL37 expression in non-infected patients that exhibited NSAID associated 
inflammation suggests that regulation of gene expression is driven by a bacterial 
specific factor (Hase et al., 2003). However, LL-37 activity has been suggested in 
neutrophils, and expression has been induced in response to cytokine stimulation 
in keratinocytes (Bucki et al., 2004; Chertov et al., 1996; Frohm et al., 1997). 
Therefore, further investigation of possible immune regulators of LL37 expression 
must be considered. 
Overall, increased LL37 expression is observed in gastric epithelial cells when 
infected with H. pylori, possibly in an NF-xB dependent manner, although other 
signalling pathways may contribute to regulation of gene expression. 
Upregulation of LL37 may also be an indirect response, as hßD2 has been shown 
to induce expression levels of the cathelicidin in breast and colon tissue (Stroinigg 
& Srivastava, 2005). This along with the observed regulation by NF-uB, which is 
a known regulator of hßD2, is suggestive of an indirect modulation of LL37. 
As with hlDl, LL-37 has tumour suppressive activity, and was found to be 
undetectable in gastric adenocarcinoma (Hase et al., 2003). Along with this 
finding, decreased expression was detected in H. Pylori infected atrophic tissue in 
comparison to non-atrophic infections in the present study. This suggests that 
cellular changes resulting in the development of premalignant pathology may 
activate cellular responses that result in the downregulation of the peptide. LL-37 
has been hypothesised to target and kill cancer cells in a similar mechanism as 
that known for killing bacterial cells (Li et al., 2006c). However, decreased LL3 7 
expression was not observed in the presence of IM, which may imply that the 
observed reduction in expression may result from the loss of glandular tissue 
which is characteristic of atrophy. 
In summary, the expression of both hßDI and LL37 are regulated during H. pylori 
infection by mechanisms involving specific bacterial factors. However, the exact 
mechanisms involved in the regulation of these AMPs are not filly understood, 
and the effect of such negative regulation on colonisation of the bacterium 
requires further study. 
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9. FINAL DISCUSSION 
Helicobacter pylori persistently colonises the human stomach even though 
inflammatory responses are mounted in response to the infection. Furthermore, H. 
pylori is the only known bacterium capable of establishing a lifelong infection in 
an otherwise sterile environment. This is mediated by numerous factors, and the 
relationship between the bacterium and host is complex. This is highlighted by the 
fact that it is not completely understood why a small proportion of infected 
individuals develop disease. Whether colonisation density greatly influences 
disease development, and the role of individual bacterial virulence factors and 
host immune responses in determining colonisation density is yet to be 
determined in detail. The focus of this study was to investigate bacterial and host 
factors that influence H. pylori burden and localisation in the human gastric 
mucosa. 
9.1 DISCUSSION OF THE RESULTS 
An intimate relationship is known to exist between gastric inflammation and 
disease progression (Reviewed by Kusters et al., 2006). Corpus-predominant or 
pan-gastritis and reduced acidity is associated with an increased risk of 
developing gastric ulcer disease (GUD) and gastric cancer. Certain host factors 
have been attributed to driving such gastric conditions such as polymorphism of 
cytokine genes. The risk of developing duodenal ulcer disease (DUD) on the other 
hand is associated with an antral-predominant gastritis and an increased acid load. 
However, little is known of the factors that drive this pattern of gastritis (Figure 
9.1). 
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Figure 9.1: Schematic representation of the relationship between gastritis 
and H. pylori-associated disease. 
H. pylori infection is associated with the development of duodenal ulcers (DU), 
gastric ulcers (GU) and gastric cancer (GC). The pattern of gastritis in the 
stomach is a known determinant of disease outcome, although the factors that 
influence the development of such patterns are still unclear. Corpus-predominant 
or pan-gastritis is associated with the development of GU and GC, and 
polymorphisms in cytokine genes such as IL-10 and TNFa have been identified 
as factors that influence these disease profiles to develop. Antral-predominant 
gastritis is associated with the development of DU. However, it is not known what 
drives the development of this pattern of inflammation. 
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In the current study, particular patterns of colonisation in the gastric mucosa were 
investigated in order to determine if bacterial localisation was also associated with 
specific H. pylori-associated disease profiles. Using qPCR as an accurate means 
of assessing bacterial load, it was demonstrated that an antral-predominant 
colonisation was significantly associated with DUD, whilst corpus-predominant 
colonisation was related to GUD. In particular, the level of colonisation in the 
corpus but not the antrum appeared to influence disease outcome. Therefore, 
bacterial localisation, like the pattern of gastritis, is related to H. pylori-associated 
disease. 
Factors that may influence localisation of the bacterium were then considered. 
The recently discovered dupA virulence factor has been associated with the 
development of DUD in numerous populations examined, but not all (Arachchi et 
al., 2007; Argent et al., 2007; Douraghi et al., 2008; Hussein et al., 2008; Lu et 
al., 2005; Zhang et al., 2008). This suggests that DupA may drive the 
development of this disease profile, although the mechanisms behind this 
association are not understood. 
In this study, it was demonstrated for the first time that the dupA status of the 
colonising strain is associated with different patterns of H. pylori colonisation in 
the gastric mucosa. dupA positive strains were associated with antral-predominant 
colonisation, and dupA negative strains with corpus-predominant colonisation. 
Therefore, it is possible that the observed association between dupA+ strains and 
DUD may result from a preferential colonisation of the antrum by bacteria 
expressing this factor. No significant association was observed between DUD and 
dupA status in this study however. 
Little is known about the function of DupA. Analysis of the gene sequence has 
indicated homology to the VirB4 ATPase which is a component of the VirB/D 
complex of type IV secretion systems known from bacteria such as 
Agrobacterium tumefaciens. Lu et al. (2005) showed that strains carrying dupA 
were linked to acid tolerance. As antral-predominant gastritis is associated with 
increased gastric acid secretion, the observed association between dupA and DUD 
may be reflective of a selective pressure in the gastric environment that favours 
growth of these strains. Whether DupA has a functional role in inducing the 
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development of DUD or if the association observed by previous studies is due to 
preferential colonisation of the antrum due to increased acid levels and antral- 
predominant gastritis is unknown. VirB4 homologues are components of type IV 
secretion systems (T4SS), suggesting that DupA may be part of another T4SS in 
the H. pylori genome. Therefore, it is possible that an as yet unidentified virulence 
determinant is translocated through this T4SS, which may have a role in inducing 
conditions in the gastric mucosa that increase the risk of developing DUD. 
As mentioned, other factors contribute to the progression of disease, including the 
vacA status of the colonising strain (Atherton et al., 1995; Basso et a!., 1998; 
Rhead et al., 2007). In the current study, ml-type strains were associated with 
increased colonisation densities in the corpus, among dupA+ strains. A trend 
towards increased density with ml and i 1-type strains was also observed in both 
the antrum and corpus among dupA- strains too. Previously, the virulent ml form 
of the toxin has been associated with increased colonisation densities (Han et a!., 
1999), suggesting that VacA may influence colonisation in the gastric mucosa. 
The mechanisms involved are not fully established, although it is possible that 
increased vacuolating activity induces leakage of key nutrients needed for 
bacterial growth and survival. 
There is a difficulty in establishing whether a particular virulence determinant is 
independently associated with influencing bacterial load. Strains frequently 
harbour more virulent forms of more than one virulence determinant, for example, 
vacA si/ml strains commonly express cagA. Therefore, a very large data set 
would need to be considered in order to analyse all combinations of H. pylori 
virulence factors. A way around these problems could be to perform in vitro 
studies. In contrast to in vivo data however, vacA status was not found to affect 
CFU counts when cultured with gastric epithelial cell lines in vitro. This may be 
due to the selective pressures in vivo, e. g. paucity of nutrients, that are not present 
in the in vitro model. 
Host factors such as cytokine production are also known to induce a gastric 
environment that is key for the development of GU and GC. Whether host 
immune responses are also related to H. pylori colonisation was assessed. The 
relationship between bacterial load and IL8 expression was not a simple linear 
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association. The majority of samples tested appeared to fall into a region of 
relatively low bacterial colonisation density and low IL8 expression. However, 
samples colonised with very high levels of H. pylori were also found to express 
low levels of IL8. Conversely, extremely high expression of IL8 was found in 
tissue samples for which low colonisation levels were measured. This suggests 
that the reciprocal relationship that was hypothesised may exist in extreme cases, 
and in most infected individuals a balance between inflanunation and colonisation 
exists. 
Interestingly, anti-inflammatory cytokine responses were associated with 
increased bacterial CFU counts in vitro but no association with bacterial load was 
observed in vivo. Our group have previously shown a significant positive 
association between IL10 expression and bacterial density (Robinson et al., 2008). 
However, this relationship did not hold when additional patient data were 
included. Cytokines such as IL-15 and IL-21 have previously been demonstrated 
to alter the suppressive functions of Tregs (Ben Ahmed et al., 2009; Peluso et al., 
2007), and may therefore alter the capability of suppressive cytokines to mediate 
bacterial survival, and hence colonisation density, in vivo. However, in the 
reductionist cell culture models used in this study, suppressive cytokines do have 
the capacity to induce epithelial responses that encourage bacterial growth. 
An important finding in this study was that Treg-associated gene expression levels 
in gastric antral biopsies were linked to the incidence of gastric atrophy and IM. 
These data suggest that increased Treg responses may be protective against the 
development of premalignant pathology, as well as PUD which we have 
previously shown (Robinson et al., 2008). As Treg-associated gene expression 
levels were negatively associated with inflammation, the mechanism behind such 
protection may involve dampening of the deleterious inflammatory response. 
Interestingly, dupA positive strains were associated with increased levels of 
FOXP3 mRNA expression, yet dupA has been associated with increased levels of 
IL8 in the gastric mucosa, and stimulation of the proinflammatory cytokine IL-12 
in vitro (Hussein et al., 2010). Further analysis of IL8 mRNA expression levels in 
the gastric mucosa showed no statistical association with dupA status. However, 
the recently reported polymorphic nature of the virulence determinant (Hussein et 
al., 2010) was not taken into consideration, and may explain the discrepancy 
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observed. Although our group have previously shown that increasing levels of IL- 
10 is associated with reduced Thi responses in vitro, it is not known if this is also 
true for FOXP3 expressing cells. It is possible that Tregs are recruited to sites of 
severe inflammation in the gastric mucosa in order to counteract the deleterious 
effects of inflammation, and therefore increased ThI responses may be found with 
increased FOXP3+ Treg responses. If pro- and anti-inflammatory responses are 
induced in response to dupA, then the outcome of infection with respect to the 
development of disease may be dependent on the overall Treg/Th 1 ratio, with 
disease developing when the immune response is skewed towards inflammation. 
This may also hold true for other bacterial factors such as cagA which is a known 
risk factor for the development of disease and induces IL-8 secretion (Brandt et 
al., 2005; Viala et al., 2004). In addition, it has recently been suggested that CagA 
may be linked to the induction of Treg responses (Chen & Blaser, 2007). 
Although bacterial burden is related to bacterial virulence determinants, which 
induce inflammation, bacterial and host cytokine responses are not directly 
responsible for killing bacteria. The host immune response utilises numerous 
mechanisms for the direct killing of bacteria, including the release of 
antimicrobial peptides (AMPs). H. pylori infection is associated with increased 
expression of numerous AMPs that have demonstrated bactericidal activity 
against the bacterium (George et at, 2003; Hase et at, 2003), yet infection 
persists. In the current study, we show H. pylori infection to be associated with 
reduced expression levels of hßDl in vivo and in vitro. This modulation was 
partly dependent on the cagPAI, and in line with this our group have now 
demonstrated an NFxB-dependent downregulation in vitro (manuscript in 
preparation). Furthermore, we have shown that bacterial load is negatively 
associated with expression of hßDi in gastric tissue, suggesting it may have 
bactericidal activity against H. pylori, and current work now shows the 
bactericidal activity of recombinant hßDI against H. pylori. The expression of 
hßDl is constitutive, reflecting the importance of the defensin in innate protection 
against infection. It is therefore possible that H. pylori has developed mechanisms 
to downregulate expression of the AMP in order to allow persistent infection. 
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Of interest is the synergistic relationship that has been observed between LL-37 
and hßD I. Hase et al. (2003) demonstrated little bactericidal activity of hßD 1 
against the H. pylori 26695 strain. However, in combination with LL-37, 
antimicrobial activity was significantly potentiated. Therefore, downregulation of 
h, BD] may benefit H pylori persistence not only directly through the function of 
h/D], but also in reducing the activity of LL-37 which also has antimicrobial 
activity against the bacterium (Hase et al., 2003). 
9.2 EXPERIMENTAL LIMITATIONS 
9.2.1 Patients and samples 
Samples in this study were collected from patients attending a routine upper GI 
endoscopy, who were referred for examination based on dyspeptic symptoms. The 
H. pylori negative control therefore may not be a true representation of an 
uninfected "normal" control group. Also, given the small sample size, it was not 
possible to match for parameters such as age and gender, which are known to 
affect immune responses. However, a wide age range and similar male: female 
ratios were found in the data set examined, and therefore these parameters were 
not anticipated to have an impact on data analysis. As mentioned, a major 
influence of the outcome of infection is host genetics, particularly polymorphisms 
in cytokine genes such as IL-iß (El-Omar et al., 2000; El-Omar et al., 2003). 
Although this was not covered in the current study, it would be interesting to see 
how such factors would relate to colonisation density and impact the observed 
association between disease and distribution of the bacterium in the gastric 
mucosa. In line with this, it would also be interesting to determine the acidity in 
the gastric corpus as demonstrated by Derakhshan et al. (2006). However, 
collection of these samples and human genotype analysis was not covered by the 
current ethics approval for this study. 
H. pylori infected patients were stratified based on the presence of disease at the 
time of endoscopy, and all others were categorised as having gastritis. However, 
this group may encompass patients that may develop disease later in life, and 
therefore investigation of parameters that may influence disease progression is 
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difficult. Importantly, it was possible to assess for atrophy and IM within this 
group, which are known risk determinants for the development of disease. Also, 
tissue samples were not collected from the duodenum although patients were 
stratified based on the presence of duodenal ulceration. This leaves the possibility 
that the immune responses in the duodenum may not reflect those in the stomach. 
It was not possible to perform all analyses on the same gastric tissue. In particular, 
histological parameters could not be assessed in the same tissue sample as other 
analyses. Therefore, sampling errors may have confounded the association 
studied. However, it was possible to assess bacterial load by qPCR and to quantify 
mRNA transcripts in the same tissue sample. Furthermore, in this study the 
analysis of Treg responses and pre-malignant pathology was assessed by RT-PCR 
and confirmed by flow cytometry, suggesting that sampling errors may not greatly 
impact association studies. Also, our group are now intending to use zoom 
endoscopy, which will allow for the identification of areas of atrophy during 
endoscopy and the collection of tissue from these areas, therefore minimising 
sampling errors. 
Importantly, it was not possible to assess the degree of patchy colonisation in the 
gastric mucosa, which may also introduce sampling errors. Investigation of 
patchiness in bacterial burden would require assessing a number of gastric tissue 
samples from the antrum and corpus. However, it was not possible to complete 
such an analysis based on ethical restrictions on the number of tissue samples 
collected. 
9.2.2 Bacterial virulence tvnin2 
The virulence status of the colonising strain was determined based on the presence 
or absence of the gene or the existence of specific allelic variants, but the presence 
of functional protein was not assessed. In the case of cagA, the functionality of the 
type IV secretion system should ideally also be considered, as the presence of the 
gene does not indicate delivery of functional protein into the cell. However, 
assessing CagA protein levels is labour intensive and involves culture of isolated 
strains and western blot analysis. An additional problem with this method is the 
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frequent difficulty in isolating H. pylori clinical isolates. Intactness of the 
CagPAI-encoded type IV secretion system can be measured by the IL-8 response, 
but again involves in vitro analysis of strains isolated from all samples tested in 
the study. The toxicity of CagA is dependent on the extent of tyrosine- 
phosphorylation (Argent et al., 2004), which was not determined for strains 
assessed in this study. 
As mentioned, the recent discovery of dupA polymorphisms (Hussein et al., 2010) 
highlights the limitation of typing for just the presence or absence of this 
virulence factor. Importantly, it is not known which forms of dupA are expressed 
as protein or if expression levels vary, making it difficult to assess the 
functionality of this virulence determinant. 
Therefore, time pressures limited the assessment of strain virulence to the 
presence or absence of the virulence gene in the current study. 
9.2.3 Investigation of the host immune response 
The quantification of mRNA transcripts by real time RT-PCR is a key tool for 
establishing how expression levels differ under certain conditions. However, 
mRNA levels may not always reflect the amount of protein produced. 
Furthermore, it was not possible to ascertain the cellular source of mRNA 
transcript expression using this method. This can be overcome to some extent by 
the use of flow cytometry, which was used in the current study to estimate the 
number of Tregs in the gastric mucosa and confirm the association between Treg- 
associated gene expression and the presence of atrophy and IM. 
9.2.4 In vitro culture assays 
As mentioned earlier, determination of bacterial CFU counts after the treatment of 
cultures with recombinant cytokine, or when investigating the effects of virulence 
determinants with mutant strains may be influenced by the culture conditions 
used. The use of serum-rich medium has been shown to support higher growth 
rates of H. pylori (Douraghi et al., 2010; Sainsus et al., 2008) which may mask 
small effects on bacterial numbers. 
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9.3 FUTURE WORK 
9.3.1 Further investigation of the relationship between colonisation 
density and H. nvlori virulence factors 
In vivo investigation of the distribution of the bacterium in the stomach suggested 
an association with dupA status of the infecting strain. To Rather confirm this 
relationship, we would need to determine the impact of strains carrying 
polymorphic variants of this virulence factor as well as dupA mutant constructs, 
which would be best studied in an animal model. The use of two-photon 
microscopy could be used to visualise the localisation of H. pylori in the stomach 
of mice or Mongolian gerbils to confirm the relationship between bacterial 
localisation and dupA status. A similar approach was used by Kao et al. (2010) 
who investigated the localisation of DCs in the stomachs of H. pylori infected 
mice. 
Another consideration is the relationship between acid secretion and bacterial 
localisation of dupA positive strains within the stomach. One way to assess this 
relationship would be to determine the patterns of colonisation that develop with 
dupA positive or negative strains in gastrin knock-out (GAS-KO) mice in 
comparison to wild-type mice. This may give insight as to the importance of 
acidity to DupA function. 
9.3.2 Further investigation of the relationship between bacterial density 
and the immune response 
The level of IL8 expression was shown to be related to bacterial density in the 
corpus, but IL-8 is not the only inflammatory cytokine that is upregulated during 
infection with H. pylori. Previous murine studies have demonstrated increased 
colonisation in IFNf-/" mice (Eaton et al., 2001 b). As IFNy is a hallmark cytokine 
released by Thl cells (Murphy & Reiner, 2002), the relationship between this 
cytokine and colonisation in the human gastric mucosa merits investigation. Also, 
numerous studies have now demonstrated the importance of Th 17 cells and IL- 17 
during H. pylori infection (Caruso et al., 2008; Luzza et al., 2000; Mizuno et al., 
2005) and therefore is also worth consideration with respect to bacterial load. 
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To further assess the inflammatory response, it may be important to determine the 
balance of Thi, Th2 and Th17 responses in the gastric mucosa. Although a Thl 
polarised immune response to H. pylori is widely accepted (Bamford et at, 1998; 
Karttunen et at, 1995; Mohammadi et at, 1996; Sommer et al., 1998), Th2 
responses are also induced, and the degree of polarisation may be related to 
colonisation (Goll et al., 2007). Evidence for the role of Th 17 in H. pylori 
infection is expanding, and a recent study in mice has demonstrated a negative 
correlation between Th17 cells and bacterial density (Kao et al., 2010); therefore 
meriting investigation in humans. 
Suppressive cytokines were not found to be associated with bacterial load in the 
antrum. Given that IL8 expression was related to bacterial density in the corpus 
but not the antrum, it would be interesting to investigate whether this was also 
true for anti-inflammatory cytokine expression. 
The immune response that is mounted during H. pylori infection is mixed, with 
upregulation of Thl, Th17 and Treg responses (Goll et al., 2007). Although no 
association was observed between Treg-associated gene expression levels and 
bacterial load, it is possible that the impact of these responses on density may be 
dependent on the predominant response, whether it is overwhelming inflammation 
or a skew towards a suppressive response. One approach to investigate this would 
be to determine the ratio of Thl and Treg cells in the gastric mucosa using flow 
cytometry. 
9.3.3 The relationshiu between immune responses and H. nvlori 
virulence determinants 
dupAI type strains have now been shown to be associated with increased IL- 12 
production in monocytic cells (Hussein et al., 2010). Whether dupAl has an 
impact on cytokine production in other immune cell types would be of interest. 
Also, given the association between FOXP3 expression levels and dupA+ cagA+ 
strains, it would be interesting to finther investigate the impact of these strains on 
suppressive responses in a larger data set. 
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Although we have shown in vitro culture models to be sufficient to determine the 
effects of dupA status on immune cells (Hussein et at, 2010), it is possible that 
localisation of the bacterium in the gastric mucosa may play a role in the function 
of this virulence factor, and may therefore have varying effects on cytokine 
expression depending on the site of infection. It may be useful to investigate this 
relationship in an animal model. 
The observed association between TGFBI expression and the vacA i-region status 
of the infecting strain also merits further investigation. Whether this relationship 
remains when additional samples are included should be investigated. Also, 
examining the effect of il- and i2-type strains on TGFBI expression in different 
cell lines is necessary in order to determine the extent of this relationship. 
9.3.4 Antimicrobial Dentides and colonisation density 
Too few samples were tested in order to determine if bacterial load estimated by 
qPCR was related to hßD1 expression levels, however histological analysis of H. 
pylori density did demonstrate a negative association. This relationship should be 
confirmed with qPCR in a larger data set as this technique was found to be a more 
accurate means of determining colonisation density (Chapter 3). 
Although a small difference in h/IDl expression was found with a H. pylori cagE 
mutant strain, this mutation did not account for most of the reduction in h/ID1 
expression observed. It is possible that another bacterial factor may be involved in 
regulating hßDI expression. Establishing the cellular compartment which induces 
such modulation would be useful in determining this bacterial factor. A similar 
approach to that used by Chakraborty et al. (2008) to determine the bacterial 
factor involved in modulating hßDI expression in Vibrio cholerae infection in 
vitro could be utilised. 
We have now shown that the modulation of hßDJ expression in gastric cell lines 
when infected with H. pylori is not specific to AGS cells, but was also observed in 
MKN7 cells. However, these are cell lines derived from tumour tissue. Given that 
the downregulation of hßD1 has also been reported in a number of cancers (Bose 
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et al., 2009; Wenghoefer et al., 2008), it may be more appropriate to confirm this 
relationship in primary gastric epithelial cells. This may also be useful for 
confirming the upregulation of LL37 during H. pylori infection as observed in 
gastric tissue. Determining a cell line that expresses detectable levels of LL37 is 
necessary to investigate the effects of this AMP on H. pylori colonisation. 
Chakraborty et al. (2008) detected LL37 expression in HT-29 cells. Also, 
identification of such a cell line would be ideal for assessing the relationship 
between hßDl and LL37. Based on a study by Hase et al. (2003) htDl may 
function to enhance the activity of LL-37. 
9.4 FINAL SUMMARY 
The data presented in this study demonstrate the complex relationship between H. 
pylori and its human host. This has implications for the overall infectious load in 
the gastric mucosa. In this study, the importance of colonisation density is 
highlighted, with the distribution of the bacterium in the stomach being associated 
with the disease that develops (summarised in Figure 9.2). This may be influenced 
by bacterial factors such as dupA. Whether density establishes an environment 
that drives disease progression, or if the gastric environment encourages the 
distribution of the bacterium is not clear. Further investigation using animal 
models is necessary to assess the factors that drive patterns of colonisation. While 
suppressive immune responses were not associated with bacterial burden, their 
role in H. pylori infection is likely to involve protecting the host against the 
deleterious effects of inflammation, and thus reduce the risk of developing 
precancerous changes in the stomach as well as peptic ulcer disease. Finally, the 
direct modulation of bacterial load is regulated through the expression of AMPs, 
but H. pylori can still persistently colonise the human stomach, possibly through 
modulating the expression of h/IDl. 
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Figure 9.2: Factors that influence the pattern of bacterial colonisation and 
contribute to H. pylori-associated disease progression. 
The current study has demonstrated that the pattern of colonisation is associated 
with disease. Antral-predominant colonisation was found to be associated with 
DU, whilst corpus-predominant colonisation was associated with GU. It is 
possible that a tight association exists between the level of acidity, the pattern of 
colonisation and gastritis. In this study, it is now shown that dupA status of the 
colonising strain may influence the development of DU. Disease development is 
also related to the number of Tregs in the gastric mucosa, which may have a 
protective role against gastric disease possibly through the modulation of 
inflammation. Tregs were not found to be associated with bacterial load. 
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11. APPENDIX 
11.1 Examples of histological findings in the H. priori 
infected gastric mucosa 
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Magnification 
Stain 
Used 
Description 
A 10 H&E Normal gastric mucosa (corpus) 
B 10 H&E Grade 1 inflammation, grade 1 IM (antrum) 
C 10 H&E Grade 2 inflammation (antrum) 
D 10 H&E Grade 3 inflammation (antrum) 
E 10 H&E Grade I inflammation (corpus) 
F 10 H&E Grade 2 inflammation (corpus) 
G 10 H&E Grade 3 Inflammation (corpus) 
H 100 TB Grade I H. pylori density (antrum) 
I 100 TB Grade 2 N. pylori density (antrum) 
J 100 TB Grade 3 H. pylori density (antrum) 
K 20 H&E Grade 2 activity (antrum) 
L 20 H&E Grade 2 activity (corpus) 
M 10 H&E Grade 1 atrophy (antrum) 
N 20 H&E Grade 3 atrophy (antrum) 
0 10 H&E Grade 2 IM (antrum) 
P 10 H&E Grade 3 IM and paneth cell metaplasia (antrum) 
Q 10 TB H. heilmanni (antrum) 
Table 11.1: Details of example slides 
Descriptions of the key histological findings are given for slides A-Q. Stains used 
include Heamotoxilin and eosin (H&E) for the visualisation of inflammation, 
activity, atrophy and intestinal metaplasia (IM), and Toluidine blue stain (TB) for 
the visualisation of H. pylori. Grading was base on the Sydney scoring system. 
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11.1 CALCULATING DNA CONCENTRATION 
AS GENOMES PER uL 
The molecular weight (MW) of a molecule of DNA l bp long is 678 daltons 
(average molecular mass). 
For a DNA template (standard) S bp long, MW = 678 xS 
Concentration of DNA template =C pgIpI 
=C pmoVµl 678xS 
c 
= 
678xSx1012 
Mot/Al 
_ 
Cx 6x1023 
molecules/µl 
678xSx1012 
ýpmo1= MWI 
[mol = 1012 pmol] 
[Imol 
= 6X 1023 molecules] 
If the template only contains 1 copy of the target sequence per molecule (e. g. PCR 
product or plasmid), then the above equation also equates to copies/µl, i. e.: 
Concentration of DNA template =Cx6x 
23 ) 
copies/µl 
678xSx10 
For concentration in `genomes' per µl, where there are n copies of the target gene 
per genome, divide above equation by n: 
Cx6x 10 2 
genomes/µl 
1012 xn 
This simplifies to: 
Cx6x 1023 
12 genomes/µl Sxn 678x10 
-Cx8.85 x 108) genomes/µ1 Sxn 
OR TemplateConcentration (pg/ul) x (8.85 x ion ) 
TemplateSize (bp)x Gene Copies perGenome 
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